Multiscale modelling of plant hormone signalling: auxin regulated lateral root emergence by Mellor, Nathan L.
Mellor, Nathan L. (2013) Multiscale modelling of plant 
hormone signalling: auxin regulated lateral root 
emergence. PhD thesis, University of Nottingham. 
Access from the University of Nottingham repository: 
http://eprints.nottingham.ac.uk/30420/1/NLMthesis_final.pdf
Copyright and reuse: 
The Nottingham ePrints service makes this work by researchers of the University of 
Nottingham available open access under the following conditions.
· Copyright and all moral rights to the version of the paper presented here belong to 
the individual author(s) and/or other copyright owners.
· To the extent reasonable and practicable the material made available in Nottingham 
ePrints has been checked for eligibility before being made available.
· Copies of full items can be used for personal research or study, educational, or not-
for-profit purposes without prior permission or charge provided that the authors, title 
and full bibliographic details are credited, a hyperlink and/or URL is given for the 
original metadata page and the content is not changed in any way.
· Quotations or similar reproductions must be sufficiently acknowledged.
Please see our full end user licence at: 
http://eprints.nottingham.ac.uk/end_user_agreement.pdf 
A note on versions: 
The version presented here may differ from the published version or from the version of 
record. If you wish to cite this item you are advised to consult the publisher’s version. Please 
see the repository url above for details on accessing the published version and note that 
access may require a subscription.
For more information, please contact eprints@nottingham.ac.uk
Multiscale Modelling of Plant Hormone
Signalling: Auxin Regulated Lateral Root
Emergence
Nathan Mellor
February 2013
Abstract
The formation of lateral roots is an important post-embryonic developmen-
tal process that allows plants to adapt to their environment via exploitation
of soil mineral resources. New lateral roots initiate as lateral root primordia
(LRP) in the pericycle cell layer adjacent to the central vascular tissue in
the primary root, and must pass through the outer cell layers of endodermis,
cortex and epidermis to emerge as mature roots. A key regulator of emer-
gence is the plant hormone auxin and it has been shown previously that in
Arabidopsis the auxin induced expression of the auxin influx carrier LAX3
in specific cortical cells over LRP is required for emergence to occur, as this
leads to the expression of cell wall remodelling enzymes such as polygalac-
turonase (PG). By developing mathematical models of auxin transport and
LAX3 expression the work in the thesis aims to test the existing concep-
tual models for lateral root emergence, and provide testable hypotheses for
the existence of additional gene regulatory components. An initial single
cell model demonstrates that hysteresis and bistability may explain the ex-
perimentally observed ‘all-or-nothing’ LAX3 spatial expression pattern in
cortical cells containing a gradient of auxin concentrations. By fitting model
parameters against experimental data, the model is then used to show that
some auxin homeostasis mechanism is present, with both endogenous and
exogenous sources of homeostasis investigated. The single cell model also
investigates the validity of several alternative gene regulatory networks for
LAX3, and its apparent repression by a key mediator of the auxin response,
ARF19. Finally, the model is extended to a multicellular context, in which
the auxin distribution from a simulated LRP source cell is used as a basis
for the expression of LAX3, leading to the expression of PG in specific cells
between which the LRP must pass.
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Chapter 1
Introduction
1.1 Biological Background
1.1.1 Motivation and objectives
Food security is defined by the World Health Organisation as ‘when all
people, at all times, have access to sufficient, safe and nutritious food for
a healthy life’ (World Health Organisation 2012a). They cite four basic
components to achieving this goal: availability, access, utilisation, and sta-
bility (World Health Organisation 2012b). Availability refers to the overall
quantity and consistency of food production, access refers to the presence
of adequate financial or practical means to acquire food, utilisation refers
to the proper use of food according to basic standards of nutrition and san-
itation, and stability refers to the volatility of the food supply to temporal
changes in conditions, such as sudden crises or seasonal shortages.
There are currently many major challenges to global food security, in-
cluding increasing demand due to population growth, the impact of climate
change, high or volatile food prices, and growing competition with biofuel
production for land use. The current predictions are for these challenges to
become more and more critical throughout the 21st century, with demand
for food projected to increase by 50% by 2030, and double by 2050 (BBSRC
2012). While many of the problems with food security may be political or so-
ciological in nature, the changes to water availabilty, temperature extremes,
and pest and disease distribution, brought about by climate change may be
addressed by science, with one of the stated aims of the BBSRC being ‘to
use the same amount of land to grow more food of greater nutritional value,
using less energy, water and pesticides whilst producing less waste’ (BBSRC
2012). Cereal crops, whether for use as feed for animals eaten as meat, or
used directly for consumption by humans, play a critical role in global food
production, with over 2000 million tonnes estimated to have been produced
worldwide in 2011/2012 (Food and Agriculture Organization of the United
Nations 2012). A key factor in crop yields is clearly the efficient utilisation
by crop plants of soil nutrient, water and mineral resources, and central to
this is an efficient root network (Lynch 1995; Smith and De Smet 2012).
Root systems perform several essential functions in the success of all crop
plants, including uptake of water and minerals, the provision of anchorage
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within the soil, and the establishment of biotic interactions in the rhizo-
sphere (Lopez-Bucio et al. 2003). Maximising a plant’s potential for growth
in a heterogenous environment therefore requires an extensive, but efficient,
exploration of the surrounding soil. Increasing the total root surface area
may be achieved by growth of the primary root via cell division near the
tip of the primary root, by the formation of root-hairs on the outer epider-
mal cells, or by the creation of lateral roots (Lopez-Bucio et al. 2003). The
first lateral roots branch from the primary root but, as those lateral roots
mature, laterals of laterals may be formed, and so on, creating a vast array
of potential root architectures (Lynch 1995). The better adapted a crop’s
root architecture is to a particular environment, the greater the potential
yield from that crop.
A plant’s root architecture is not entirely pre-defined by its genotype,
rather it is highly plastic and able to adapt to a range of environmental cues.
These include the content and distribution of minerals within the soil, such
as nitrogen, phosphorus, iron and sulphur, all of which have been shown to
alter root architecture, either by affecting primary root growth, the growth
of root hairs, or the formation of lateral roots (Lopez-Bucio et al. 2003;
Smith and De Smet 2012). In particular, low levels of phosphate are known
to increase the density of lateral root formation, while nitrogen is seen to
have an effect on lateral root elongation rather than the formation of new
laterals (Zhang and Forde 1998; Linkohr et al. 2002). Additional factors
affecting root architecture include the heterogeneity or ‘patchiness’ of the
soil matrix (Hinsinger et al. 2005; Hodge 2006), and biotic interactions, such
as those with either pathogens or mycorrhizae (Osmont et al. 2007).
There is a broad and on-going body of research into the effect of en-
vironmental cues on plant root systems, and how this affects agricultural
yields. The focus of this thesis however, is on a particular aspect of one
of the fundamental developmental processes that defines a plant’s root ar-
chitecture, that of the emergence of new lateral roots. Like much of plant
development, the growth of a new lateral root occurs post-embryonically
and is an example of organogenesis. While this organogenesis can occur in
response to exogenous cues from the environment, many of the endogenous
mechanisms by which it takes place remain unknown. As will be discussed
in more detail in Section 1.1.6, lateral roots are initiated in an inner cell
layer adjacent to the central vascular tissue of the primary root, and develop
via a series of cell divisions, which will ultimately form the new lateral root
with a new meristem at its tip (Peret et al. 2009a). Before the lateral root
can be fully formed, however, it must emerge through the outer cell layers
of the root, without damaging the primary root, or exposing the plant to
pathogens from the soil (Peret et al. 2009b). The number of cell layers
through which the lateral root must emerge varies with different species,
with three outer cell layers in the model plant species Arabidopsis thaliana
(Arabidopsis), and as many as 15 to 20 cell layers in cereal crops such as
rice and maize (Hochholdinger and Zimmermann 2008).
A better understanding of lateral root emergence will require an under-
standing of several inter-connected developmental processes. These include
the intracellular signalling and gene regulatory events that lead up to the
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expression of genes controlling emergence of new laterals, and how these
signalling events are arranged spatially by cell position within the root. In
particular, the plant hormone auxin is central to the current understand-
ing and conceptual models of how emergence is regulated, as described in
detail in Sections 1.1.3-1.1.6. In Swarup et al. (2008) it was proposed that
the focusing of auxin into particular cells near to the developing lateral root
leads to the expression of cell wall remodelling enzymes (CWREs) in these
cells, allowing for cell separation, and facilitating emergence between them
without further damage to root tissues. Mathematical modelling provides
a means by which this conceptual model may be investigated further, and
extended and refined in order to generate new hypotheses for testing. Since
much of the existing literature and data on emergence relate to Arabidop-
sis, this species is chosen as a basis for the models developed. However, as
discussed above, due to the importance of lateral root emergence on cereal
crops, it is desirable for the framework for the models to be easily trans-
ferable to species with different cellular structures of their primary roots.
The initial objectives for the work described in the thesis are therefore as
follows:
1. Develop a gene network scale model of the key genes and auxin sig-
nalling events involved in lateral root emergence in Arabidopsis.
2. Develop a tissue scale model of the spatial distribution of auxin leading
up to the expression of cell wall remodelling enzymes.
3. Combine the gene network and tissue scale models into a multi-scale
model, which may be transferable to the different spatial cellular struc-
tures found in cereal roots.
1.1.2 Plant root architecture and cellular structure
Before looking in more detail at the role of auxin in plant development
(Section 1.1.3), in particular its role in lateral root initiation, development
and emergence (Section 1.1.6), we first describe some basic aspects of plant
physiology important to the discussion, and compare the overall root archi-
tecture, morphology and cellular structure of Arabidopsis with cereals such
as rice and maize.
One of the important differences between plants and animal species is
the presence in plants of a cell wall made of cellulose, outside of the cell
membrane, between every cell. This provides a rigid cellular structure,
support and protection, and also a fixed matrix known as the apoplast,
within which water and other small molecules such as plant hormones may
travel. For a lateral root to emerge without damaging the primary root,
specific cell walls must be softened and separated, but this process must be
tightly controlled to maintain the integrity of the root.
In vascular plants there may be a secondary thickening of cell walls
with lignin, providing even more rigidity, and a means to transport water,
sugars, hormones and minerals over large distances. This vascular tissue
consists of xylem, which conducts water and other solutes from the root
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to the shoot and leaves, and phloem vessels, which conduct the products
of photosynthesis from the leaves to the tissues of the shoot and the root.
The plant embryo is part of the seed of a vascular plant and contains the
precursor to the shoot, known as the hypocotyl, the precursor to the primary
root, known as the radicle, and one or more cotyledons. Cotyledons form
the first leaves of the plant post-germination. If a plant has one cotyledon,
such as cereals or grasses, it is known as a monocot, if it has two cotyledons,
as does Arabidopsis, it is a dicot.
Following germination, growth occurs at meristems, which are the small
regions of the plant containing undifferentiated stem cells which are able to
divide. The meristem near the tip of the shoot is known as the shoot apical
meristem (SAM), while that near the tip of the primary root is the root
apical meristem (RAM). Growth of the primary root is determined by cell
division at the RAM. During the process of forming a lateral root, a new
meristem must be formed near the tip of the emerging root.
Lynch (1995) defines root morphology as the surface appearance of a
root system, including epidermal features such as root hairs, and also the
pattern of appearance of daughter roots from the main axis of the plant.
In general, cereals such as rice (Oryza sativa) and maize (Zea mays) have
a relatively complex root morphology, with several different types of root
present in addition to the primary root established during embryogenesis
(Hochholdinger et al. 2004; Hochholdinger and Zimmermann 2008). Both
maize and rice form shoot-borne roots, with those initiating below ground
known as crown roots and those initiating above ground known as brace
roots. In addition, maize has another type of root, known as seminal roots,
which originate from the scutellar node, between the primary root and the
mesocotyl, which is the section of the seedling between the primary root
and the developing shoot (Hochholdinger et al. 2004).
In comparison to cereals, and many other plant species, Arabidopsis has
a very simple root morphology, with the root system limited to the embry-
onic primary root, and laterals originating from the primary root. It is this
simplicity which makes Arabidopsis suitable for use as a model plant or-
ganism for detailed study. Many genetic mutants affecting different aspects
of root morphology have been identified, in both cereals and Arabidopsis.
In cereals these mutants can affect the formation of either shoot-borne or
lateral roots, primary root length, or formation of root hairs (for reviews,
see Hochholdinger et al. (2004), Hochholdinger and Zimmermann (2008),
Smith and De Smet (2012)). Mutants affecting lateral root formation in
Arabidopsis are discussed further in Section 1.1.6.
Though cereal roots are generally much larger in diameter than Ara-
bidopsis roots, the basic radial cellular structure of the primary root is
similar in both, with a central group of cells forming vascular tissue known
as the stele, surrounded by concentric rings of cell types, divided into four
layers, known as the pericycle, endodermis, cortex and epidermis (Figure
1.1, Peret et al. (2009b)). In both cases, the pericycle is a single layer of cells
surrounding the stele, the endodermis a single layer of cells surrounding the
pericycle, and the epidermis is the outer cell layer where the root hairs are
located on the outer surface of the root. The endodermis contains a band
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Figure 1.1: Cross section of Arabidopsis root without (A) and with (B) an
emerging lateral root primordium. The root is arranged in well
defined cell layers surrounding the central vascular tissue or stele.
Lateral root primordia initiate and develop in the innermost layer,
the pericycle, and to emerge as lateral roots must pass between
cells in the outer layers, endodermis, cortex, and epidermis. The
cell separation which allows for emergence is believed to be regu-
lated by auxin induced expression of cell wall remodelling enzymes
(CWREs) in specific cells in the outer cell layers. In cereals such
as rice (Oryza sativa) there are many more cell layers comprising
the outer cell layers, including the extra cell types exodermis and
schlerenchyma (C), presenting a greater barrier to emergence of lat-
eral root primordia (D) than in Arabidopsis. The Arabidopsis root
diameter is 100 µm, that for rice is 300 µm. (Reproduced from
Peret et al. (2009b).)
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of differentiated cell wall known as the Casparian strip, a protective barrier
which blocks passive flow of water and other solutes taken in by the root
into the vascular tissue, and therefore the rest of the plant.
The main differences in primary root anatomy between Arabidopsis and
cereals occur when comparing the composition and size of the stele, and
also the number of cells comprising the cortex. In Arabidopsis the stele
is generally much smaller than in cereals, with just two phloem poles and
two xylem poles, while in cereals there may be as many as 10 xylem and
10 phloem poles in the stele (Smith and De Smet 2012). New lateral roots
are initiated adjacent to alternating left-right xylem poles in Arabidopsis,
but adjacent to phloem poles in cereals. In addition, in cereals the initial
cells ultimately forming lateral roots may be in both the pericycle and the
endodermis, while in Arabidopsis all lateral roots are initiated in the peri-
cycle (Hochholdinger et al. 2004). In the context of lateral root emergence,
perhaps the most important difference between Arabidopsis and cereals is
the width of the cortex, which in cereals may consist of 10-15 cell layers,
compared to just a single cell layer in Arabidopsis (Hochholdinger and Zim-
mermann 2008). The multiple cortical cell layers found in cereals mean that
emergence of lateral roots through the outer tissues is likely to be a more
complex process than in Arabidopsis, where just one cortical cell layer must
be negotiated. Because of this, and the higher volume of data and litera-
ture available, we restrict the discussion from now on to root development
in Arabidopsis, in particular in response to the plant hormone auxin.
Figure 1.2 (Peret et al. 2009a) shows a longitudinal section of the tip of
an Arabidopsis root, showing the different cell types on the left, and the sites
of auxin maxima on the right. The apical meristem region is the primary
site of cell division and also contains the quiescent centre, which is a group
of cells at the centre of the dividing undifferentiated cells of the meristem
which themselves remain undivided. Above this is the basal meristem in
which there is both division and elongation, and the elongation zone itself,
which is the primary site of cell elongation and growth. Above the elon-
gation zone, about 500 µm from the root tip, is the differentiation zone,
in which the elongated cells differentiate into the mature root tissue as
organised in Figure 1.1 (Dolan et al. 1993). As shown in Figure 1.2 the ini-
tialisation of lateral roots occurs very early on following the initial divisions
in the apical meristem in response to maxima of the plant hormone auxin in
the basal meristem region. This phytohormone is central to many plant de-
velopmental processes, in particular in relation to lateral root development,
as discussed further in Sections 1.1.3-1.1.6
1.1.3 Auxin and plant development
Plant hormones
The development and growth of plants is regulated by a range of hormones,
small molecules synthesised within plant cells, acting as signals for develop-
mental changes to cells either local to the site of synthesis, or in cells at a
distance from the hormone source. There are several main classes of plant
hormones including auxin, cytokinin, brassinosteroids (BR), gibberellins or
11
Figure 1.2: (a.) Schematic overview of the different cell types and developmen-
tal zones near the tip of the Arabidopsis root tip. (b.) Sites of
auxin response maxima as detected by the DR5::GUS marker line.
(Reproduced from Peret et al. (2009a).)
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gibberellic acid (GA), abscisic acid (ABA), jasmonates or jasmonic acid
(JA) and strigolactones. These hormones may act alone, or in combination
with others to regulate a vast array of developmental processes (Depuydt
and Hardtke 2011; Durbak et al. 2012), with the means of signal perception
within the cell varying for different types of hormone (Santner and Estelle
2009; Shan et al. 2012). For example, brassinosteroids, ABA, and cytokinins
are perceived by receptors at the cell membrane, resulting in a signalling
cascade and transcription of target genes in the nucleus, while auxin, GA
and JA are shown to accelerate the degradation of a repressor of target
genes.
The hormones auxin, cytokinin, ethylene, ABA, BR, and GA have all
been shown to affect root growth in different and interacting ways (Benkova
and Hejtko 2009). Brassinosteroids are known mainly as promoters of or-
gan growth via cell division and expansion (Gudesblat and Russinova 2011),
with application of exogenous BR shown to increase the length of the pri-
mary root (Mussig et al. 2003). GA also regulates root growth by stimulat-
ing cell expansion in the endodermis, and this expansion limits the overall
growth of the primary root (Ubeda-Tomas et al. 2008). Cytokinins are
known to have a negative effect on root growth (Benkova and Hejtko 2009),
and the interaction between cytokinin and auxin regulates the size of the
root apical meristem (Nordstrom et al. 2004; Muraro et al. 2011).
Auxin
Of all the plant hormones, perhaps the best known and most studied is
auxin, and it is involved in almost every aspect of plant development (Wood-
ward and Bartel 2005; Teale et al. 2006; Benjamins and Scheres 2008). Per-
haps the earliest recorded observation of an effect of auxin is given in Darwin
and Darwin (1880), where the bending of grass coleoptiles towards the light,
or phototropism, was observed. This was later found to be due to the ac-
cumulation of auxin on the side of the shoot furthest from the light source,
promoting an increased growth rate on that side (Cholodny 1926; Went
1926). This effect of auxin in promoting growth in the shoot is reversed in
the root, where it is shown to inhibit growth. This inhibitory effect on root
growth is seen during gravitropism, the bending of roots toward a gravis-
timulus, where auxin accumulates on the lower side of the root, inhibiting
growth on that side and bending the root downwards (Bennett et al. 1996).
In addition to tropisms, auxin is a key regulator in many important
developmental processes, including embryo patterning (Friml et al. 2003;
Jenik et al. 2007), leaf vein formation (Sieburth 1999; Rolland-Lagan and
Prusinkiewicz 2005), and phyllotaxis (Bohn-Courseau 2010), the ordered
formation of new leaves at the shoot apical meristem. In the root, in ad-
dition to its role in gravitropism (Bennett et al. 1996) and in controlling
the size of the RAM (Sabatini et al. 1999), auxin is involved in root hair
formation (Jones et al. 2009), and in every aspect of lateral root initiation,
development and emergence (Section 1.1.6). Before discussing the role of
auxin in lateral root development in detail, however, it is helpful to outline
the existing knowledge on the mechanisms by which auxin is transported
within the plant (Section 1.1.4), and how it is perceived by the cell, lead-
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ing to the expression of genes which result in the numerous developmental
changes described above (Section 1.1.5).
1.1.4 Auxin biosynthesis, metabolism and transport
The most common endogenous form of auxin is indole-3-acetic acid (IAA),
of a similar structure to the amino acid tryptophan (Ljung et al. 2002),
though other endogenous auxins including indole-3-butyric acid (IBA), 4-
chloroindole-3-acetic acid (4-Cl-IAA) and phenylacetic acid (PAA) are present
in the plant, and synthetic auxins such as 2,4-dichlorophenoxy acetic acid
(2,4-D) and naphthalene-1-acetic acid (NAA) may also be used experimen-
tally (Simon and Petresek 2011). The primary site of auxin synthesis is in
the leaves, though all tissues within seedlings may synthesise some auxin
(Ljung et al. 2001).
In general, the developmental changes brought about by auxin occur due
to the establishment of concentration gradients within tissues, with morpho-
logical changes usually occurring at the site of auxin maxima, but in some
cases at auxin minima (Sorefan et al. 2009). Though the principal deter-
minant of the location of these maxima and minima is transport of auxin
from source to site of action, they may also be controlled in part by local
auxin biosynthesis and metabolism (Normanly 2010). Both tryptophan-
dependent and tryptophan-independent auxin biosynthesis pathways have
been characterised (Ljung et al. 2002; Normanly 2010), with many of the
genes found to regulate these pathways, in Arabidopsis as well as other
species, reviewed in Mano and Nemoto (2012). Ljung et al. (2002) de-
scribes several metabolic pathways by which the biologically active pool
of auxin may be decreased, including oxidisation and conjugation of auxin
to amino acids, peptides or sugars. In particular, a set of auxin respon-
sive genes known as the GH3 family has been shown to conjugate auxin to
amino acids (Staswick et al. 2005), which may provide an auto-regulatory or
homeostatic mechanism by which cells can buffer high auxin concentrations.
The best described mechanism by which plants establish and maintain
auxin gradients within organs and tissues, is by moving auxin from the
source of biosynthesis to the site of activity. This is achieved by the or-
ganised polar localisation of auxin transporters on plant cell membranes,
resulting in the directional flow of auxin within and between organs (Pe-
tresek and Friml 2009; Zazimalova et al. 2010). As a weak acid, auxin is
present in both anionic and protonated forms, the proportions of which are
determined by the local pH. The apoplast is relatively acidic (pH ≈ 5.5) and
so there is a significant proportion of auxin in the protonated form, while
in the cytoplasm, with neutral pH, most auxin is present in the anionic
form. This is important since auxin can only diffuse freely across the cell
membrane in its protonated form, and in the anionic form active carriers
for auxin are needed for it to cross the cell membrane, meaning that auxin
is able to diffuse freely from the apoplast into the cytoplasm, but active
eﬄux is required to move auxin from cytoplasm to apoplast (Kramer and
Bennett 2006). This acid trapping in conjunction with polar or directional
localisation of transporters allows the plant to move auxin over long dis-
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tances within its tissues, and establish gradients within organs triggering
developmental changes.
Auxin transporters are either eﬄux (from cell to apoplast) or influx
(from apoplast to cell) carriers, with the main class of eﬄux carriers being
the PIN gene family (Paponov et al. 2005), and the main class of influx
carriers being the AUX/LAX gene family (Peret et al. 2012). An additional
class of eﬄux carriers, the ABCB transporters, have also been shown to
have a role in plant development (Petresek and Friml 2009). There are
eight members of the PIN family in Arabidopsis, PIN1-8, which have been
shown to have different and overlapping expression patterns and functions
in development. Perhaps the most the important of these is PIN1, which
is the primary PIN facilitating polar auxin transport from shoot to root
(Glweiler et al. 1998), as well as having a role in phyllotaxis at the shoot
apical meristem (SAM) (Reinhardt et al. 2003; Benkova et al. 2003), the
establishment of apical-basal cell polarity in developing embryos (Weijers
et al. 2005), leaf vascular patterning (Scarpella et al. 2006), and in the
development of lateral roots, along with PIN2 and PIN3 (Benkova et al.
2003). PIN2 (Muller et al. 1998), PIN3 (Friml et al. 2002b), along with
PIN7 (Blilou et al. 2005), also have a role in root gravitropism, while PIN4
is involved in patterning at the root apical meristem (Friml et al. 2002a).
Rather than localisation at the cell membrane causing auxin eﬄux out of
the cell, PIN5 (Mravec et al. 2009) and PIN8 (Ding et al. 2012) are localised
at the ER (endoplasmic reticulum) so that auxin may be compartmentalised
within the cell, suggesting a role for PIN expression in intracellular auxin
homeostasis.
The best known auxin influx carrier is AUX1, shown to have a role
in gravitropism (Bennett et al. 1996), phyllotactic patterning (Bainbridge
et al. 2008), and root hair growth (Jones et al. 2009). In contrast to PINs
which are usually localised to a particular face, or faces of a cell, giving di-
rectionality to the flow of auxin, influx carriers such as AUX1 are generally
localised to all faces of a cell, restricting the spread of auxin within the do-
main of expression. In addition to AUX1, there are three other members of
the AUX/LAX family of influx carriers, LAX1, LAX2 and LAX3. LAX1-3
are shown to act redundantly with AUX1 to maintain regular phyllotactic
patterning (Bainbridge et al. 2008), while LAX2 is shown to regulate vascu-
lar patterning in cotyledons (Peret et al. 2012). Of particular interest to the
study of lateral roots, however, is the role of LAX3 in facilitating emergence
(Swarup et al. 2008), discussed in detail in Section 1.1.6.
As with the AUX/LAX influx carriers, and in contrast to the PIN ef-
flux carriers, the ABCB eﬄux carriers are generally localised to all cell
membranes. Since they are eﬄux carriers, they are likely to prevent auxin
accumulating in the cells where they are expressed. In particular ABCB19
and ABCB4 are expressed in the stele and the epidermis above the RAM,
and ABCB1 and ABCB19 are expressed below the SAM (Petresek and Friml
2009). In addition, both ABCB1 and ABCB19 are shown to be involved in
the initiation of lateral roots (Mravec et al. 2008).
Figure 1.3 summarises the location of the different carriers within root
tissues. In the primary root this forms the basis of the auxin reflux/ re-
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Figure 1.3: (A) Schematic overview of the direction of flow of auxin in the root
and shoot of Arabidopsis. Location of auxin transporters in the
root tip (B), developing lateral roots (C), and at the shoot apical
meristem (D). Arrows indicate auxin flow due to a particular trans-
porter, while the dotted lines represent the presence of transporters
with no apparent polarity. (Reproduced from Petresek and Friml
(2009))
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verse fountain model (Petresek and Friml 2009; Peer et al. 2011), in which
polar auxin transport mediated by PIN1 transports auxin through the vas-
cular tissue towards the root tip, PINs 3,4 and 7 combine to move auxin
through the columella and laterally into the root cap, and PIN2 and AUX1
in the cortex and epidermis transport auxin back towards the shoot. This
reverse fountain model is partially mimicked during the development of a
new lateral root, with PIN1 directing auxin towards the new root tip, and
PIN2 directing auxin laterally and away from the root tip. Before looking
in more detail at how auxin and auxin transport regulate the development
and emergence of lateral roots in Section 1.1.6, the mechanisms by which
auxin signals are detected and acted upon by plant cells are described in
Section 1.1.5.
1.1.5 Auxin signalling and gene activation
The most established conceptual model for auxin signalling involves the in-
teraction of two gene families, the ARFs and the Aux/IAAs (Overvoorde
et al. 2005; Okushima et al. 2005; Teale et al. 2006). The ARFs may be
either transcriptional activators or repressors and, in the absence of auxin,
the Aux/IAAs are able to dimerise with the activating ARFs and repress
transcription. In the presence of an auxin signal, however, the degrada-
tion of the Aux/IAAs is accelerated and the ARFs are free to activate a
set of context-dependent response genes, leading to a range of developmen-
tal changes (Figure 1.4). Auxin is perceived in the cell via binding with
a receptor complex, SCF TIR1 (TIR1). The Aux/IAAs then bind with the
TIR1-auxin complex, and are targeted for degradation. Though an addi-
tional possible auxin receptor has been identified, ABP1, which may provide
a mechanism for a more rapid auxin response than the SCF TIR1 receptor
(Sauer and Kleine-Vehn 2011), it remains relatively poorly understood. Be-
cause of this, the attention of this thesis is restricted to the transcriptional
changes brought about by auxin signalling via the SCF TIR1 pathway.
The SCF TIR1 complex is an ubiquitin (Ub) protein ligase, meaning that
it catalyses the conjugation of a chain of polymerised Ub to its binding
substrate, in this case the Aux/IAAs. Once ubiquitinated in this way, the
proteins are then targeted for degradation by the 26s proteasome (Mockaitis
and Estelle 2008). This interaction between TIR1 and Aux/IAA is shown to
be dependent on auxin (Gray et al. 2001; Dharmasiri et al. 2003), and this
occurs due to the direct binding of auxin to the TIR1 receptor (Dharmasiri
et al. 2005; Kepinski and Leyser 2005). Furthermore, it is shown that the
binding of auxin to TIR1 facilitates the binding of Aux/IAAs to the TIR1
receptors, thus forming a TIR1-auxin-Aux/IAA complex (Tan et al. 2007).
Though TIR1 was the first such receptor to be found, there is a family
of genes in Arabidopsis with high sequence similarity, named AFB1-AFB5
(Mockaitis and Estelle 2008). AFB1-AFB3 were shown to largely share
expression domains with TIR1, and function redundantly in mediating the
auxin response.
The Aux/IAA are a family of short-lived nuclear proteins, of which there
are 29 identified in Arabidopsis, named IAA1-IAA20 and IAA26-IAA34,
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Figure 1.4: Auxin binds with the SCF TIR1 complex, which is then able to
bind Aux/IAA. The Aux/IAAs are then be ubiquitinated and tar-
geted for degradation by the 26S proteasome. The ARFs, free from
dimerisation with Aux/IAAs, are then able to activate auxin re-
sponsive genes. When Aux/IAA is bound to on the target gene
promoter ARF transcription is repressed. Unless stated the arrows
represent binding of the different biomolecular complexes. (Figure
adapted from Middleton et al. (2010))
which have a mostly conserved modular structure consisting of four domains
(I-IV), in addition to a nuclear localisation sequence (Abel et al. 1994; Reed
2001; Overvoorde et al. 2005). Domain I gives the Aux/IAAs their ability
to repress transcription (Tiwari et al. 2004), and in IAA12 this domain
was shown to interact with the co-repressor TOPLESS (TPL), TPL being
required to repress auxin responsive genes (Szemenyei et al. 2008). Domain
II is required for interaction with the auxin receptor TIR1, and so it is this
domain which causes the degradation of Aux/IAAs in the presence of auxin
(Worley et al. 2000; Gray et al. 2001; Ouellet et al. 2001). In Brunoud
et al. (2012), domain II of IAA28 was fused to the fast maturing fluorescent
protein VENUS, to create a rapidly responding sensor for auxin with cellular
resolution. Two of the Aux/IAAs, IAA20 and IAA30, lack a functional
domain II and so are not responsive to auxin, though the physiological role
for this is unclear (Sato and Yamamoto 2008). The final two domains, III
and IV, are required for dimerisation with other Aux/IAAs (Kim et al.
1997) and with ARFs (Ulmasov et al. 1997a). The binding with ARFs is
central to the conceptual model of auxin-mediated de-repression of ARFs
by degradation of the Aux/IAAs.
The ARFs are a large gene family of transcription factors with 23 mem-
bers, named ARF1-ARF23 and, as with the Aux/IAAs, they have a highly
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conserved four domain structure (Okushima et al. 2005). Domains III and
IV are similar to those found in the Aux/IAAs, and allow for dimerisation
with both other ARFs and with Aux/IAAs (Ulmasov et al. 1997a, 1999a).
Domain I is a DNA binding domain, allowing for the binding by ARFs to
the DNA sequence TGTCTC on gene promoters, known as auxin response
elements (AuxREs) (Ulmasov et al. 1997a). The gene sequence of domain II
is thought to determine whether the ARF acts as a transcriptional activator
or repressor (Ulmasov et al. 1999b; Tiwari et al. 2003). Those ARFs with a
domain II rich in glutamine, serine and leucine residues (ARF5-ARF8 and
ARF19) are thought to act as transcriptional activators, while the remain-
ing ARFs are thought to act as repressors, with the exception of ARF23
which lacks a domain II altogether (Guilfoyle and Hagen 2007). ARF3,
ARF13 and ARF17 have a repressing domain II but lack domains III and
IV so cannot interact with Aux/IAAs and other ARFs in the usual way.
Among the first downstream targets of the activating or positive ARFs
are the Aux/IAAs (Abel et al. 1994, 1995; Abel and Theologis 1996), mean-
ing that there is a negative feedback on the auxin response. This is due to
the increased Aux/IAA expression leading to increased Aux/IAA protein
dimerisation and subsequent repression of ARF target genes. Other classes
of genes known to respond rapidly to auxin are the GH3s and the SAURs
(Abel and Theologis 1996). The GH3s have been shown to conjugate amino
acids to auxin and other plant hormones such as jasmonic or salicylic acid,
and so may play a role in auxin homeostasis and other signalling pathways
(Staswick et al. 2005). The role of the SAURs, however, remains unknown
(Okushima et al. 2005).
The size of the Aux/IAA and ARF gene families (29 and 23 members
respectively) means that there are a large number of possible interactions
between the key players in the auxin response. If different combinations
of transcriptional activators and repressors are present in different tissues
in the plant, this may account for the diverse range of developmental re-
sponses regulated by auxin (Lokerse and Weijers 2009). In particular, the
specificity of different ARFs for different gene promoters, and the spatial
and transcriptional regulation of different ARFs is likely to account for much
of the variation in auxin response. A spatial expression map of the ARFs
in the Arabidopsis root tip and developing embryo is given in Rademacher
et al. (2011). Despite the potential number and complexity of interactions
between the Aux/IAAs and ARFs, a study of all the possible connections
using a yeast two-hybrid assay, as performed by Vernoux et al. (2011), re-
veals that certain modes of interactivity between the different classes of
proteins occur, rather than full connectivity between every protein. Divid-
ing the ARFs into positive or activating (ARF+) and negative or repressing
(ARF−) ARFs, it is observed that by far the most common interactions are
between the Aux/IAAs and the ARF+, and between pairs of Aux/IAAs.
The ARF− did not show high connectivity with each other, or with either
the Aux/IAA or the ARF+. Because of this, it is hypothesised that the
ARF− act independently of the Aux/IAA ARF+ auxin signalling system
described above.
Via the study of mutant plant phenotypes, many Aux/IAAs and ARFs
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have been identified as having important roles in the auxin response dur-
ing a variety of developmental processes. For the Aux/IAAs, the mutants
showing greatest developmental defects are gain of function mutants, which
have mutations in domain II, meaning they are no longer degraded in re-
sponse to auxin, and so repression of the downstream targets remains with
or without an auxin signal. Examples of gain of function Aux/IAA mu-
tants include shy2/iaa3, which affects lateral root formation, gravitopic
response, hypocotyl length, and root curvature (Tian and Reed 1999),
bdl/iaa12 in which the root meristem fails to form during embryogene-
sis (Hamann et al. 2002), and slr/iaa14 or solitary root, in which lateral
root formation is blocked entirely (Fukaki et al. 2002). In general, loss
of function or knockout mutants in Aux/IAAs do not show obvious phe-
notypic differences to wild type, most likely due to redundancy between
the Aux/IAAs (Okushima et al. 2005). Loss of function mutants in the
ARFs include arf3/ett, which affects gynoecium (the seed bearing organ
in flowers) patterning (Nemhauser et al. 2000), arf5/mp, which has de-
fects in the embryo and vascular patterning (Hardtke and Berleth 1998),
and arf7/nph4/msg1/tir5, which shows a range of developmental defects
(Okushima et al. 2005). ARF7 is also shown to affect lateral root formation
in conjunction with ARF19 (Okushima et al. 2007), as will be discussed
further in Section 1.1.6.
1.1.6 Lateral root development in Arabidopsis
In Arabidopsis, lateral roots originate from cells within the pericycle cell
layer, which undergo a series of ordered cell divisions and develop into lateral
root primordia (LRP) (Peret et al. 2009a). As the LRP grow they must pass
between cells in the outer cell layers in order to emerge and develop into
a mature lateral root (Peret et al. 2009b). Though the different processes
in lateral root development are continuous and interlinked, it is helpful to
divide them into three sections for study, namely priming, patterning and
emergence, all of which are strongly regulated by auxin. Priming refers to
the identification and marking of specific pericycle founder cells in the basal
meristem to go on and develop into LRP, patterning refers to the initiation
and regulation of divisions and growth of LRP, and emergence refers to
the programming of the outer cell layers to allow for the passing of LRP
between them as they grow.
Priming
As shown in Figure 1.1, lateral roots originate in the pericycle cell layer,
the cell layer surrounding the stele. However, in addition to this, the peri-
cycle can be divided into two distinct cell types with diarch symmetry (i.e.
there are two right-angled intersecting planes of symmety), with those cells
adjacent to the xylem referred to as the xylem pole pericycle (XPP), and
those adjacent to the phloem referred to as phloem pole pericycle (PPP),
and it is only the XPP that have the potential to divide and from which
lateral roots develop (Parizot et al. 2008). De Smet et al. (2007) showed
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that in general, there is an alternate left-right pattern to lateral root ini-
tiation sites correlating to bends formed by lateral waving of the root as
it grows. This left-right lateral root pattern was found to be dependent
on the auxin influx carrier AUX1, which is also required for gravitropism,
suggesting the priming of lateral roots is regulated by auxin. Furthermore,
regular oscillations in auxin response with a period of 15 hours were de-
tected in the basal meristem using the auxin reporter gene DR5 (Ulmasov
et al. 1997b), correlating with the frequency of future lateral root produc-
tion. These oscillatory auxin maxima were later shown by De Rybel et al.
(2010) to correlate with the expression of the transcription factor GATA23,
which in turn was shown to be dependent on auxin signalling mediated by
the degradation of IAA28 and activation by one or all of ARF5, 6, 7, 8 and
19. It is also possible for the priming of lateral root founder cells to occur
outside of the basal meristem, following experimentally induced local auxin
production, showing that auxin alone is sufficient to prime cells to form new
lateral roots (Dubrovsky et al. 2008).
Patterning
Figure 1.5: (a) Lateral roots originate in the pericycle cell layer adjacent to
the central stele in Arabidopsis. (b) Cartoon of the eight stages
of LRP development as defined by Malamy and Benfey (1997). (c)
Cartoon of the auxin response maxima as detected by Benkova et al.
(2003) using the DR5:GUS reporter gene. (d) Aniline-blue stained
roots showing the celluar structure at each developmental stage.
(Reproduced from Peret et al. (2009a).)
LRP are initiated by the migration of the nucleii of two primed cells in
the same longitudinal file of XPP cells to their shared cell wall (De Smet
et al. 2007). Following this there is a series of anticlinal (perpendicular
to the primary root axis) cell divisions, creating what is is referred to as
a stage I primordium, of up to ten cells (Malamy and Benfey 1997), as
shown in Figure 1.5. The next set of divisions are periclinal (parallel to
the primary root axis), creating a stage II primordium with two layers.
A sequential series of periclinal and anticlinal divisions during stages III-
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VII, as defined by Malamy and Benfey (1997) and shown in Figure 1.5,
result in the gradual formation of a dome structure, until the primordium
emerges through the outer tissue layers at stage VIII. Though the priming
of lateral roots occurs in the basal meristem less than 1mm from the root
tip, the initial stage I divisions occur several millimetres from the RAM,
and the first fully emerged lateral roots appear around 20mm from the root
apex (Casimiro et al. 2001). Throughout all stages of development an auxin
maximum is maintained at the tip of developing LRP (Benkova et al. 2003).
As with the priming of lateral roots, auxin is shown to have an im-
portant role in regulating the initiation and patterning of the developing
LRP (Peret et al. 2009a). The gain of function IAA14 mutant slr-1, with
a stabilised IAA14 insensitive to degradation by auxin is shown to fail to
initiate lateral roots (Fukaki et al. 2002), and have impaired expression of
cell-cycle genes (Vanneste et al. 2005). A similar phenotype is observed in
the arf7 arf19 double knock out mutant (Okushima et al. 2005; Wilmoth
et al. 2005), and the interaction between IAA14 and both ARF7 and ARF19
is observed in a yeast two-hybrid assay (Fukaki et al. 2005), suggesting that
an auxin signalling module involving ARF7, ARF19 and IAA14 is impor-
tant for lateral root patterning. Overexpression of the transcription factors
LDB16 and LDB29 was shown to rescue the mutant phenotypes of slr-1
and arf7 arf19 and, since the promoters of both LDB16 and LDB29 have
ARF binding sites, it is likely that these transcription factors are direct
targets of an ARF7 ARF19 auxin signalling module regulating lateral root
patterning and development (Okushima et al. 2007). Another component
in the development of lateral root primordia is the hormone cytokinin, ele-
vated levels of which appear to disrupt normal cell division and patterning
in the primordia by perturbing the expression of PIN eﬄux carriers, so pre-
venting the formation of auxin gradients (Laplaze et al. 2007). Finally, the
expression of a receptor-like kinase ACR4 is shown to be needed to restrict
divisions in the cells flanking the primordia, and to prevent development of
ectopic lateral roots (De Smet et al. 2008).
Emergence
In order for lateral roots to emerge from their site of initiation in the XPP,
they must first pass through the outer cell layers of the endodermis, cortex
and epidermis (Figure 1.1). In Arabidopsis these tissue types consist of one
cell layer each, and the process of emergence presents a major disruption
to the local structure of the primary root (Figure 1.6, Peret et al. (2009b)).
For successful emergence, the LRP must be able to pass between cells in
the outer layers without damaging the surrounding tissue. This requires
the softening and separation of only the the specific cells between which the
LRP must pass, and recent evidence shows that this cell separation process
is highly regulated by auxin (Peret et al. 2009b). In cereals, the cortical
tissue may consist of between 10 and 15 cell layers, presenting a even greater
biomechanical challenge (Hochholdinger and Zimmermann 2008).
The link between auxin and cell separation was established by Boerjan
et al. (1995), with the auxin over-producing mutant superroot sur1 shown
to have widespread separation of cells in the epidermal and cortical cell lay-
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Figure 1.6: Environment scanning electron microscopy (ESEM) of 5 to 7 day
old Arabidopsis seedlings; scale bars are 20 µm. Before emergence
the epidermal cells are tighly attached (A), before detaching and
separating during emergence (B),(C). Even after the lateral root is
fully emerged, gaps, as shown by the small arrows, remain between
the separated cells (D). (Reproduced from Peret et al. (2009b).)
ers in both the root and the hypocotyl, in addition to excessive numbers of
lateral roots. In contrast to lateral root priming and initiation, the source of
auxin required for emergence is demonstrated to be derived from the shoot,
with plants with aerial tissue removed having fewer emerged LRP, while
the number of LRP initiated remains unchanged (Bhalerao et al. 2002).
The main mechanism by which auxin induces cell separation is proposed
to be through the expression of a range of cell wall remodelling enzymes
(CWREs), several of which, including pectate lyase, pectin methyl esterase,
expansin and β-xylosidase, were shown to be induced following auxin treat-
ment (Laskowski et al. 2006). More recently, several CWREs were found
to be expressed locally to the specific cells in the outer tissues overlying
LRP (Peret et al. 2009b). In particular, polygalacturonase (PG), a set of
CWREs known to cleave pectin polymers in the cell wall (Kim et al. 2006),
and have a role in cell separation in floral organs (Ogawa et al. 2009),
is expressed in the outer cell layers in front of developing LRP (Gonzlez-
Carranza et al. 2007; Swarup et al. 2008). Other CWREs with a similar
expression pattern during emergence which may be involed in separation
include xyloglucan endotransglucosylase/hydrolase (XTR6), pectate lyase
(PLA2) and a subtilisin-like protease (AIR3) (Swarup et al. 2008).
LAX3 and emergence
As described above, the ARF7/ARF19 and IAA14 auxin signalling module
is known to be an important regulator of LRP initiation and development
(Fukaki et al. 2002; Okushima et al. 2005; Fukaki et al. 2005). However, due
to the lack of developing primordia in the slr-1 and arf7arf19 mutants, its
additional role in lateral root emergence was not noted until the publication
by Swarup et al. (2008), in which the importance of the auxin influx carrier
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LAX3 on emergence was described. LAX3 is a member of the same auxin
influx carrier family as AUX1 and, while AUX1 is shown to promote LRP
initiation (Marchant et al. 2002; De Smet et al. 2007), LAX3 is shown to
promote emergence (Swarup et al. 2008). In lax3 mutant plants, though
there is an increased frequency of LRP compared to wild type, the ability of
these LRP to emerge is significantly impaired. Genetic markers show that
LAX3 expression in the root is limited to the stele and specific cortical and
epidermal cells overlying developing LRP (Figure 1.7). Furthermore, this
Figure 1.7: Spatial expression of LAX3, detected using the LAX3:GUS marker
line in (a) seedling root stele, (b) exanding root stele cells, (c) stele
in radial cross section of root, (d) stele of root with emerged lateral
root, (e) root section with stage I primordium, (f) stage II pri-
mordium (g) stage V primordium and (h) stage VII primordium.
From stage II onwards LAX3:GUS is visible in the cortical cells
over the developing LRP. LAX3pro:LAX3-YFP expression in corti-
cal cells above (i) stage III, (j) stage V and (k) stage VII primordia.
(l) LAX3pro:LAX3-YFP expression in epidermal cells separating
to allow for emergence of LRP. (Reproduced from Swarup et al.
(2008).)
restriction of LAX3 expression outside of the stele to cells directly in front
of LRP matches that seen for the CWREs, PG, XTR6, PLA2 and AIR3,
and expression of CWREs in these cells is reduced in the lax3 mutant. A
link between auxin and the expression of CWREs facilitating emergence
is given by the inducibility of LAX3 throughout the cortex and epidermis
following treatment with exogenous auxin (1 µM), and the dependence
of PG expression and normal emergence on a supply of auxin from the
shoot. This is corroborated by qRT-PCR data which shows elevated mRNA
expression in LAX3, PG and other CWREs following auxin treatment, and
reduced induction of the CWREs in the lax3 mutant. Evidence that the
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auxin maximum at the tip of the developing LRP is the source of the signal
that programmes cells in the outer layers to express CWREs and facilitate
emergence is given by the enhanced rate of emergence in the pin2 mutant,
which has greater accumulation of auxin at its tip. Finally, the role of the
ARF7/ARF19 and IAA14 auxin signalling module is confirmed by the lack
of induction of LAX3 in both the slr-1 and arf7arf19 mutants.
As well as the ARF7/ARF19 dependent expression of LAX3 and CWREs
in the cortex and epidermis, the expression of IAA3 in the endodermis is
also shown to regulate lateral root emergence (Swarup et al. 2008). In the
loss of function IAA3 mutant allele shy2-24 emergence is accelerated, while
in shy2, a gain of function IAA3 mutant, emergence is delayed and induc-
tion of the CWREs GLH17 and PLA2 following auxin treatment is reduced.
On the other hand, IAA14 does not appear to regulate the auxin response
in the endodermis, with the expression of the auxin response reporter gene
DR5 remaining unaffected in the stabilised IAA14 mutant slr-1. Because of
this, the degradation of IAA3 in the endodermis leading to the expression
of CWREs is hypothesised to facilitate emergence through the endodermis,
though the ARF activator or activators paired with IAA3 in this context
are undetermined.
The various lines of evidence given by Swarup et al. (2008) and de-
scribed above lead to the proposal of the conceptual model shown in Figure
1.8. The auxin maximum at the centre of the LRP results in elevated auxin
in the adjacent endodermal cell, degrading IAA3 and resulting in the acti-
vation of CWREs. Auxin is also elevated in the nearest cortical cell(s), but
here IAA14 is degraded, inducing the expression of LAX3 via activation by
ARF7/ARF19. Positive feedback on auxin in the cortical cell caused by
influx from LAX3 activity elevates auxin concentration further, sufficient
for the expression of CWREs. This expression of CWREs in the endoder-
mis and cortex facilitates the emergence of the primordia through these cell
layers, and moves the source of auxin closer to the epidermis. The process
of IAA14 and ARF7/ARF19 dependent expression of LAX3, followed by in-
creased auxin influx due to LAX3 and finally CWRE expression, is repeated
in the epidermis, allowing for the full emergence of the LRP.
Further insight into the relationship between the known regulators of
LAX3 expression, and their behaviour following auxin treatment, is given
by the qRT-PCR data shown in Figure 1.9 (Benjamin Peret, Personal Com-
munication). This shows 36 hour time course mRNA expression data for
ARF7, ARF19, LAX3, IAA14 and PG, in wild type (Col-0), and arf7, arf19,
and lax3 mutant backgrounds, following treatment with 1 µM exogenous
auxin. The data show a clear distinction in the behaviour of ARF7 and
ARF19 following auxin treatment. While ARF7 is unresponsive to auxin
and present at similar level in all genotypes, ARF19 is induced by auxin,
peaking in expression between 3 and 6 hours after treatment. The reduced
induction of ARF19 in the arf7 mutant suggests a partial role for ARF7 in
ARF19 activation, while ARF19 expression is unaffected by the lax3 mu-
tation. IAA14 is induced by auxin, peaking in expression 12 to 18 hours
post-treatment, and appears to be exclusively dependent on ARF7, and
independent of ARF19. LAX3 is also induced by auxin, with a peak in
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Figure 1.8: Conceptual model of LAX3 regulated lateral root emergence. (a)
Auxin (IAA) diffuses from the LRP in the pericycle (P) into the
endodermis (End) and degrades the Aux/IAA IAA3, leading to the
expression of cell wall remodelling enzymes (CWR). (b) A lower
level of auxin diffuses into the adjacent cortical cell (C), degrading
IAA14 sufficiently to allow the ARF7/ARF19 mediated activation
of LAX3. (c) The additional auxin influx provided by LAX3 pos-
itive feedback further elevates auxin in the cortical cell enough to
activate CWR. (d) The expression of CWR in the endodermis and
cortex facilitates the emergence of the growing LRP so that it is
now below the epidermis (Epi), and as in the cortex, the increase
of auxin, expression of LAX, and LAX3 positive feedback on auxin
is enough to induce CWR. (Reproduced from Peret et al. (2009a).)
expression 12 hours post-treatment, and again is dependent on ARF7. The
expression of LAX3 in the arf19 mutant, however, is clearly increased, both
at basal pre-treatment level, and at peak expression level, suggesting ARF19
may have a negative effect on LAX3 expression. Finally, the peak induc-
tion of PG following auxin treatment occurs at the time point following
peak LAX3 expression, after 18 hours, and is reduced in the lax3 mutant,
and absent in the arf7 mutant, demonstrating a link between the ARF7
dependent expression of LAX3 and the induction of CWREs.
The final key pieces of experimental evidence available suggest the exis-
tence of an additional, unidentified transcription factor (TF) downstream of
ARF7, activating LAX3. Firstly, treatment with cycloheximide (CHX) in
addition to auxin results in the decay of the LAX3 signal post-treatment, as
shown in Figure 1.9 (Silvana Porco, personal communication). CHX is an
inhibitor of protein translation and can be used experimentally to determine
whether auxin responsive genes are direct targets of ARF activators, or an
intermediate TF is required for induction. If a gene is activated directly
by an ARF following the degradation of an Aux/IAA repressor, though the
translation of the mRNA into protein will be blocked by CHX, the initial
induction of the mRNA will be unaffected. If on the other hand the gene is
a secondary response, i.e. it is itself a downstream target of a gene activated
directly by auxin, although the mRNA of its activator will be up-regulated
by auxin, the presence of CHX means that the mRNA is not translated
to protein and so the target gene is not activated. Since the LAX3 mRNA
signal decays post-auxin treatment in the presence of CHX, this suggests an
additional TF needs to be expressed and translated in order for LAX3 up-
regulation to occur. Nonetheless, the presence of a potential ARF binding
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Figure 1.9: qRT-PCR time course data following 1 µM auxin treatment for
(a) ARF7, (b) ARF19, (c) IAA14, (d) LAX3 and (e) PG mRNAs
in wild type, lax3, arf7, and arf19 mutant backgrounds (Benjamin
Peret, personal communication). (f) Wild type LAX3 mRNA ex-
pression following treatment with 10 µM cyclohexamide (CHX),
1 µM auxin (IAA) and both CHX and IAA (Silvana Porco, per-
sonal communication).
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site (AuxRE) on the LAX3 gene promoter may suggest that both the extra
TF and an ARF are needed for LAX3 activation. However, mutation of
this potential ARF binding site does not negatively affect the expression of
LAX3 (Larrieu 2011), suggesting that LAX3 is activated exclusively by one
or more indirect targets of ARF7. The simplest conceptual model for this is
this addition of a TF, denoted tfX below, to the LAX3 regulatory module,
directly activated by ARF7, and itself acting to activate LAX3 directly.
The currently available literature and experimental data point to the
importance of the regulation of LAX3 by auxin to the process of lateral
root emergence. A better understanding of how specific cells within the
Arabidopsis root are reprogrammed by auxin to express LAX3, leading to
the expression of CWREs, will be gained by the development of mathemat-
ical models of these processes. The first step in this is to create a single
cell scale model of the LAX3 gene regulatory network, to be followed by
a multiscale model in which the realistic spatial distribution of auxin and
LAX3 expression between root cells is simulated. Existing modelling ap-
proaches to plant developmental processes, in particular relevant models of
auxin signalling and transport, are reviewed briefly in Section 1.2.
1.2 Modelling of Plant Hormone Signalling
Computational modelling has been used to investigate many different as-
pects of plant growth and development, including the key processes relevant
to lateral root emergence of hormone distribution and transport, genetic reg-
ulation, and growth and mechanics, as reviewed by Jonsson and Krupinski
(2010). The growth and mechanical properties of root tissues are beyond
the scope of this thesis and so we restrict attention here to models of hor-
mone distribution and transport and of gene regulation, with particular
attention on models involving auxin, the key hormone regulating lateral
root emergence.
1.2.1 Auxin transport models
One of the most common topics for the application of computational mod-
elling in plants is that of auxin transport, i.e. simulating the movement of
auxin via either diffusion or carrier mediated active transport around plant
tissues and organs. These models generally have some geometric framework
throughout which auxin can move according to mathematically formulated
rules based on biological rules and the hypothesis to be tested (Kramer
2008; Krupinski and Jonsson 2010). The frameworks often have the res-
olution of one compartment per cell, but may include sub-cellular com-
partments or alternatively, combine many cells together into larger com-
partments (Kramer 2008). Auxin transport models have been applied to
several different morphological processes including development of vascular
strands in leaves and stems (Smith and Bayer 2009), wood grain pattern
formation (Kramer 2002), and phyllotaxis (Jonsson et al. 2006; de Reuille
et al. 2006). The latter publications demonstrated that a pre-defined popu-
lation of PIN auxin eﬄux carriers could produce local auxin maxima at the
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shoot apical meristem (SAM) corresponding to the sites of new leaf primor-
dia. Extending these models so that rather than the location of the PINs
being pre-determined, the PINs are polarised to the cell membranes facing
towards the cells with highest auxin, provides a pattern-forming mechanism
by which the experimentally observed carrier distribution can be established
(Jonsson et al. 2006; Smith et al. 2006).
In addition to the examples above, a number of auxin transport models
based on processes within the root have also been published. Swarup et al.
(2005) demonstrated the importance of auxin transport during gravitropism
using a three-dimensional model of the outer cell layers in the root, where
the asymmetry in auxin between the upper and lower surface of the root
following a simulated gravitropic stimulus is maintained by the presence
of the influx transporter AUX1 in the epidermis. A similar model frame-
work was used by Jones et al. (2009) to describe the role of AUX1, which
is expressed in cells without root hairs to maintain the level of auxin in
adjacent files of cells which grow root hairs, but do not express AUX1. The
reverse fountain model described in Section 1.1.4, in which the arrangement
of eﬄux and influx carriers causes the polar flow of auxin through the stele
towards an auxin maximum at the root tip, with some lateral and shoot-
ward reflux back toward the shoot in the outer tissue, was simulated by
Grieneisen et al. (2007). In this model, a two-dimensional regular array of
cells with a fixed distribution of carriers was able re-produce the experimen-
tally observed maximum of auxin near the root tip. A similar model was
used to show that a change of cellular geometry caused by root bending may
produce auxin maxima corresponding to the site of lateral root initiation
sites (Laskowski et al. 2008). Finally, in Band and King (2011) asymptotic
methods were used to derive a continuum description of auxin transport in
the root from a model with individual compartments for each cell and the
apoplastic spaces between them. The cellular resolution model including
the apoplast was first published by Perrine-Walker et al. (2010) and was
selected as the basis for the auxin transport model used in Chapters 5 and
6 due to the presence of the apoplastic compartments in the model and
the derivation of parameter estimates for the relative flux due to diffusion,
influx and eﬄux, both in the direction of cytoplasm to apoplast and in the
direction of apoplast to cytoplasm.
1.2.2 Auxin signalling and gene regulation models
Single cell scale gene regulatory models have been used on several occasions
as a tool to investigate and simulate different gene regulatory and hormone
signalling processes within plants. These include ordinary differential equa-
tion (ODE) models of the circadian clock (Locke et al. 2005) and gibberelin
signalling (Middleton et al. 2012), and boolean and stochastic models of the
regulation of floral genes (Espinosa-Soto et al. 2004; Alvarez-Buylla et al.
2008; Lenser et al. 2009). Jonsson et al. (2005) used an ODE model to put
a gene regulatory network model of the regulation of the key regulatory
genes in determining the size of the SAM, CLAVATA and WUSCHEL, into
a tissue scale model with cellular resolution, in order to simulate the real-
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istic spatial distribution of the key model components. This approach, of
embedding a cellular scale ODE gene expression model into a tissue scale
model with realistic cellular geometry through which key diffusive molecules
can move is implemented in Chapter 6.
Compared to models of auxin transport and distribution on a tissue
or organ scale, there are relatively few models published which simulate
auxin activity on a biomolecular or gene network scale within a single cell.
One such model is that published by Middleton et al. (2010) in which the
transcription, translation and degradation of Aux/IAA proteins was mod-
elled explictly, via interactions with auxin, the auxin receptor TIR1 and
the ARF transcription factors. When the ARFs are free of the repression
by Aux/IAAs they are free to activate downstream targets, among which
are the Aux/IAAs themselves, thus generating a negative feedback loop on
Aux/IAA auxin activated expression. This model network was found to
have parameter regimes in which the expression of Aux/IAA oscillates sta-
bly over time. These oscillations depend on the homodimerisation of the
ARF activators occuring at a similar rate as the degradation of Aux/IAA
mRNA and so if, as suggested by Vernoux et al. (2011), homodimerisation
interactions between activating ARFs are uncommon, this reaction may not
be present during auxin signalling in many cases. Nevertheless, the model
equations in Middleton et al. (2010), with the omission of the ARF-ARF
homodimerisation, provide the basis for the auxin signalling module used
in the LAX3 expression model in Chapter 2. The auxin signalling network
model published by Middleton et al. (2010) was also extended by Muraro
et al. (2011), to include crosstalk from cytokinin signalling during the prim-
ing of new lateral root sites. Here, the antagonistic effect of cytokinin on
the auxin response is shown to disrupt the stable oscillations in Aux/IAA
expression seen in the previous model and decrease the level of auxin re-
sponsive expression of PIN carrier proteins.
In addition to the data on the full interactome of the 23 ARFs and
29 Aux/IAAs, Vernoux et al. (2011) also present a model for the auxin
response at the SAM containing the two main motifs found in the ARF-
Aux/IAA interactome, the first being the dimerisation of Aux/IAAs with
positive or activating ARFs and homodimerisation with other Aux/IAAs,
and the second being negative or repressing ARFs acting alone to compete
for binding sites with the positive ARFs. The balance between the level of
positive and negative ARFs was shown to affect the sensitivity of response
genes to auxin, and the robustness of the level of expression to fluctua-
tions in auxin input, with increased levels of the negative ARFs attenuating
the fold-change response to an auxin signal. The impact of the ARF and
Aux/IAA interactome on auxin signalling is investigated further by Bridge
et al. (2012), in which model systems with two ARFs and Aux/IAAs are
presented which may show bistability in dominant expression between two
response genes depending on the strength of auxin signal. Though the model
was formulated to investigate the mechanism for the initiation of root hairs,
the number of possible interactions between the ARFs and the Aux/IAAs
throughout the plant mean that the system could be applicable to a number
of other developmental contexts.
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1.2.3 Frameworks for model implementation
The single cell modelling in Chapters 2, 3, and 4 was implemented using the
commercial software package MATLAB1, with all the ODE solutions found
using the ode15s solver. Also used were the parameter fitting algorithms
ga and fmincon found in the MATLAB Optimization Toolbox package2 in
order to fit model parameter values to experimental data.
The bifurcation diagrams for model steady states in Chapters 2 and 3
were found using the open source software XPPAUT3 (Ermentrout 2002).
Finally, the multiscale model developed in Chapters 5 and 6 was imple-
mented using the Python programming language, with the core topological
structure of the model provided by packages from the open source software
package Open Alea4, the ODEs solved by the python package SciPy5, and
the graphical output produced by the python package Matplotlib6.
1.3 Thesis Summary
The plant hormone auxin is known to be central to virtually every aspect of
plant root development, and in particular the formation of new lateral roots
(Peret et al. 2009a,b). In Arabidopsis, lateral roots initiate as and develop
from lateral root primordia (LRP) in the pericycle cell layer, adjacent to the
central vascular tissue (stele) deep within the root, and in order to emerge
as mature lateral roots the LRP must pass between cells in the outer cell
layers without causing excessive tissue damage (Peret et al. 2009a,b). To
facilitate emergence the cell walls in the outer layers over the LRP must first
be softened via the expression of cell wall remodelling enzymes (CWREs),
but only in the specific cells necessary for emergence. The auxin induced
expression of the auxin influx transporter LAX3 in these cells was shown by
Swarup et al. (2008) to be required for the expression of CWREs including
polygalacturonase (PG), and for normal emergence. The main aim of the
thesis is to use mathematical modelling to investigate whether the all or
nothing spatial expression pattern of LAX3 and PG can be explained by
the conceptual model shown in Figure 1.8. In doing so, the model will also
be used to investgate in more detail the gene regulatory network leading to
the expression of LAX3.
The modelling work presented in the thesis may be divided into two main
sections. Firstly, in Chapters 2-4 the expression of the key gene required for
emergence, LAX3, is modelled at a gene network scale, in order to address
biological questions about how LAX3 may be regulated within a single
cell. After this, in Chapter 5 the model is expanded to the multi-cellular
scale by modelling auxin transport in a two-dimensional cross section of an
Arabidopsis root, and in Chapter 6 this tissue scale model is combined with
1http://www.mathworks.co.uk/products/matlab/
2http://www.mathworks.co.uk/products/optimization/
3http://www.math.pitt.edu/ bard/xpp/xpp.html
4http://openalea.gforge.inria.fr
5http://www.scipy.org/
6http://matplotlib.sourceforge.net/
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the gene regulatory network model to create a multi-scale model of auxin
transport and LAX3 expression.
Figure 1.10 shows an overview of the different gene network variants
modelled in each thesis chapter. All of the models in some way include
the core auxin signalling mechanism by which auxin binds with the TIR1
receptor, which can then bind the Aux/IAA IAA14, thus targeting it for
degradation and freeing the repression of target genes caused by binding
with the ARFs. In Chapter 2, a single cell model of the core LAX3 network
is developed, with a single ARF, ARF7, activating the primary response
genes IAA14 and the unknown transcription factor tfX, with tfX then ac-
tivating LAX3 resulting in a positive feedback on auxin. With some pa-
rameter sets this model is shown have a bistable switch between low and
high LAX3 expression with increasing persistent auxin signal, providing a
possible explanation for the experimentally observed all or nothing LAX3
spatial expression pattern. Parameter fitting is then used to fit the model
with experimental data, with a key conclusion being that in order to match
all the data some form of auxin homeostasis mechanism is needed in the
model. Finally, the fitted model is used to make time course predictions
for the model components for which no data is available, in particular the
unidentified transcription factor tfX.
Chapter 3 presents a hypothetical auxin homeostasis mechanism, in
which the auxin responsive expression of a member of the GH3 gene family
increases the degradation rate of intracellular auxin by irreversibly conju-
gating it with amino acids (Figure 1.10). The parameter fitting shows that
it is possible for this model to match the experimental data with long period
damped oscillations of gene expression, the timing and magnitude of which
are very sensitive to small changes in parameter values. Additionally, some
parameter sets result in stable limit cycles in gene expression, meaning that
the model provides an alternative mechanism to that given by Middleton
et al. (2010) by which oscillations in the auxin response may be generated
from a persistent auxin signal.
The effect of adding an additional ARF to the model is investigated in
Chapter 4 by adding the auxin responsive ARF19. Of particular interest
is the mechanism by which ARF19 appears to partially repress LAX3 ex-
pression (Figure 1.9). Several different mechanisms are investigated, with
the model network producing the best fit with experimental data shown in
Figure 1.10. Though the evidence for selecting this model above the oth-
ers is inconclusive, it provides a conceptual basis for further experimental
research.
In Chapter 5 the focus moves to a tissue scale model of auxin transport
in a two-dimensional radial cross-section of an Arabidopsis root (Figure
1.11). The model is used to simulate the response of the tissue to both ex-
ogenous auxin treatment and the introduction of an auxin source in a single
pericycle cell to represent a LRP. A key parameter in both simulations is
the intracellular auxin turnover rate. In the primordium simulation it is
shown that a high auxin turnover rate broadens the range of auxin concen-
trations between cortical cells which, in conjunction with a sharp switch in
LAX3 expression with increasing auxin, may provide a basis for the spatial
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Figure 1.10: Overview of the gene network models described in Chapters 2, 3, 4
and 6. Each model has the core network in which the degradation
of IAA14 is accelerated by auxin, freeing the repression of ARF7
activated IAA14 and tfX. IAA14 then feeds back negatively on the
activation by ARF7, while tfX activates LAX3, which feeds back
positively on the level of auxin. In Chapter 3 an auxin homeostasis
mechanism is modelled by adding the auxin responsive gene GH3,
which feeds back negatively on auxin by binding with it and con-
jugating it to amino acids, effectively removing it from the active
pool of auxin. In Chapter 4 ARF19 is added and various model
networks investigated. In the model shown here, in addition to
being activated by ARF7, ARF19 is also activated by one or more
other activators (A1, A2), and ARF19 itself activates a repressor
of LAX3, ARFr. In Chapter 6 the core network is extended by the
addition of the tertiary auxin response gene PG, and embedded in
a multicellular context with the auxin transport model described
in Chapter 5.
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Figure 1.11: Example output from the multiscale model developed in Chap-
ters 5 and 6. A strong auxin source in the pericycle represent-
ing a developing lateral root primordium results in degradation of
Aux/IAA in adjacent and local cells. LAX3, which is restricted to
expression in the cortex and epidermis, is strongly expressed only
in the two cortical cells nearest the primordium auxin source.
LAX3 expression pattern. A high turnover rate is also shown to increase
the power of LAX3 to amplify cellular auxin in a threshold based model for
LAX3 expression.
The final chapter (Chapter 6) combines a gene regulatory network model
of LAX3 and PG expression (Figure 1.10) with the tissue scale model from
Chapter 5 to produce a multi-scale model for auxin transport and auxin re-
sponsive gene expression in an Arabidopsis root cross-section (Figure 1.11).
The model is used to show that the spatial position of cortical cells relative
to the primordium auxin source is sufficient to explain the experimentally
observed LAX3 expression pattern, provided there is a reasonably sharp
switch between low and high LAX3 expression with increasing auxin. Fur-
thermore, this expression pattern can be consistently produced for a large
range of primordium signal strengths. Finally, if PG has a similar switch
like change in expression with increasing auxin, then provided the threshold
for the switch from low to high expression is higher than that for LAX3, the
model shows that the amplification on cellular auxin due to LAX3 expres-
sion is required for PG to be expressed. Removing LAX3 from the model
to simulate the lax3 mutant greatly reduces the expression of PG, mean-
ing that the model can replicate the PG expression pattern in both wild
type and the lax3 mutant, demonstrating how the expression of LAX3 may
be linked to the expression of cell wall remodelling enzymes and facilitate
lateral root emergence.
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Chapter 2
Gene Regulatory Network
Model: One Auxin Response
Factor (ARF7)
2.1 Initial LAX3 Gene Network Model
2.1.1 The LAX3 gene regulatory network
To investigate whether the conceptual model published by Swarup et al.
(2008) can explain the observed expression pattern of LAX3 in specific
cells overlying LRP, a mathematical model of auxin signalling and LAX3
expression in a single cortical cell was developed. This initial model was
then used to find conditions under which the model can produce a bistable
response, similar to the all or nothing response of LAX3 observed in Swarup
et al. (2008), with a low level of expression at a low auxin signal, high
expression at a high auxin signal, and the existence of both high and low
steady states for some intermediate range of auxin concentrations.
To refine the model further it was first compared qualitatively, and then
fitted quantitatively, to qRT-PCR data for key model components. In doing
so we found that several additional previously unidentified model compo-
nents are needed to explain the experimental observations in full.
As discussed in section 1.1.6, the ARF7/ARF19 and IAA14 mediated
induction of the auxin influx transporter LAX3 is shown to be required for
normal emergence of lateral roots (Swarup et al. 2008). The qRT-PCR data
shown in figure 1.9 gives further insight into the relationship between the
key LAX3 regulators, IAA14, ARF7 and ARF19. The working hypothesis
based on the experimental evidence is that both IAA14 and ARF19 are
direct targets for activation by ARF7 following the release from repression
by degradation of IAA14 with an auxin signal. While ARF7 has a positive
effect on LAX3 expression, ARF19 has a negative effect. The evidence pro-
vided by mutation of the potential ARF binding site on the LAX3 promoter
(Larrieu 2011), and the degradation of LAX3 mRNA seen following treat-
ment with auxin and cyclohexamide (Larrieu 2011) indicates that at least
one additional activatory step must be present between ARF7 and LAX3.
This activation is proposed here to be due to an unidentified transcription
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factor (tfX) directly activated by ARF7, itself binding directly with the
LAX3 promoter to activate expression. A summary of the proposed wild
type and mutant gene regulatory networks is given in figure 2.1. The mech-
anism by which ARF19 negatively regulates LAX3 is initially unclear and
so, for simplicity, the model is first formulated with just ARF7 regulating
LAX3 via tfX. A more complex model, including ARF19, is developed in
chapter 4.
2.1.2 Model Formulation and Initial Parameter Esti-
mates
In the absence of LAX3, auxin is assumed to enter the cell via diffusion
only, at a low rate (αx) proportional to extracellular concentration (xaux).
We assume this transport occurs only from outside to inside the cell, not
vice versa, due to the higher pH within the cell resulting in auxin dissociat-
ing into an anionic form, unable to diffuse freely back through the plasma
membrane (Petresek and Friml 2009). Once in the cell, the pool of auxin
available to other reactions (auxin) can then be depleted by several pro-
cesses, including eﬄux via transporters such as PIN or PGP, conjugation
with other molecules, and degradation. This depletion is initially approxi-
mated as linear in the auxin concentration with rate constant µaux. Assum-
ing that the number of LAX3 transporters present at the plasma membrane
at any time is proportional to the LAX3 concentration (LAX), and that
extracellular auxin is not present in saturating quantities, the additional
auxin influx due to transporter activity is proportional to the parameter
αlax:
xaux
αx
−→ auxin
µaux
−→ ∅,
xaux
αlax
−→ auxin
µaux
−→ ∅.
To begin with, we assume the auxin maximum near the tip of the LRP
and represented by xaux is maintained throughout, regardless of the rate of
diffusion and active transport into the cell. Both auxin diffusion and active
transport happen at the plasma membrane, while the remainder of model
reactions occur within the nucleus as we assume the Aux/IAAs, ARFs and
other transcription factors are localised to the nucleus. For this reason,
another model simplification is that spatial effects of transport of auxin,
LAX3, and other molecules within the cell are ignored.
Within the cell, auxin is able to bind reversibly with the SCF TIR1
complex (TIR), the resulting complex (TIRa) itself being able to bind re-
versibly with Aux/IAA protein (IAA) to another complex (TIRai). Finally,
Aux/IAA bound up in TIRai can be ubiquitinated (IAA
∗), after which it
is targeted for degradation (Dharmasiri et al. 2005; Kepinski and Leyser
2005). Since this step is assumed here to be irreversible, for the purposes of
the model Aux/IAA is considered to be degraded following ubiquitination.
The total concentration of SCF TIR1 complex in its various forms (tirT ) is
assumed to be relatively stable, and is considered to be conserved:
TIR + auxin
pa
−⇀↽−
pd
TIRa,
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Figure 2.1: Hypothetical model network tested in Chapters 2 and 4 showing
the site of simulated gene mutations. a) Wild type. Auxin enters
the cell via diffusion and binds with the TIR1 complex. This com-
plex can then bind Aux/IAA (IAA14) and target it for degradation.
In the absence of auxin, Aux/IAA dimerises with ARF7, but once
Aux/IAA is degraded ARF7 is free to activate auxin responsive
genes. Among these genes is Aux/IAA itself, creating a negative
feedback effect. Evidence suggests that while LAX3 is expressed
in response to auxin, it is not itself a primary auxin gene; because
of this an unknown transcription factor ‘tfX’ is included between
ARF and LAX3. Once transcribed and translated, LAX3 acts as a
positive feedback on auxin by actively transporting more into the
cell. ARF19 production is activated by ARF7 and has a negative
effect on LAX3 expression. b) arf7. Since ARF7 is required for
activation of all genes in the model, in the arf7 mutant no expres-
sion is possible. c) arf19. In the arf19 mutant the negative effect
of ARF19 on LAX3 is removed. d) lax3. In the lax3 mutant the
positive feedback on cellular auxin is removed.
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TIRa + IAA
qa
−⇀↽−
qd
TIRai
qm
→ IAA∗ + TIRa,
T IR + TIRa + TIRai = tirT . (2.1)
Auxin acts within the nucleus by accelerating the degradation of IAA
by the pathway described above. When present (i.e. when there is no auxin
signal so IAA is relatively stable) IAA can bind to ARF in a reversible
reaction to form dimers (AI):
IAA+ ARF
ka
−⇀↽−
kd
AI.
For the model, ARF transcription and degradation are assumed to be un-
affected by auxin on the timescale of interest and so the total of bound and
unbound ARF is conserved:
ARF + AI = arfT . (2.2)
Following an auxin signal, Aux/IAA is degraded and the amount of free
ARF protein increases, activating transcription of various mRNAs. These
mRNAs include those of Aux/IAA itself, which acts as a negative feedback
on the auxin response. Homodimerisation of ARF and Aux/IAA molecules
is not considered. In the model, transcription of both IAA and the unknown
transcription factor X mRNAs (IAAm and Xm) are activated by ARF and
repressed by AI:
∅
λiFtc
−→ IAAm, ∅
λxFtc
−→ Xm.
Translation of IAAm and Xm into Aux/IAA and the unknown transcription
factor X (X) occurs at different fixed rates, proportional to the current level
of mRNA:
∅
δiIAAm
−→ IAA, ∅
δxXm
−→ X.
IAA and X mRNAs and proteins degrade at different linear rates:
IAAm
µim
−→ ∅, Xm
µxm
−→ ∅, IAA
µi
−→ ∅, X
µx
−→ ∅.
Finally, LAX3 mRNA (LAXm)is transcribed in response to X and degraded
at a linear rate, and LAX3 protein (LAX) is translated at a rate propor-
tional to LAXm and degrades at a fixed linear rate:
∅
λlFtc
−→ LAXm
µlm
−→ ∅, ∅
δlLAXm
−→ LAX
µl
−→ ∅.
In the notation the symbol used for each molecular species represents in-
tracellular concentration and the symbol ∅ refers to the pool of molecules
from which mRNAs and proteins are transcribed and translated, and into
which model species are degraded.
LAX3 model equations
With the reactions described above, the law of mass action gives an ODE
model for LAX3 expression as stated in Equations 2.3a-2.4. The key differ-
ences from the model given by Middleton et al. (2010) are that for simplicity
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ARF homodimers and ubiquitinated auxin are not included explicitly, the
functions used for transcription are simplified, and the expression of LAX3
(via the intermediate transcription factor X) and its positive feedback effect
on cellular auxin concentration are included; thus two ODEs from Middle-
ton et al. (2010) are excluded and four extra ODEs for the variables Xm, X,
LAXm, and LAX are needed. Other than transcription, the reactions are
assumed to take place according to the laws of mass action kinetics, giving
the following dimensional model in twelve variables:
dauxin
dt
= xaux(αx + αlaxLAX)− µauxauxin
−paTIR auxin+ pdTIRa, (2.3a)
dTIR
dt
= −paTIR auxin+ pdTIRa, (2.3b)
dTIRa
dt
= paTIR auxin− pdTIRa
+(qd + qm)TIRai − qaTIRa IAA, (2.3c)
dTIRai
dt
= −(qd + qm)TIRai + qaTIRa IAA, (2.3d)
dIAA
dt
= qdTIRai − qaTIRa IAA− µiIAA+ δiIAAm
−kaARF IAA+ kdAI, (2.3e)
dARF
dt
= −kaARF IAA+ kdAI, (2.3f)
dAI
dt
= kaARF IAA− kdAI, (2.3g)
dIAAm
dt
= λiFtc
(
ARF
θia
,
AI
θir
, ni
)
− µimIAAm, (2.3h)
dXm
dt
= λxFtc
(
ARF
θxa
,
AI
θxr
, nx
)
− µxmXm, (2.3i)
dX
dt
= δxXm − µxX, (2.3j)
dLAXm
dt
= λlFtc
(
X
θla
, 0, nl
)
− µlmLAXm, (2.3k)
dLAX
dt
= δlLAXm − µlLAX, (2.3l)
where:
Ftc(ACT,REP, n) ≡
(ACT )n
1 + (ACT )n + (REP )n
(2.4)
The functions for transcriptional activity are based on the models of
Ackers et al. (1982) and Alon (2007) with the following assumptions. For
the transcription of Aux/IAA and X, ARF monomers and ARF-Aux/IAA
dimers compete for the same binding site(s). Aux/IAA monomers cannot
bind to a promoter. If ARF is bound, transcription is activated, while
if an ARF-Aux/IAA dimer is bound transcription is repressed. When X
binds the LAX3 promoter, transcription is activated, otherwise LAX3 will
not be expressed. Therefore there are three possible states for any binding
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site, unbound, repressor bound and activator bound. The function (2.4)
is based on the probability of the only situations in which transcription
occurs, i.e. when it is bound by ARF, or by X in the case of LAX3. The
co-operativity coefficient (n) allows for the possibility of more than one
binding site. For n = 1 there is a single binding site, for n > 1 there
is more than one binding site and the transcription function captures the
probability of n sites being bound independently. Alternatively, the co-
operativity could represent a number of copies of the same transcription
factor binding together before binding to a single site, e.g. a co-operativity
of two requires a homodimerisation before promoter binding.
Nondimensionalisation
In the following description the bar notation is used to represent the dimen-
sional form of model quantities.
Given the total concentrations of ARF and TIR1 as arfT and tirT re-
spectively, the respective conservation expressions (2.1) and (2.2) of TIR
and ARF in various bound and unbound forms follows from the system of
ODEs given by (2.3). A suitable scaling for the concentrations of bound
and unbound ARF is then arfT , so that ARF = arfTARF and AI =
arfTAI. TIR in its various forms is similarly scaled with tirT so that
TIR = tirTTIR, TIRa = tirTTIRa, TIRai = tirTTIRai. The rate of
Aux/IAA mRNA degradation should be a reasonable timescale over which
auxin signalling evolves, and experimentally obtained values are available in
the literature (Narsai et al. 2007), so we rescale time according to t = τ/µim .
mRNA concentrations are scaled with the ratio of mRNA transcription and
degradation so IAAm =
λi
µim
IAAm, Xm =
λx
µxm
Xm, LAXm =
λl
µlm
LAXm,
and the corresponding protein concentrations are scaled with the product
of the ratio between mRNA transcription and degradation and the ratio
between protein translation and degradation, so that LAX = λlδl
µlmµl
LAX,
X = λxδx
µxmµx
X; the exception is Aux/IAA protein which is scaled so that
IAA = λiδi
µ2im
IAA, since we later assume that µi is negligible and omit the
auxin independent degradation of Aux/IAA from the model. Finally, auxin
is scaled relative to an arbitrary treatment concentration xauxT so that
auxin = xauxTauxin. This means that when comparing the model re-
sponse to experimental data, the cellular auxin concentration at any given
time is expressed relative to a known treatment concentration.
Introducing the dimensionless parameters as shown in Table 2.1, and
using t rather than τ for non-dimensional time, gives the dimensionless
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model in twelve variables:
dauxin
dt
= xaux(αaux + αlaxLAX)− µauxauxin
+ηtir(−paTIR auxin+ pdTIRa), (2.5a)
dTIR
dt
= −paTIR auxin+ pdTIRa, (2.5b)
dTIRa
dt
= paTIR auxin− pdTIRa + (qd + qm)TIRai
−qaTIRa IAA, (2.5c)
dTIRai
dt
= −(qd + qm)TIRai + qaTIRa IAA, (2.5d)
dIAA
dt
= ηiaa(qdTIRai − qaTIRa IAA) + IAAm
ηarf (−kaARF IAA+ kdAI)− µiIAA, (2.5e)
dARF
dt
= −kaARF IAA+ kdAI, (2.5f)
dAI
dt
= kaARF IAA− kdAI, (2.5g)
dIAAm
dt
= Ftc
(
ARF
θia
,
AI
θir
, ni
)
− IAAm, (2.5h)
dXm
dt
= µxm
(
Ftc
(
ARF
θxa
,
AI
θxr
, nx
)
−Xm
)
, (2.5i)
dX
dt
= µx(Xm −X), (2.5j)
dLAXm
dt
= µlm
(
Ftc
(
X
θla
, 0, nl
)
− LAXm
)
, (2.5k)
dLAX
dt
= µl(LAXm − LAX), (2.5l)
together with the conservation laws:
ARF + AI = 1, (2.6a)
TIR + TIRa + TIRai = 1 (2.6b)
where, as before:
Ftc(ACT,REP, n) ≡
(ACT )n
1 + (ACT )n + (REP )n
. (2.7)
Parameter Estimates
The initial default dimensionless parameter estimates are given in Table 2.1.
A key assumption is that µi is negligible. This means that, even at very
low auxin concentrations, the only way by which Aux/IAA is degraded is
by the TIR1-auxin pathway. ηtir is the ratio of total receptor concentra-
tion to the 1µM treatment concentration and estimated to be very low, as
are ηarf , and ηiaa which are respectively the ratios of total ARF and total
receptor concentrations to the Aux/IAA rescaling. Since the model time
is scaled using the rate of Aux/IAA mRNA decay (µim), the estimates for
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µx, µxm , µl, and µlm are of O(1). We set µx, µxm = 2 to reflect the experi-
mental observation that, while LAX3 is a secondary response gene, its peak
in expression is relatively close to that of Aux/IAA, a primary response
gene, suggesting that its activator, X, may peak sooner than Aux/IAA.
The parameters relating to protein-protein and protein-auxin interaction
are estimated to be much larger in size than those for mRNA/protein decay
and so pa, pd, ka, kd, qa, qd, qm are all set ≥ 1000. The auxin transport and
decay parameters (αx, αlax, µaux) are initially set in the range 1 to 10, but
larger values can produce similar time-course expression profiles for model
mRNA, provided all are increased by a similar order of magnitude. Swarup
et al. (2005) estimate that active transport via AUX1, an influx transporter
in the same family as LAX3, happens at a rate approximately 15 times
that of auxin diffusion, and this ratio is used for αlax and αx. Basal cellu-
lar auxin concentration is estimated to be around 1nM and since we know
the treatment concentration xauxT = 1000nM , we have the dimensionless
parameter xaux0 = 0.001. Following auxin treatment we set xaux = 1.
The binding thresholds for ARF binding sites are all set to 0.1 since non-
dimensional ARF and ARF-Aux/IAA are limited to between 0 and 1, while
the binding threshold for X on the LAX3 promoter is set to 1 to allow for
sensitivity in the value of X, which varies between 0 and 1 depending on
auxin concentration. The default values of the co-operativity coefficients
ni, nx and nl are initially set equal to one but the effect of increasing these
values on steady state values is investigated further in section 2.1.3.
2.1.3 Steady State Analysis
To investigate the possibility that the model can explain the observed all-
or-nothing expression pattern of LAX3 in cortical cells overlying LRP, we
investigate its steady states as parameters are varied by plotting bifurcation
diagrams using the computer software Xppaut (Ermentrout 2002). Xppaut
has an interface with the programme AUTO, which can find the steady
states of a system of ODEs as a parameter varies by continuation from an
initial steady state, found using Xppaut. In particular, AUTO can identify
any regions of parameter space where multistability occurs, and also give
information on the stability of steady states and the location and type of
any bifurcations present.
There are several examples of bistability due to interconnected posi-
tive and negative feedbacks producing all or nothing responses in biological
systems, including in frogs during Xenopus laevis oocyte maturation (Fer-
rell and Xiong 2001), in bacteria during regulation of the lactose operon
in Escherichia coli (Laurent and Kellershohn 1999), and in the yeast Sac-
charomyces cerevisiae (Becskei et al. 2001). Of particular interest then is
whether or not, and if so under what conditions, bistability in LAX3 ex-
pression with increasing auxin signal can occur.
Increasing the co-operativity coefficient in the function for transcription
for both X (nx) and LAX3 (nl) can introduce a bistable region of gene ex-
pression with increasing xaux (figure 2.2). For the parameter set given in
table 2.1, if either or both of nx and nl are greater than two, there is bista-
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Table 2.1: Nondimensional parameters, with initial estimates and description.
Parameter Estimate Description
µi =
µi
µim
0 Auxin independent Aux/IAA decay rate
ηtir =
tirT
xauxT
0.001 Total TIR relative to auxin treatment
ηarf =
arfTµ
2
im
λiδi
0.001 Total ARF relative to IAA14 rescaling
ηiaa =
tirTµ
2
im
λiδi
0.001 Total TIR relative to IAA14 rescaling
µx =
µx
µim
2 X protein decay relative to IAA14 mRNA de-
cay
µxm =
µxm
µim
2 X mRNA decay relative to IAA14 mRNA de-
cay
µl =
µl
µim
1 LAX3 protein decay relative to IAA14
mRNA decay
µlm =
µlm
µim
1 LAX3 mRNA decay relative to IAA14
mRNA decay
pa =
paxauxT
µim
1000 Association of auxin with TIR1
pd =
pd
µim
1000 Disassociation of auxin with TIR1
qa =
qaλiδi
µ3im
10000 Association of TIR1-auxin with Aux/IAA
qd =
qd
µim
1000 Disassociation of TIR1-auxin with Aux/IAA
qm =
qm
µim
100000 Ubiqutination of TIR1-auxin-Aux/IAA
ka =
kaλiδi
µ3im
1000 Association of ARF with Aux/IAA
kd =
kd
µim
1000 Disassociation of ARF with Aux/IAA
αx =
αx
µim
1 Rate of auxin diffusion into cell
αlax =
αlaxλlδl
µimµlµlm
15 Rate of auxin transport by LAX3 into cell
µaux =
µaux
µim
10 Rate of cellular auxin decay
xaux0 =
xaux
xauxT
0.001 Basal auxin concentration (relative to treat-
ment of 1µM)
θia =
θia
arfT
0.1 Binding threshold on Aux/IAA promoter for
free ARF relative to total ARF
θir =
θir
arfT
0.1 Threshold on Aux/IAA promoter for ARF-
Aux/IAA dimers relative to total ARF
θxa =
θxa
arfT
0.1 Threshold on X promoter for free ARF rela-
tive to total ARF
θxr =
θxr
arfT
0.1 Threshold on X promoter for ARF-Aux/IAA
dimers relative to total ARF
θla =
θlaµxmµx
λxδx
1 Threshold on LAX3 promoter for X relative
to its scaling factor
ni = ni 1 Co-operativity coefficient of binding of tran-
scription factors to the Aux/IAA promoter
nx = nx 1 Co-operativity coefficient of binding of tran-
scription factors to the tfX promoter
nl = nl 1 Co-operativity coefficient of binding of tran-
scription factors to the LAX3 promoter
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Figure 2.2: LAX3 steady state (s.s.) against xaux (extracellular auxin concen-
tration) for varying values for nx (co-operativity in X promoter)
and nl (co-operativity on LAX3 promoter). Solid lines represent
stable steady states, while thinner dotted lines represent unstable
steady states.
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bility. Increasing the co-operativity on the Aux/IAA promoter, ni, above 1
always appears to reduce the width of the bistable region or remove bista-
bility altogether (not shown). The bistable region means that for low and
high xaux there is a single stable steady state, but for a central range of val-
ues of xaux there exist two stable steady states along with an intermediate
unstable steady state (figure 2.2, middle right, bottom middle and bottom
right). The result of this is that there is an intermediate steady state for
LAX3 expression which is always unstable. In other words, depending on
initial conditions, LAX3 can settle to either a high or a low range of ex-
pression. With the bistability present, if xaux begins at a low level and is
gradually increased, LAX3 expression will remain low until enough auxin
accumulates to switch LAX3 expression to the higher steady state. Once
this occurs, even if auxin levels drop slightly LAX3 expression will remain
high; once the lower critical value is reached LAX3 expression will drop into
the lower range once more. This hysteretic effect associated with bistability
would have the effect that LAX3 expression could be buffered from small
fluctuations in auxin concentration.
Without co-operativity (nx = 1, nl = 1) LAX3 expression increases ap-
proximately linearly from zero at low xaux, before saturating at higher
xaux. In this case an all or nothing LAX3 expression pattern cannot be
explained by the single cell model, unless there are extreme differences in
auxin concentration between adjacent cells. For higher co-operativities that
do not show bistability e.g. nx = 2, nl = 2, there is ultra-sensitivity. This
means that for low and high ranges of xaux there is little difference in ex-
pression for small perturbations in auxin, but for a specific central range
of xaux a small increase in xaux will result in a large change in LAX3 ex-
pression. This could result in an all or nothing expression pattern even for
small differences in auxin between adjacent cells. However, this expression
pattern would be unstable due to the sensitivity of adjacent cells to small
auxin fluctuations, which is biologically undesirable in comparison to the
bistable case where the bistable region acts as a buffer between high and
low expression.
For the parameter set used in figure 2.2, when nx = 2 and nl = 2 there is
no bistability, only a sigmoidal or ultra-sensitive response of LAX3 expres-
sion to increasing auxin. However, it is possible to achieve bistability for
these co-operativity values if the ratio αlax/αx, of auxin active transport to
diffusion rate is increased. Figure 2.3 shows how the values of the upper and
lower critical values for bistability in LAX3 expression of xaux vary with
increasing αlax, for the case nx = 2 and nl = 2. For values of αlax below
about 20 there are no critical values, and hence no bistability, but above this
there is bistability for an increasing large range of xaux for increasing αlax.
For large αlax (> 100) the bistability range appears to approach a limit.
Figure 2.3 has µaux set to 100. Lowering it to 10 as in figure 2.2 produces a
similar diagram, but with a greatly reduced range for xaux critical values
(around 0 to 0.1).
Auxin turnover rate (µaux) also affects the width of any bistable re-
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Figure 2.3: Upper and lower limit values of xaux for the bistable region of
steady state LAX3 expression with increasing αlax with αx = 1.
Parameter values are set as in table 2.1, except µaux = 100, nx = 2,
and nl = 2.
gion and the position of the upper and lower critical values (figure 2.4).
Increasing µaux increases both the lower and upper critical values for the
bistable region. The upper critical value increases at a higher rate than the
lower, causing the width of the bistable region to increase with increasing
µaux. A biological interpretation for this is that a higher basal turnover
rate for cellular auxin results in increased robustness in LAX3 expression
to small fluctuations in cellular auxin.
While bistability is possible in the model, it relies either on high co-
operativity (figure 2.2) or on lower co-operativity in conjunction with a
high value for active auxin transport relative to diffusion (figure 2.3). The
estimate given in Swarup et al. (2005) is of around 15:1 transport to diffu-
sion, which is not high enough to give bistability for the case nx = 2 and
nl = 2 for the parameter set used here. This estimate was based though
on a fixed concentration of AUX1 transporters on the cell membrane, while
here we assume that the rate of transport is proportional to a variable
amount of LAX3 present at any time, and it may be that when strongly
expressed there are many more LAX3 transporters present than AUX1 for
the previous estimate.
Co-operativity may result from multiple promoter binding sites and/or
transcription factor dimerisation, but more experimental evidence would be
needed to support whether or not this is the case for LAX3 expression.
In particular, the auxin responsive transcription factor that is assumed to
activate LAX3 is still unidentified, so its behaviour and possible binding
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Figure 2.4: Upper and lower limit values of xaux for the bistable region of
steady state LAX3 expression with increasing auxin degradation or
turnover rate µaux. Parameter values are set as in table 2.1, except
αlax = 100, nx = 2, and nl = 2.
sites remain unknown. Nonetheless, Swarup et al. (2008) give evidence for
a nonlinear relationship between increasing treatment concentrations of the
synthetic auxin 2,4-D and LAX3 mRNA expression. There appears to be
a sharp step increase in expression between treatment at 0.1µM and 1µM .
These PCR results were taken from whole root data, but LAX3 expression
appears more or less uniform throughout the cortex at the 1µM treatment
concentration, so we assume the PCR results are a reasonable approxima-
tion for what is happening in a single cortical cell. It seems likely that
some co-operativity effect of auxin inducible transcription factors on the
LAX3 promoter is acting in conjunction with the positive feedback due to
increased auxin influx via LAX3 active transport to produce a switch in
LAX3 expression with increasing auxin signal. For treatment with exoge-
nous auxin there will be a strong auxin signal throughout the length of the
root and so expression is uniform. A weaker source of auxin from a spe-
cific cell or cells within the root could instead produce spatially restricted
expression patterns of LAX3, due to the switch like response of LAX3 to
increasing auxin.
Bistability may be desirable in the expression of LAX3 to ensure con-
sistency in the spatial expression pattern. Assuming there are two cortical
cells nearest the LRP that need to express LAX3 and CWREs in order for
the LRP to pass between them, then their two neighbouring cortical cells
ought not to express LAX3 in order to maintain the structural integrity of
the root. Assuming all the cortical cells have low auxin concentration be-
fore the auxin signal from the LRP reaches them, all the cells begin on the
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low expression branch of the bifurcation diagram. As the signal strength
increases, the auxin in the two cortical cells nearest the LRP (central cells)
ought to increase higher than that in the two neighbouring cells. With a
high enough signal, and difference between the two pairs of cells, LAX3 ex-
pression will jump to the high expression branch of the birurcation diagram
in the two central cells while remaining on the low expression branch in the
two neighbouring cells. Furthermore, the expression of LAX3 in the central
cells will reduce auxin in the neighbouring cells due to increased auxin influx
into the LAX3 expressing cells, ensuring expression in those cells remains
on the low expression branch. The bistability ensures that even if the auxin
signal from the LRP drops slightly, either temporarily or permanently, ex-
pression in the two central cortical cells remains on the higher branch of the
bifurcation diagram, so that LAX3 expression is kept switched on, and the
required spatial expression pattern is maintained.
2.1.4 Time Course Simulations
Simulation of Auxin Treatment
To simulate the addition of exogenous auxin to 7 day old seedlings as in
the qRT-PCR data we first run the model to steady state using a value
of xaux = 0.001, then change to xaux = 1 and run the model from the
previous steady state. Initially we assume this increase in xaux is constant
throughout the time course. If the treatment concentration represented by
xaux = 1 is 1µM auxin, then the basal estimate for endogenous auxin of
xaux = 0.001 represents a concentration of 1nM . All numerical solutions
of the model presented here were found using the ode15s ODE solver within
the MATLAB software package. The model time course response using the
parameters in table 2.1 is given in figure 2.5. The model species concen-
trations are dimensionless, but time is shown in hours using a value for
the scaling parameter µim = 0.4, obtained from an average of values for
Aux/IAA mRNA decay rates given in Narsai et al. (2007).
As expected, initially there is a rapid increase in auxin followed by a
decrease to near zero of Aux/IAA within around 2 hours due to the per-
ception of auxin by TIR1 accelerating its degradation. Levels of free ARF
increase while ARF-Aux/IAA dimers decrease leading to expression of the
primary response genes, Aux/IAA and X, then the secondary response gene
LAX3. LAX3 then feeds back into the pool of intracellular auxin with an
additional auxin increase after 5 hours. The main qualitative difference
between this and the observed expression data is that the expression data
peak after 12 hours before tailing off (figure 1.9), while the model mRNAs
stay upregulated as long as the auxin signal persists.
Time Course with Bistability
Figure 2.6 shows model LAX3 mRNA against time using a parameter set
identified to have bistability in section 2.1.3. The parameters are as given in
table 2.1, but with the co-operativity coefficients for binding of ARF to the
tfX promoter (nx), and the binding of tfX to the LAX3 promoter (nl) set
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Figure 2.5: Model response (y-axis) against time (hours, x-axis) for each model
species using the parameter estimates given in table 2.1, following
an increase in signal at t = 0. Blue lines: persistent auxin signal,
red lines: exponential decay of auxin signal (µtr = 0.5). Nondi-
mensional time is scaled into hours using a value for the rescaling
parameter µim = 0.4.
equal to 3. In each case the model is run from steady state, at either a basal
auxin level of xaux0 = 0.01, or xaux0 = 0.03, following a change in xaux
to a range of treatment values between the upper and lower basal concen-
trations. For the lowest two treatment concentrations (xaux = 0.01, 0.015)
steady state LAX3 mRNA is very low regardless of the initial concentra-
tion, while for the higher treatments (xaux = 0.025, 0.03) steady state
LAX3 expression is relatively high regardless of the initial concentration.
For xaux = 0.02, however, LAX3 mRNA can have either a high steady
state, if the initial level of auxin is high, or a low steady state if the initial
auxin level is low.
The steady state analysis (section 2.1.3), and the time course described
above, show that it is possible for the LAX3 model to have bistability, and
that this may explain the all-or-nothing LAX3-YFP expression observed
in cortical cells during lateral root emergence. This possibility will be in-
vestigated in the spatial context using tissue and multi-scale modelling in
chapters 5 and 6. In particular, greater consideration will be given to the
time-scales over which changes in auxin diffusion and transport are tak-
ing place. In figure 2.6, while the possibility of bistability is shown, when
using the current parameter values for auxin turnover, transport and dif-
fusion, the time-scales over which changes in LAX3 expression occur can
be many hours. Further investigation is needed to establish whether or not
these parameter values are biologically realistic. In the following sections,
we compare the existing model with the qRT-PCR data following auxin
treatment shown in figure 1.9.
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Figure 2.6: Model response (y-axis) against time (hours, x-axis) for LAX3
mRNA using the parameter estimates given in table 2.1, but with
nx, nl = 3, following a change in auxin signal at t = 0 (see figure
legend). Solid lines are the model response from steady state at
xaux0 = 0.01, dashed lines the response from xaux0 = 0.03. For
a change in signal to xaux = 0.02 (blue lines) there is a different
steady state depending on initial conditions, demonstrating bista-
bility. For all other values there is a single steady state regardless of
initial conditions. Nondimensional time is scaled into hours using
a value for the rescaling parameter µim = 0.4.
Decay of auxin signal
With the initial parameter estimates, we see that in order for the model
to match experimental data (figure 1.9), even qualitatively, an additional
model component is needed which will result in downregulation of genes
over the latter part of the time course simulation. The simplest mechanism
by which this can occur is that following the initial treatment the exogenous
auxin signal is degraded exponentially over time so that:
xaux(t) = xaux0 + (xauxtr − xaux0)e
−µtrt, (2.8)
where xaux0 represents the basal auxin concentration pre-treatment, xauxtr
is the auxin treatment concentration, and µtr is the rate of exponential decay
of the signal.
With an initial estimate of µtr = 0.5 hour
−1, the model gives a much
improved qualitative comparison between model and experiment as shown
in figure 2.5. After the initial rapid increase in cellular auxin following
treatment, rather than continuing to increase with the expression of LAX3,
auxin gradually returns toward its initial basal level. Though this would
appear to negate the effect of LAX3 expression, it should be noted that the
aim here initially is to simulate the genetic response of the plant to an ex-
cess (1µM concentration) of exogenous auxin, rather than model the effect
of LAX3 expression on cellular auxin during normal lateral root emergence.
The effect of LAX3 on cellular accumulation of auxin and the spatial dis-
tribution of auxin within the root will be investigated in detail in chapters
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5 and 6. As the auxin in the cell decreases, so this is perceived by the TIR1
receptors, causing a recovery of Aux/IAA protein, which results in the re-
pression of free ARF, and ultimately a decrease in the rate of expression of
the response mRNAs causes the levels of mRNAs and response proteins to
drop back toward basal levels.
There are a number of mechanisms that may cause the decay in signal.
There may be a degradation of auxin in the experimental medium due to
high exposure to light (Dunlap and Robacker 1988). Alternatively there
may be a mechanism endogenous to the plant such as increased auxin con-
jugation to amino acids, following which its signalling capability is removed
(Ljung et al. 2002), reduced auxin biosynthesis, or compartmentalisation of
auxin away from detection in the nucleus. Two of these mechanisms in par-
ticular, auxin inducible auxin conjugation and the decay in the experimental
medium, are investigated further in sections 3.1 and 2.2.4 respectively.
2.2 Parameter Fitting and Predictions From
Initial LAX3 Models
Previously, we saw that using the initial parameter estimates and adding
an exponential decay to the initial auxin signal it is possible to match qual-
itatively the experimentally observed behaviour of model components. In
this section we test the model further by optimising parameter values to fit
the model response with quantitative experimental data.
After first describing the fitting algorithm used, we show the best fit
of the model with LAX3 and IAA14 mRNA expression data, with un-
constrained parameters, and no decay of the auxin signal. Next, by not-
ing that there is likely to be a separation of timescales between protein-
protein/auxin-receptor interactions and gene expression, we simplify the
model and, using the parameter fitting algorithm again, establish that with
this separation of timescales the decay in auxin signal is required. Finally,
we show new data that supports the model predictions, while also suggest-
ing that an additional auxin homeostasis mechanism is needed in the model
to simulate the temporal response of LAX3 and IAA14 to auxin treatment.
2.2.1 Fitting Algorithm
The parameter fitting in this section and throughout was done using the
optimization toolbox within MATLAB. A hybrid of two fitting algorithms
was used. First an evolutionary or genetic algorithm (MATLAB function
‘ga’) was used to search the global parameter space. The genetic algorithm
starts at the first iteration with a randomly generated population of param-
eter sets and for this and each further generation of iteration selects a subset
of the the best fits of the model with the data according to a pre-defined
objective or fitness function. For each further iteration the subset of best
fits is added not only to a new set of randomly generated parameter sets,
but also to a set of parameter sets of slightly altered or ‘mutated’ versions
and recombined pairs or ‘offspring’ of the best fits from the previous itera-
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tion. In this way, at each generation a better fit to the data is found, or the
best fit from the previous iteration is retained, until a stopping criterion
is reached. This may be a maxium number of iterations, or a threshold
in the fitness function, or no change in the fitness function for a number
of generations, any other user-definable criteria. Because the genetic algo-
rithm is a stochastic process however, it may need to be run a number of
times to improve the likelihood of finding a good fit to the data, or to help
establish that no good agreement between model and data is possible. The
parameter space searched was chosen to be logarithmic (base 10) so that
e.g. a value of between 0.001 and 0.01 is as likely to be selected as a value
between 100 and 1000. Initially, bounds were placed on parameter values
of between 10−10 and 1010, with the exception of co-operativity coefficients
which are bounded between 1 and 4, and basal cellular auxin (xaux0) which
is bounded between 10−4 and 1.
The best solution found with the genetic algorithm was then optimised
further using the Matlab function ‘fmincon’. Taking the result of the genetic
algorithm as a starting point, at each iteration a small step is taken in n-
dimensional space (where n is the number of parameters being fitted) along
the line of steepest descent in the fitness function. This continues until
a local minimum is found. Adding the local minimum search generally
improves the result found by the genetic algorithm. For both algorithms
the objective function to be minimised is the sum of squared differences
between each data point and the model value at that time point relative to
steady state at t = 0, relative to the squared sum of differences between the
mean of the data and the data themselves (i.e. the variance of the data):
f =
n∑
i=1
( modeli
modelss
− datai)
2
n∑
i=1
(data− datai)2
,
where n is the number of time points, modelss is model steady state at
t = 0, modeli and datai are the respective model and data values at the i
th
time point, and data is the mean of the data values.
Since all the quantitative data used for the parameter fitting represents
relative values or fold-changes from time=0, all model values are scaled rel-
ative to their steady state values. Similarly, scaling the objective function
with the variance of the data allows for similar weights to be given to mul-
tiple data series when optimising the model parameters against them all si-
multaneously. For example, in the following section the model is optimised
against data series for both LAX3 and IAA14 mRNAs. The magnitude
of auxin response of LAX3 and IAA14 may differ greatly, but evaluating
the objective function for a given parameter set for each separately, scaling
with the variance of the data, and then adding the values helps to give equal
weighting to both data series. This can prevent the algorithm preferentially
fitting the model to the data series with the greatest magnitude response.
Since time is scaled in the non-dimensional model so that t = τ/µim ,
where τ is non-dimensional time and t dimensional time, the time points
in the data series are also scaled into non-dimensional time using a value
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of µim = 0.4 hour
−1 before the parameter fitting algorithm is run. When
using the fitted parameter values therefore, time must be rescaled back to
dimensional time in order to compare with the data on the same axes. In
general, most of the fitted parameters values given from now on will be
non-dimensional, while the plots will be shown in dimensional time using
µim = 0.4 hour
−1.
2.2.2 Parameter Fitting using Full Model
Though we estimate that protein-protein and auxin-receptor reaction rates
are likely to be an order of magnitude greater than mRNA and protein
turnover rates, we first attempt to fit the model with the qRT-PCR data
shown in figure 1.9 for wild type LAX3 and IAA14 mRNA following treat-
ment with 1µM auxin, using a persistent auxin signal, and with wide bounds
(10−10 to 1010) on the rate parameter values. With these criteria, it is pos-
sible to find parameter sets for which model and data show good agreement
(f = 0.0315, figure 2.7, for parameter values see table 2.2). The param-
eter set presented here is one of several found using the fitting algorithm
with similar values for f , and while individual parameter values differ be-
tween them, the overall behaviour is representative and conclusions made
are similar for all parameter sets fitted in this way.
The model behaviour using the fitted parameter values can be explained
as follows. For any fixed value of exogenous auxin, there will be a corre-
sponding steady state value of Aux/IAA, the key regulator of auxin genes
(with this parameter set there is no bistability, see figure 2.8(a)). If, as here,
the rates of protein-protein interactions and ubiquitination are sufficiently
slow so that it takes many hours for Aux/IAA to reach its steady state,
shortly following the introduction of the auxin signal there is a temporary
low level of Aux/IAA allowing response genes to be expressed, before there
is a gradual accumulation of Aux/IAA later on in the time course, as the
positive feedback on Aux/IAA due to increased expression takes time to be
perceived. Though there is a temporary dip in Aux/IAA before recovery
over longer timescales, as long as the auxin signal remains the steady state
Aux/IAA will always remain lower than the basal level without the signal.
In this case however, the steady state with the signal is relatively close to
the basal level and so, in conjunction with relatively slow rate parameters
this causes the large drop, followed by re-accumulation of Aux/IAA to the
new steady state, as required to simulate the mRNA time course profiles
(figure 2.7) .
If we compare the steady state Aux/IAA with increasing auxin signal
using the fitted parameter set 2.2 and the estimated parameters given in
table 2.1, we see that the steady state auxin using the fitted parameters
is much less sensitive, even to very large changes in auxin, than with the
parameter estimates (figure 2.8(a)). It is only via the adding of auxin to ex-
cess, as in the qRT-PCR experiment, that a transient low level of Aux/IAA
occurs, allowing a temporary genetic response. During endogenous pro-
cesses within the plant however, changes in cellular auxin are likely to be
much less dramatic, and so with this range of steady states for Aux/IAA
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Figure 2.7: Response of model given by equations (2.5), relative to initial steady
state, following simulated 1µM auxin treatment (y-axis) against
time for each model species using the parameter estimates given in
table 2.2 (solid lines). The initial conditions are the steady state
values at the basal level of auxin, xaux0. Diamonds show experi-
mental data points for LAX3 and IAA14 mRNAs. The model shows
good agreement with the data, but this depends on relatively slow
rates for protein-protein interactions and the rate of Aux/IAA ubiq-
uitination.
54
Table 2.2: Fitted non-dimensional parameters used in figures 2.7 and 2.8. Other
parameter sets were found, using the fitting algorithm, which pro-
duce similar results for all model species.
pa pd ka kd qa qd qm
1.8080 2.6259 8.2037 12.3684 7.1601 0.3002 0.0746
ηarf ηiaa ηtir xaux0 αx αlax µaux
1.1473 8.0930 0.2375 0.0044 9.9254 11.9277 1.7213
ni θa θr µl µlm nl ψx
3.5732 0.1566 0.1127 7.0816 0.6072 1.3975 0.5369
µx µxm nx φa φr
11.4126 11.2955 1.5197 0.0417 0.0400
the cells will be relatively unresponsive to auxin.
Another argument against the biological relevance of this fitted param-
eter set is given by looking at the very early response of Aux/IAA to the
auxin treatment (figure 2.8(b)). Looking at the first hour there is a sig-
moidal shape, with a delay of around 5 to 10 minutes before the Aux/IAA
begins to be rapidly degraded. This is contrary to previous experimen-
tal observations in which there is more rapid reponse in the degradation
of Aux/IAAs (2 minutes in PS-IAA4 and PS-IAA6 (Abel et al. 1994), 2
minutes for IAA1 (Zenser et al. 2001), 2.5 minutes for IAA17 (Dreher et al.
2006)). For this and the reasons above, while the model can show agreement
with the mRNA data, the parameter set required is not biologically realis-
tic, and the early response of model Aux/IAA is qualitatively different to
that previously observed eperimentally. In particular, data and modelling
shown in the recent publication by Band et al. (2012) give evidence that
auxin mediated degradation of Aux/IAA is at its maximum rate within 2
minutes following auxin treatment. The data published in that paper will
be used to refine the model further in section 2.2.4.
2.2.3 Model Simplifications
The model given by equations (2.5a)-(2.5l), with a persistent auxin signal,
is able to simulate mRNA data for LAX3 and IAA14 mRNAs, provided
protein-protein, receptor-auxin, and ubiquitination reactions are permitted
to occur on a similar or slower timescale than mRNA and protein turnover
rates. However, for reasons discussed in section 2.2.2 this is unlikely to
be biologically realistic. It would be possible to adjust the bounds on the
parameter values in question during the parameter fitting to within a more
biologically realistic range, however since we estimate some parameter values
to be large in magnitude compared to the others this allows for one or more
quasi-steady state approximations to be made, and so simplify the model,
as described below.
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(a) Steady state Aux/IAA protein with increasing exogenous auxin. Auxin is relative to
the estimated or fitted basal concentration, while Aux/IAA is relative to the steady state
at basal auxin.
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(b) Aux/IAA protein against time for 60 minutes following simulated 1µM auxin treat-
ment.
Figure 2.8: Comparison of steady state (figure 2.8(a)) and early time course
(figure 2.8(b)) Aux/IAA for both the fitted parameters given in
table 2.2 (blue line), and the estimated parameters given in table
2.1 (black line).
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Protein-protein auxin-receptor and ubiquitination reactions
If we assume that the nondimensional parameter values ka, kd, pa, pd, qa,
qd, and qm are large in magnitude in comparison to the nondimensional
timescale µim , we can neglect the derivatives in equations (2.5b)-(2.5d) and
(2.5f)-(2.5g). Rearranging, we have the following quasi-steady state values
for TIR, TIRa, TIRai, ARF and AI (the
∗ notation indicates quasi-steady
state values):
TIR∗ =
QP
QP +Qauxin+ auxinIAA
, (2.9)
TIR∗a =
Qauxin
QP +Qauxin+ auxin IAA
, (2.10)
TIR∗ai =
auxin IAA
QP +Qauxin+ auxin IAA
, (2.11)
ARF ∗ =
K
IAA+K
, (2.12)
AI∗ =
IAA
IAA+K
, (2.13)
where we define K ≡ kd
ka
, P ≡ pd
pa
, Q ≡ (qd+qm)
qa
, and η ≡ ηiaaqm. Substituting
for TIR, TIRa, TIRai, ARF and AI in the original model (2.5a)-(2.5l) we
have the following nondimensional model in 7 variables:
dauxin
dt
= xaux(t)(αaux + αlaxLAX)− µauxauxin, (2.14a)
dIAA
dt
=
−ηauxinIAA
QP +Qauxin+ auxinIAA
+ IAAm, (2.14b)
dIAAm
dt
= Ftc
(
K
θia(IAA+K)
,
IAA
θir(IAA+K)
, ni
)
− IAAm, (2.14c)
dXm
dt
= µxm
(
Ftc
(
K
θxa(IAA+K)
,
IAA
θxr(IAA+K)
, nx
)
−Xm
)
,
(2.14d)
dX
dt
= µx(Xm −X), (2.14e)
dLAXm
dt
= µlm
(
Ftc
(
X
θla
, 0, nl
)
− LAXm
)
, (2.14f)
dLAX
dt
= µl(LAXm − LAX), (2.14g)
Of particular note are the quasi-steady state substitutions for ARF and
AI given in equations (2.12) and (2.13), which depend only on the values
of the constant K and the variable IAA at any given time. This is a
consequence of the assumption that ARF remains constant, as seen in the
ARF7 expression data, and means that the rate of expression of ARF7
responsive genes depends only on the level of Aux/IAA protein and the
parameter value K, which may be thought of as the equilibrium coefficient
in the binding and unbinding of ARF with Aux/IAA. In other words, for a
fixed amount of total ARF, K is the value of Aux/IAA at which unbound
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ARF activator is equal to bound ARF-Aux/IAA repressor dimers. This
relationship is shown in figure 2.9.
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Figure 2.9: Quasi-steady state unbound ARF and ARF-Aux/IAA dimers for
increasing fixed values of unbound Aux/IAA. Total bound and un-
bound ARF is always equal to one and, when Aux/IAA is equal to
the parameter value K, the proportion of free ARF activators and
ARF-Aux/IAA dimer repressors is equal.
Auxin diffusion, transport and turnover
The initial parameter estimates for auxin diffusion across the cell mem-
brane (αx), active transport (αlax), and cellular turnover (µaux), are only
around 10-fold greater than the turnover rates for the response mRNAs and
proteins. However, the rapid response of plant tissues to auxin treatment
suggests these estimates may be too small. If we assume then that αx, αlax,
and µaux are all comparably large compared to the nondimensional timescale
µim we can also neglect the derivative of auxin in (2.14a). Rearranging gives
the following expression for quasi-steady state auxin (auxin∗):
auxin∗ = xaux(t)
(
αx
µaux
)(
1 +
αlax
αx
LAX
)
(2.15)
Substituting this in (2.14b), rearranging, and setting p ≡ Pµlax/αx and
α ≡ αlax/αx, we have the following nondimensional model in 6 variables:
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dIAA
dt
=
−η xaux(t)(1 + αLAX)IAA
Qp+ xaux(t)(1 + αLAX)(Q+ IAA)
+ IAAm, (2.16a)
dIAAm
dt
= Ftc
(
K
θia(IAA+K)
,
IAA
θir(IAA+K)
, ni
)
− IAAm, (2.16b)
dXm
dt
= µxm
(
Ftc
(
K
θxa(IAA+K)
,
IAA
θxr(IAA+K)
, nx
)
−Xm
)
,
(2.16c)
dX
dt
= µx(Xm −X), (2.16d)
dLAXm
dt
= µlm
(
Ftc
(
X
θla
, 0, nl
)
− LAXm
)
, (2.16e)
dLAX
dt
= µl(LAXm − LAX). (2.16f)
Comparison of model simplifications
We now have our original model and two sucessive simplifications: -
1. Original model in twelve variables - equations (2.5)
2. Assumption that auxin signalling via TIR1 and dimerisation of ARF
and Aux/IAAs is rapid compared to nondimensional timescale - equa-
tions (2.14)
3. Assumption that auxin diffusion, transport and turnover is rapid com-
pared to nondimensional timescale - equations (2.16)
Figure 2.10 shows a time course simulation using the default parameter
set given in table 2.1 for each of the three models listed above. Over the
longer 40-hour time scale shown in figure 2.10(a) all the models are clearly
very similar for the given parameter regime. Even when looking closely over
the first 2 hours as in figure 2.10(b), the original model is indistinguishable
from the first approximation. There are however some differences between
the second approximation and the other models. Firstly, the instantaneous
change in auxin at t = 0 results in corresponding instantaneous changes in
the balance between the concentrations of TIR1 in its different bound and
unbound forms. In particular, TIRai is immediately many times greater
than in the other models. The result of this is that IAA14 protein is de-
graded slightly more rapidly over the earliest part of the time course, though
after two hours this difference is no longer apparent. The earlier degradation
of Aux/IAA does, however, result in a slightly earlier increase in ARF and
decrease in ARF-Aux/IAA dimers, and so the response mRNAs are initially
up-regulated very slightly earlier. As we see in figure 2.10(a) though, there
is little or no difference to the peak expression values attained.
While for the estimated parameters there does not appear to be much
difference between the three models used over the longer time scale (tens
of hours), the subtle differences in values for model species over the first
two hours shown in the model with the second approximation compared
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(a) Model response (y-axis) against time (hours, x-axis) for each model species using the
parameter estimates given in table 2.1, for the original ‘full’ model and 2 approximations,
following an increased auxin signal at t = 0, with a subsequent decay of that signal (µtr =
0.5). Nondimensional time is scaled into hours using a value for the rescaling parameter
µim = 0.4.
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(b) As 2.10(a) but only the first two hours of the time-course are shown.
Figure 2.10: Comparison of model response over time between original model,
and two sucessive quasi-steady state simplifications.
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to the other two models may be more significant when additional compo-
nents are added to the model, and when, as in section 2.3 we attempt to
fit model parameters relating to the early degradation of Aux/IAA. In ad-
dition, in section 3.1 we investigate possible auxin homeostasis mechanisms
which may occur over longer time scales than diffusion and transport, mean-
ing that the quasi-steady state approximation for auxin may no longer be
valid. For these reasons, in the following sections we use the model given
by equations (2.14) as a reasonable approximation for the full model given
by equations (2.5), provided the assumption that protein-protein, auxin-
receptor and ubiquitination reactions are relatively rapid holds. In Chapter
5 we investigate the processes and rate parameter values of auxin transport
and turnover further, in the context of a multicellular model.
2.2.4 Parameter Fitting Using Reduced Model
Before testing the ability of the model to match the data with the addition
of a decay in the auxin signal, we first run the parameter fitting algorithm
using the reduced model with a persistent auxin signal. In addition to the
constraints on parameter values described previously, we have the additional
constraint that αlax, the maximum rate of active transport, is between 1 and
100 times αx, the rate of auxin diffusion. The fitting algorithm was run a
total of five times for the model given by equations (2.14) and the best fit
found had an f-value of 0.302. This is in comparison to the best f-value of
0.0315 found for the full model, as shown in figures 2.7 and 2.8. Figure 2.11
shows the best fit for simulated LAX3 and IAA14 mRNA in comparison
with the PCR data, in addition to model IAA14 protein.
There is some down-regulation of the mRNAs following the initial induc-
tion, due to the positive feedback on IAA14 protein. However, the speed
of key reactions means induction of the response mRNAs is arrested too
quickly due to increased IAA14 protein, for the model to show good agree-
ment with the data. The short and long term behaviour of Aux/IAA protein
will be investigated further in section 2.3. For now however, if we keep the
assumption of a separation of timescales between protein-protein interac-
tions and mRNA and protein turnover, then we conclude the reduced model
cannot show a good agreement with the data when simulating a persistent
auxin signal.
Decay of Auxin Signal
As described in section 2.1.4, adding an exponential decay to the initial
auxin signal (equation 2.8) will, in general, significantly improve the qual-
itative fit of the model with the mRNA data. Using the parameter fitting
algorithm enables a quantitative fit with the data to be made, using the de-
cay of exogenous auxin, as shown in figure 2.11. The best fit has an f-value
of 0.0336, with the fitted parameter values given in Table 2.3.
In total the parameter fitting algorithm was run 5 times for the reduced
models, with a threshold for a ‘good’ fit with the data of f = 0.1. For the
best fit, the nondimensional signal decay rate µtr = 1.451, which, with an
estimate for µim = 0.4, represents a dimensional decay rate of 0.58 hour
−1.
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Figure 2.11: Best fits of the model IAA14 and LAX3 mRNAs with qRT-PCR
data shown in figure 1.9 (Benjamin Peret, personal communica-
tion), following 1 µM simulated auxin treatment. Also shown is
the model prediction for IAA14 protein. Blue lines have a per-
sisitent auxin signal, red lines have the measured decay of auxin
on the experimental medium (µtr = 0.0729 hour
−1), while for the
black lines the decay rate is fitted along with the other parame-
ters (µtr = 0.58 hour
−1). The crosses represent the data points
against which the parameters were fitted.
Table 2.3: Best fitted (f = 0.0336) non-dimensional parameters for the model
given in equations (2.14a)-(2.14g) with decay of exogenous auxin
signal (equation 2.8).
P Q K η xaux0 µtr αlax αx
4.0955 1.3724 2.1671 60.2363 0.0007 1.4514 53.6719 1.6135
µaux ni θia θir µx µxm nx θxa
1.4371 2.5026 0.0261 0.0660 241.1434 3.7905 1.1050 0.3830
θxr µl µlm nl θla µtr
0.9718 3.0628 0.6947 1.8588 0.9355 1.451
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In the following section, we investigate whether the degradation of auxin on
the experimental medium is a plausible explanation for a decay rate of this
magnitude.
Decay rate of auxin on experimental medium
A possible source of decay in the auxin signal is degradation in light of
the auxin in the experimental medium itself. This decay was measured
in the study by Dunlap and Robacker (1988), from which a half-life of
approximately 2.4 days can be estimated, or a decay rate of 0.012 hour−1.
This decay rate was measured using a weaker light source than was used
during the qRT-PCR experiment for which we have data, and so to establish
the likely auxin decay rate for the data used to test the model a similar
experiment was performed using the same light conditions (Ilkka Sairanen,
personal communication). Both 1µM and 0.01µM auxin in liquid medium
was exposed to light, and the auxin concentration was measured, relative
to the initial value, after 2, 15, and 38 hours (figure 2.12).
For both auxin concentrations there was a clear decay over the time
course, at a similar rate. This decay can be modelled using an exponential
decay as in equation 2.8, but with xaux0, the basal auxin concentration, set
to zero in the medium so that:
xaux(t) = xauxtre
−µtrt, (2.17)
with an optimal fitted decay rate (µtr) of 0.0729 hour
−1 (figure 2.12). With
an estimate of µim = 0.4 for the timescale this gives a non-dimensional value
of µtr = 0.182.
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Figure 2.12: The degradation of auxin in light over time can be modelled
with a exponential decay from the initial value, with decay rate
0.0729 hour−1. 1µM and 0.01µM auxin in liquid medium was ex-
posed to light, and the auxin concentration measured, relative to
the initial value, after 2, 15, and 38 hours (Ilkka Sairanen, personal
communication).
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As would be expected when using a stronger light source than in the
previous study, the auxin decay rate is higher. However, this value is less
than one third of the value fitted to the mRNA data in the previous section.
To test whether the measured value is still sufficient to account for the
recovery of Aux/IAA needed to repress the auxin response genes following
initial activation, the parameter fitting algorithm was again run a total of
five times, but with a fixed value for µtr = 0.182. Figure 2.11 shows the
best fit of the model against the LAX3 and IAA14 mRNA data.
As shown in figure 2.11 it is possible for the model LAX3 and IAA14
mRNA to show good agreement with the data (f = 0.0363), using the exper-
imentally determined rate for the decay of auxin on the medium. However,
as in the case where there is no decay in the signal, this depends on a rel-
atively small proportion of the total IAA14 to be degraded following the
initial increase in auxin signal. In contrast to the zero decay case though,
the recovery of Aux/IAA depends on a decrease of auxin in the cell, rather
than the positive feedback of Aux/IAA expression but, in both cases, at
the treatment concentration simulated, the degradation rate of Aux/IAA
has not yet reached saturation, and so gene expression is more sensitive to
smaller changes in Aux/IAA. For this case then, a relatively slow degra-
dation rate of auxin is able to alter Aux/IAA sufficiently to reduce gene
expression rates enough within the time frame in order to fit the data.
Close inspection of the data in figure 2.12 shows that after around 30
hours exposure to light, there is still around 10% of the initial value of
auxin remaining. For 1µM treatment this represents 100nM remaining on
the medium. As shown in Band et al. (2012) we would still expect to see
strong degradation of Aux/IAA at this auxin concentration, and so even
with degradation of auxin at the experimentally determined rate, there
would be insufficient recovery of Aux/IAA within the timescale needed to
down-regulate the response genes. In section 2.3 therefore, the parameter-
isation of the model will be improved further using the dose response data
and modelling first published in Band et al. (2012), along with additional
experimental results that give further evidence for a homeostatic response
to auxin treatment on cellular auxin levels.
2.3 Short and long term behaviour of Aux/IAA
(DII-VENUS model)
In section 2.2.4 it was shown that some form of decay of the auxin signal
is required to fit the reduced model with the LAX3 and IAA14 qRT-PCR
data shown in figure 1.9. However, to test whether the measured decay rate
of auxin on the experimental medium is sufficiently fast to cause enough of
a recovery in Aux/IAA within the time frame needed to down-regulate the
response genes, closer attention must be paid to the short and long term
behaviour of the Aux/IAA protein. In particular, the response of Aux/IAA
to a range of auxin treatments must be considered.
In Band et al. (2012), the auxin sensor DII-VENUS, which is the Aux/IAA
IAA28 domain II fused to the yellow fluorescent protein VENUS, was used
64
to quantify and model the response of roots to a range of auxin concentra-
tions for two hours after treatment. A parameter fitting algorithm was used
to obtain parameter estimates for the auxin influx rate for each treatment
in the range, and estimates for the parameters relating to the degradation
of DII-VENUS. In this section, an alternative version of the published DII-
VENUS model is used to show that the dose response DII-VENUS data
can still be modelled, even with the measured rate of auxin decay on the
experimental medium. The prediction of the fitted model for DII-VENUS
over a longer (30 hour) time scale is then compared with new DII-VENUS
data over this longer time frame, and used to conclude that an additional
auxin homeostasis mechanism is required to explain the apparent recovery
of DII-VENUS levels over time.
2.3.1 Model formulation
Following Band et al. (2012), with the same notation as used here previ-
ously, we have the full dimensional model for DII-VENUS expression in five
variables:
dTIR
dt
= −paTIR auxin+ pdTIRa, (2.18a)
dTIRa
dt
= paTIR auxin− pdTIRa
+(qd + qm)TIRav − qaTIRa DII
∗,(2.18b)
dTIRav
dt
= −(qd + qm)TIRav + qaTIRa DII
∗,(2.18c)
dDII∗
dt
= qdTIRav − qaTIRa DII
∗ − λ∗vDII
∗
+δvDII
∗
m, (2.18d)
dauxin∗
dt
= α∗0 − µ
∗
auxauxin+ α
∗
trxaux(t)
−paTIR auxin+ pdTIRa, (2.18e)
TIR + TIRa + TIRai = tirT , (2.18f)
where DII∗ represents dimensional DII-VENUS, δv is the rate of translation
of the constitutively expressed and constant quantity of DII mRNA, DII∗m,
and λ∗v represents the rate of degradation of DII-VENUS due to photo-
bleaching of the VENUS fluorescence during exposure under the confocal
microscope. The key difference in the behaviour of DII-VENUS, compared
to Aux/IAAs in general is that DII-VENUS mRNA is expressed constitu-
tively, whereas Aux/IAA, in our case IAA14, is expressed in response to
auxin. Replacing xaux, αx, and αlax in the equation for auxin there is a
basal influx rate of auxin (α0) plus an auxin treatment influx rate (α
∗
tr)
which is proportional to the time dependent exogenous auxin (xaux(t)).
To nondimensionalise, we use the same scaling for TIR, TIRa, TIRai
auxin as in section 2.1.2, and also similarly to before we scale DII∗ by the
same factor as IAA so that:
DII =
λiδi
µ2im
DII∗.
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If the auxin-receptor reactions are assumed to be rapid as before, we
can make a similar quasi-steady state approximation as in section 2.2.3 and
rearrange to give the reduced nondimensional model:
dDII
dt
=
−ηauxinDII
QP +Qauxin+ auxinDII
− λvDII + β, (2.19a)
dauxin
dt
= α0 + αtrxaux(t)− µauxauxin, (2.19b)
where the nondimensional parameters Q, P , η and µaux are defined as be-
fore, and with αtr =
α∗tr
xauxTµim
, α0 =
α∗
0
xauxTµim
, β = δvDII
∗
mµim
δiλi
, and λv =
λ∗v
µim
.
xaux(t) remains a dimensional quantity, but when combined with αtr be-
comes a dimensionless term in the model.
If we assume that DII-VENUS and IAA14 mRNA are translated at
similar rates, and that the constitutive level of DII mRNA (DII∗m) is a
similar level as the maximum level of IAA14 mRNA ( λi
µim
), then we can
estimate β = 1. This value for β is used in the parameter fitting that
follows, but the effect of using different values for β is investigated further
in section 2.4.1.
The effect of the decay of auxin in the experimental medium is modelled
as follows:
xaux(t) = (auxintr − auxin0)e
−µtrt, (2.19c)
where auxintr is the treatment concentration, auxin0 =
α∗
0
µ∗aux
is the basal
(no treatment) concentration of auxin, and µtr is the rate of degradation
due to light exposure. Formulating xaux in this way ensures that only when
auxin on the medium is greater than the basal concentration in the root is
there any flux from the medium to the root.
2.3.2 Parameter Fitting
Two hour dataset
Using the same parameter fitting algorithm as described in section 2.2 the
model given by equations (2.19) was fitted with the data published in Band
et al. (2012), using the experimentally measured rate of auxin decay on the
experimental medium (0.0729 hour−1). The dimensional units used for the
auxin treatments are in nM , and the parameter values are bounded between
10−3 and 103, with the exception of auxin0 which is bound between 10
−3
and 1, since as there is some reponse of DII to 1 nM auxin treatment we
assume the basal auxin concentration is less than this value. Again the
estimated value for the timescale is µim = 0.4, and so we multiply the right
hand side of both equations (2.19a)-(2.19b) by this when fitting with time
dimensional data.
As shown in figure 2.13(a), even with a decay of auxin on the medium,
the model is able to show good agreement with the data, with the minimum
value for the objective function found of f = 0.176 (in this case the objective
function used was just the sum of squared differences between model and
data for each auxin treatment, rather than a scaled sum of squares as in
section 2.2). The fitted parameter values are given in Table 2.4. To see
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Table 2.4: Best fitted (f = 0.176) parameter values for the model given by
equations 2.19a-2.19b, with the decay of exogenous auxin, µtr =
0.182 (dimensional value 0.0729 hour−1, with timescale µim = 0.4).
P Q η auxin0 αtr µaux λv α0
5.0006 0.6773 17.5942 0.2717 1.7252 8.2817 0.4229 2.250
whether the measured auxin decay rate is sufficient to cause enough of
a recovery in DII-VENUS, and by extension Aux/IAA, so explaining the
down-regulation of IAA14 and LAX3 following auxin induction, we need to
look at the longer term behaviour of DII-VENUS.
30 hour dataset
Figure 2.13(b) shows DII-VENUS quantification over a 30 hour timecourse
following 1µM auxin treatment (Silvana Porco, personal communication),
along with the simulated time course given by the model with the fitted
parameters given in Table 2.4. We see that the measured rate of auxin
decay on the medium is not fast enough to predict a significant recovery in
DII-VENUS within the 36 hours of the qRT-PCR time course. This can
also be inferred from the amount of DII-VENUS degradation seen following
100nM auxin treatment, which appears to be almost as great as for 1000nM
treatment (figure 2.13(a)), and as we see in figure 2.12 even with the decay
of auxin on the medium we would expect at least 10% of the initial auxin
to remain for 30 hours post-treatment.
In figure 2.14, the parameter values given in table 2.4 were fixed, while
instead of setting µtr to the experimentally determined value for degradation
on the medium, µtr is fitted with the 30 hour DII-VENUS data. The fit
between model and data is clearly imperfect, but the model appears to be
able to match the overall trend of DII-VENUS recovery after about 10 hours
post-auxin treatment, with a dimensional value for µtr = 0.264 hour
−1. The
fitted value of µtr is 3.6 times greater in magnitude than the experimentally
determined value for degradation on the medium. This difference between
the estimate for the decay of exogenous auxin signal, and the apparent rate
of recovery of DII-VENUS caused by removal of intracellular auxin suggests
that an additional mechanism, endogenous to the plant root, is acting to
maintain auxin homeostasis (chapter 3).
Using the fitted value for µtr does not seriously affect the behaviour of
the model in comparison to data over the first two hours post-auxin. Using
the parameter values given in table 2.4 with µtr = 0.264 gives a value for the
objective function f = 0.184 when fitted with the two hour dose response
data, compared with f = 0.176 when µtr = 0.0729. The goodness of fit
is reduced, but the model prediction remains almost completely within the
bounds of experimental error shown.
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(a) DII-VENUS model (Equations 2.19) with decay of auxin on experimental medium
set to the measured value of 0.0729 hour−1 fitted with data published in Band et al.
(2012), following a range of auxin treatments. For parameter values see Table 2.4. The
crosses represent the data with standard error bars shown, while the solid lines the model
simulations at the range of auxin treatments(see key).
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(b) Model with signal decay as in figure 2.13(a) (µtr = 0.0729 hour
−1) following simulated
1000 nM auxin treatment, over 40 hour time course (solid line), and DII-VENUS data
(Silvana Porco, personal communication) following 1000nM auxin treatment for 30 hours
post-treatment (crosses).
Figure 2.13: The DII-VENUS model with a decay in auxin signal is able to
match the short term (2 hour) behaviour observed experimentally,
but the measured rate of degradation of auxin on the medium is
insufficient to account for the longer term (post 10 hours) recov-
ery of DII-VENUS. Data in figure 2.13(a) published in Band et al.
(2012), data in figure 2.13(b) courtesy of Silvana Porco, The Uni-
versity of Nottingham.
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Figure 2.14: The model given by equations (2.19a)-(2.19c) with parameter val-
ues as given in table 2.4, and a faster rate of degradation of the
auxin signal (µtr = 0.264 hour
−1), is able to match the observed
recovery of DII-VENUS (Silvana Porco, personal communication)
without significantly affecting the initial degradation.
2.4 Model Predictions
In section 2.3, it was shown that by adding an exponential decay of a suf-
ficiently high rate to the initial auxin signal, the DII-VENUS model can
show good agreement with the experimental data over both the 2 hour and
30 hour time-courses and, by assumption, approximate intracellular auxin
over that time scale. In section 3.1 further consideration is given to the
mechanism by which the apparent auxin homeostasis occurs, but in this
section we assume that the decay in signal is a reasonable empirical model
for the behaviour of intracellular auxin post-treatment.
The additional assumption when using this model for cellular auxin is
that the positive feedback from LAX3 need not be included. Both the qRT-
PCR and DII-VENUS data represent average values over a whole root and
so while LAX3 auxin feedback is likely to affect auxin distribution and gene
expression spatially within the root, the spatial variations ought to cancel
each over out for whole root data. Even if LAX3 expression late on in the
time course is affecting overall auxin concentration in the root it is taken
into account when fitting µtr (the rate of auxin signal degradation). In
short, any effect of LAX3 on auxin is already factored into the model by
fitting the parameter values to match the DII-VENUS data.
With the assumption that LAX3 feedback is accounted for, and using
the model and fitted parameter values for the DII-VENUS model (equa-
tions 2.19), we can then add back in the expression of IAA14, tfX, and
LAX3 in a stepwise manner, and by fitting the known components to the
mRNA expression data, make predictions for the unknown or unmeasured
components in the model.
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2.4.1 IAA14 mRNA
The first step is to add in the key regulator of LAX3, IAA14 (in conjunction
with ARF7, which we assume is constitutively expressed). Though DII-
VENUS contains domain II of IAA28 rather than that of IAA14, in the
absence of further data we assume that IAA14 is degraded at a similar
rate and dose response as DII-VENUS, and so can use the fitted parameter
values for Q,P , η, α0, αtr and µaux given in Table 2.4 in the following model
of the evolution of IAA14 protein, IAA14 mRNA and auxin:
dIAA
dt
= βIAAm −
ηauxinIAA
QP +Qauxin+ auxinIAA
, (2.20a)
dIAAm
dt
= µ∗im(Ftc
(
K
θia(IAA+K)
,
IAA
θir(IAA+K)
, ni
)
− IAAm), (2.20b)
dauxin
dt
= α0 + αtrxaux(t)− µauxauxin, (2.20c)
where xaux(t) is defined as in equation 2.19c.
The key difference in the equation for IAA14 protein compared to that
for DII-VENUS (equation 2.19a) is the variable level of IAAm, in contrast
to the constitutive value for DII-VENUS mRNA. Since DII-VENUS was
scaled so that the rate of translation was equal to 1, and the scaling of IAAm
used constrains it between 0 and 1, β then represents the maximum rate
rate of translation of IAA14 relative to the constitutive rate of DII-VENUS
translation. The equation for IAA14 mRNA expression is as (2.14c), with
the additional parameter µ∗im representing the true value of IAA14 mRNA
turnover relative to the estimate used previously to scale time (µim = 0.4).
Adding this parameter allows a slower turnover rate for IAA14 mRNA than
if it is fixed according to what may be an incorrect estimate, as was the
case previously.
The three equations (2.20a)-(2.20c) then have 6 parameter values to be
fitted to the IAA14 expression data (K, β, µ∗im , θai, θri and ni) using the
parameter fitting algorithm described previously. Figure 2.15 shows the best
fit for IAA14 mRNA, along with the resulting prediction for IAA14 protein,
and by way of comparison, the DII-VENUS model fit, and both IAA14
mRNA and protein with no decay in auxin treatment signal (µtr = 0). The
fitted parameter values are given in Table 2.5. Using the fitted parameter
values there is a reasonable agreement between model and experimental
values for IAA14 mRNA. The resulting prediction for IAA14 protein is
the expected rapid degradation within the first two hours, with Aux/IAA
staying low for several hours after this. As the auxin signal is degraded, so
the Aux/IAA level increases. However, in contrast to the DII-VENUS, there
is positive feedback on Aux/IAA due to the induced expression of IAA14
mRNA, and so the result is a peak in Aux/IAA protein of around three
times its initial value after about 30 hours. It is only the combination of
low auxin and high mRNA that gives this peak in Aux/IAA as can be seen
by comparing with the plot for µtr = 0 in figure 2.15. Here auxin remains
high and, while there is strong expression of mRNA, the degradation rate
of the protein is also very high and so the protein cannot accumulate.
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Figure 2.15: Model IAA14 mRNA fitted using a parameter fitting algorithm
with qRT-PCR data, along with associated prediction for IAA14
protein. Also shown by way of comparison is the output of the
same set of model parameters with the auxin signal decay set to
zero, and the output of the DII-VENUS model. Only the combi-
nation of high mRNA and low auxin results in strong Aux/IAA
protein levels.
Table 2.5: Best fitted (f = 0.0282) parameter values for IAA14 mRNA to the
data in figure 1.9 using the model given by equations (2.21), plus the
parameter values given in Table 2.4, and with µtr = 0.264 hour
−1.
K µim ni θai θri
0.1011 0.0915 1.7432 0.1179 0.0021
The parameter fitting algorithm was repeated several times, and despite
different sets of fitted parameter values, there was a high degree of consis-
tency in the predictions for IAA14 protein (figure 2.16). In particular, there
was large range of fitted values for the rate of mRNA translation (β = 0.648
to β = 39.4). Since this tightly coupled relationship between IAA14 protein
and mRNA seems to be conserved, regardless of the value of β, we fix β = 1
and run the fitting algorithm once more, resulting in the set of parameters
given in Table 2.5.
2.4.2 LAX3 mRNA
Using β = 1 in equation (2.20a), and equations (2.14d)-(2.14g) for tfX and
LAX3 mRNA and protein gives the following model in seven variables for
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Figure 2.16: Multiple fits of the model in section 2.4.1 with the IAA14 mRNA
data following auxin treatment, plus predictions for IAA14 pro-
tein. Each line of the same colour represents the result from a
different parameter set (see figure legend). Despite differences in
parameter values the predicted profile for both IAA14 mRNA and
IAA14 protein remains the same.
LAX3 expression:
dauxin
dt
= α0 + αtrxaux(t)− µauxauxin, (2.21a)
dIAA
dt
=
−ηauxinIAA
QP +Qauxin+ auxinIAA
+ IAAm, (2.21b)
dIAAm
dt
= µim(Ftc
(
K
θia(IAA+K)
,
IAA
θir(IAA+K)
, ni
)
− IAAm),
(2.21c)
dXm
dt
= µxm
(
Ftc
(
K
θxa(IAA+K)
,
IAA
θxr(IAA+K)
, nx
)
−Xm
)
,
(2.21d)
dX
dt
= µx(Xm −X), (2.21e)
dLAXm
dt
= µlm
(
Ftc
(
X
θla
, 0, nl
)
− LAXm
)
, (2.21f)
dLAX
dt
= µl(LAXm − LAX), (2.21g)
where as before xaux(t) is defined as in equation (2.19c).
Using the parameter values in Tables 2.4 and 2.5, we can then fit the
remaining parameters in the model (2.21) to the LAX3 mRNA data. Figure
2.17 shows the best five model fits to the data.
Though for each fit there is good agreement between model and data
LAX3 mRNA (0.0104 < f < 0.0107), there is some variation in the pre-
dicted expression profile of tfX that, as the upstream activator of LAX3,
will produce the required profile of LAX3. There are several reasons for
this, each relating to parameters in the model. Firstly, there are obvious
differences in the magnitude of the peak level of tfX expression. This will
72
0 5 10 15 20 25 30 35 40
0
2
4
6
8
10
12
14
16
18
20
time / hours
re
la
tiv
e 
ex
pr
es
sio
n
 
 
model LAX3 mRNA
model tfX mRNA
LAX3 mRNA data
Figure 2.17: Best fits of the LAX3 mRNA in the model given by (2.21a)-(2.21g)
(black lines) with the qRT-PCR data from figure 1.9 (black dia-
monds). Also shown are the predictions for tfX for each parameter
set fitted. Five separate parameter sets are shown in total. While
as may be expected there is consistency in the model prediction
for LAX3, and good agreement with the data, there are variations
in timing and magnitude of response for the predictions for tfX.
be due to differences in the parameter θal, which is the affinity of tfX to the
LAX3 promoter. If this value is relatively high, more of the transcription
factor is needed to cause the same level of expression of LAX3 as when the
value is low, and more sensitive to tfX. In other words, changing this param-
eter means that different profiles of tfX can result in the similar expression
profiles for LAX3.
There are also slight differences in the timing of peak tfX expression.
This is due to the biological steps, represented in the model, between the
expression of tfX mRNA and LAX3 mRNA. Firstly, there is a time de-
lay due to the translation of tfX mRNA into protein. This is affected by
the parameter µx, the turnover rate of tfX protein. A low value for this
parameter results in longer delay between peak mRNA and peak protein,
while a high value means that the peak protein occurs soon after the peak
in mRNA expression. In a similar way, the turnover of tfX mRNA, µxm ,
affects the timing of peak mRNA expression following the inductive auxin
signal, with the speed of response increasing with increasing turnover rate.
Because of this, variations in both µx and µxm can result in different tim-
ings of expression profiles of tfX producing the same temporal profile of
tfX protein, and since it is the tfX protein, rather than mRNA that affects
LAX3 expression directly, it is this profile that is important in simulating
the LAX3 expression data.
The second step between tfX and LAX3 mRNA expression is the tran-
scription of LAX3 mRNA in response to the tfX protein. As with tfX, the
turnover rate of LAX3 mRNA (µlm) affects the speed of response follow-
ing transcriptional activation. In this case, a high value for µlm results in
a close relationship in the timing of LAX3 mRNA and tfX protein, while
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a low value results in a longer delay between the two. Again, this means
different profiles for tfX protein can result in the same expression profile for
LAX3 mRNA.
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Figure 2.18: Comparison of model predictions for tfX mRNA, tfX protein, and
LAX3 mRNA, for five different parameter sets fitted to the LAX3
mRNA data. Each profile was normalised by subtracting the basal
level of each profile from every time-point, and then normalising
with the peak value in each profile. Different profiles of tfX mRNA
and protein can result in the same LAX3 mRNA profile.
Figure 2.18 demonstrates how different timings of both tfX mRNA and
tfX protein can result in the same expression profile of LAX3 mRNA. The
figure shows model predictions of tfX mRNA, tfX protein and LAX3 mRNA
for the same five parameter sets as in Figure 2.17. In each case the model
prediction has been normalised so that the magnitude of peak expression is
the same. This was done by subtracting the basal level of each profile from
every time-point, and then normalising with the peak value in each profile:
x =
x− x0
max(x− x0)
,
where x is the normalised value for each time point, x0 is the steady state
value at t = 0, and x is the model value at each time point. By doing this
each expression profile is restricted between zero and one (while expression
remains above the basal level), and so comparisons in the relative timing
can be made more directly.
For four out of the five parameter sets there is a high degree of consis-
tency in the temporal profile of the tfX protein, with the peak level occuring
between two and three hours post-treatment, while the fifth parameter set
has a peak in tfX protein much later, occuring shortly before LAX3. Nev-
ertheless, in each case the expression of LAX3 mRNA is nearly identical.
As described above, this can be explained by the values of the parameter
µlm . For the four cases with a similiar timing of peak tfX protein, the value
of µlm is also very similar (0.179 < µlm < 0.180), while the fifth parame-
ter set where the protein peaks much later the value of µlm is much higher
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(µlm = 3.42), which means that the level of LAX3 mRNA responds much
more quickly to a change in the level of tfX. There is the most variety in the
predictions for tfX mRNA, though the peak expression still occurs within
a range of one or two hours. As discussed above, differences in the timing
of the subsequent steps means that a range of expression profiles can result
in the same expression profile for the downstream target.
2.5 Discussion and Conclusions
Steady State Analysis
By adding LAX3 expression and positive feedback via active auxin transport
to an auxin signalling model it is shown that it is possible for the model to
show bistability in steady state response to an increasing auxin signal. This
bistability may represent a biological switch in gene expression, where at low
auxin expression is very low, at high auxin there is strong gene expression,
and in some intermediate region of auxin levels steady state expression may
be either high or low depending on the previous state of the system. The
observed all or nothing expression pattern of LAX3 (Swarup et al. 2008)
may be explained by this bistable system, as in cells overlying the LRP we
may expect auxin to be higher than in adjacent cells, meaning that in cells
with sufficiently high auxin expression is switched on, while in cells with
slightly less auxin LAX3 expression remains switched off.
The bistability in the model depends on two sets of key parameter values.
Firstly, a relatively high value for the rate of active auxin transport relative
to diffusion is needed. In particular, it should be noted that a higher value
for this parameter is needed than that previously estimated in Swarup et al.
(2005). However, this estimate was based on a fixed concentration of AUX1
transporters on the cell membrane, while here we assume that the rate
of transport is proportional to a variable amount of LAX3 present at any
time, and it may be that when strongly expressed there are many more
LAX3 transporters present than there was AUX1 for the previous estimate.
The second set of key parameters affecting bistability are the co-operativity
coefficients of binding of transcription factors to the tfX (the auxin respon-
sive transcription factor that is assumed to activate LAX3), and LAX3
promoters. If either or both of these values are high enough there will be
bistability, if both are low there will be a more linear response of LAX3
to increasing auxin, and for intermediate values there will be an ultrasen-
sitive response where, though there is only one possible steady state, there
is a range of auxin for which the response changes very rapidly. A high co-
operativity value may represent a number of separate binding sites that must
be occupied for transcription to occur, or a number of copies of a transcrip-
tion factors binding with each other before binding the promoter. Since tfX
remains unidentified, it is currently impossible to gather further evidence to
support or weaken this hypothesis for the presence of co-operativity effects.
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Parameter fitting - persistent auxin signal
The parameter fitting algorithm shows that it is possible for the full model
with weakly constrained parameters to match the transient response of
LAX3 and IAA14 mRNAs seen in the data (figure 1.9) with a persistent
simulated auxin treatment. This is possible due to the negative feedback
from increased Aux/IAA expression occuring relatively slowly, and being
able to significantly change the level of ARF7-bound Aux/IAA. A key pa-
rameter value that allows this to happen is a slow rate of ubiquitination,
which acts a rate limiting step in the degradation of Aux/IAA. In the case
where there is a transient response of Aux/IAA, and so also the response
mRNAs, the TIR1 receptors appear to be saturated with Aux/IAA due to
the slow ubiquitination rate, and so when more Aux/IAA is translated in
response to increased mRNA expression it has a greater relative effect on the
current Aux/IAA protein level than when the Aux/IAA is degraded much
more rapidly (figure 2.7). In general, this fit of the model with the data
is only possible if the protein-protein, auxin-receptor, and protein-receptor
reactions are allowed to occur at a similar or slower rate than transcription,
translation, and protein and mRNA turnover, and this is unlikely to reflect
the biological reality. Because of this the assumption was made that these
reactions occur on a much faster time-scale, and so simplify the model.
Simplifying the model by assuming that the protein-protein and auxin-
receptor interactions occur much more rapidly means that the model is no
longer able to fit the data, in response to a persistent auxin signal. The
mRNAs can still show a transient response, but the speed of the reactions
means that the peak in mRNA occurs too soon to reflect the data. In
addition, this depends on a relatively small proportion of Aux/IAA being
degraded following the initial auxin signal, which is contrary to the response
of Aux/IAA seen experimentally at the simulated 1 µM auxin treatment
(Band et al. 2012).
Parameter fitting - decay in auxin signal
Though with some parameter sets the model is able to simulate, either
qualitatively or quantitatively, the transient response of LAX3 and IAA14
mRNAs to auxin treatment, this results in a prediction for the early re-
sponse of Aux/IAA contrary to that seen experimentally. If, instead of
assuming the auxin treatment concentration remains constant, there is an
exponential degradation of the auxin treatment concentration over time,
it is straightforward to find parameter sets which qualitatively match ex-
perimental observation. for both LAX3 and IAA14 mRNA, and Aux/IAA
protein (figure 2.5).
One possible source of decay in the auxin signal is decay in light of
auxin in the experimental medium. Experimentally, measurements indicate
a half-life of between 9 and 10 hours. The parameter fitting shows that this
rate of decay is enough to simulate the mRNA data, but as before depends
on a shallow initial response of Aux/IAA to the auxin signal. A faster
exogenous auxin decay rate is however able to fit both the mRNA data and
show a more realistic initial response by the Aux/IAA protein.
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DII-VENUS model
To investigate the Aux/IAA response and exogenous auxin decay rate fur-
ther, the modelling and data published in Band et al. (2012) was first tested
with the experimentally determined decay rate of exogenous auxin. Though
there will be differences in the actual fitted parameter values, including the
degradation of auxin on the experimental medium (section 2.2.4) does not
affect the ability of the model to match the DII-VENUS dose response time
course data, for the first two hours post-auxin treatment (figure 2.13(a)).
However, the experimentally determined rate of decay, µtr = 0.0729 hour
−1,
is not sufficiently rapid to account for the observed recovery of DII-VENUS
over the longer, 30 hour, time course (figure 2.13(b)). Using a faster rate of
µtr = 0.264 hour
−1, the model is able to simulate the overall trend of recov-
ery in DII-VENUS after around 10 hours following 1 µM auxin treatment
(figure 2.14). Since we know that any degradation of the exogenous auxin
signal is likely to be occuring at a lower rate than this, the suggests that
there must be another mechanism, endogenous to the plant root, acting to
maintain a homeostasis of intracellular auxin. One such mechanism, auxin
inducible auxin conjugation by the auxin early response gene family GH3,
is discussed and modelled in chapter 3.
Since even with the higher rate for µtr, so that the observed recovery
of DII-VENUS occurs within the correct time frame, the early response of
DII-VENUS is not greatly affected, then the exponential decay of the initial
auxin signal at this rate would appear to be a reasonable empirical model
for cellular auxin post-treatment. Because of this, the signal decay model
was fitted to the available data, allowing predictions about the unknown or
unmeasured model components to be made. In chapter 4 we also use this
model as an approximation for intracellular auxin when simulating more
complex regulatory networks for LAX3, under the influence of two auxin
response factors (ARF7 and ARF19).
Predictions for mRNA expression
With the assumption that when modelling the whole root data the positive
feedback on intracellular auxin from LAX3 can be omitted, it is straightfor-
ward to fit the model with first the IAA14 mRNA data, and then the LAX3
mRNA data. When fitting with the IAA14 mRNA data the model predicts
that following the initial rapid degradation of the IAA14 protein, the com-
bination of positive feedback on protein level, and the degradation of the
exogenous auxin signal causing the Aux/IAA degradation rate to return to
a lower rate results in a recovery in IAA14 protein after around 15-20 hours
to a level higher than that seen pre-auxin treatment. As the rate of IAA14
mRNA expression returns to basal level, so does the level of the protein. It
is only the combination of the auxin homeostasis and increased Aux/IAA
mRNA expression that causes the high level of Aux/IAA, which will act to
strongly repress auxin responsive genes. Without the auxin homeostasis,
IAA14 mRNA expression remains high throughout the latter part of the
time-course, but the high level of auxin remaining means that the trans-
lated protein is still rapidly degraded following binding with auxin bound
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TIR1 , and so any recovery in Aux/IAA protein levels is limited.
Fitting the LAX3 mRNA expression data results in a number of parame-
ter sets which all show good agreement with the data. These parameter sets
produce a range of predictions for both tfX mRNA and tfX protein, which
differ in magnitude of peak expression and in the timing of mRNA and
protein, relative to LAX3 mRNA. The key parameters which allow for this
variation in timing are the turnover rate of tfX protein, and the turnover
rate of LAX3 mRNA. While the turnover rate of tfX is still unknown, mea-
suring the rate for LAX3 mRNA would effectively fix a prediction for the
tfX protein, from which a narrower range of predictions for the tfX mRNA
could be inferred. Though Narsai et al. (2007) published a large dataset
of mRNA degradation rates, LAX3 was not among them. However, the
range of fitted values for LAX3 mRNA turnover is well within the mea-
sured physiological range, and can result in a prediction of the time of peak
tfX protein level varying by several hours (figure 2.18). Nonetheless, there
is some consistency in the prediction of the shape of the expression profile
for tfX mRNA, which may be used to identify the best candidates for tfX
from experimental data. In the above discussion we only consider the possi-
bility that there is a single transcription factor activating LAX3. In general
terms, adding more unknown components to the model will only add to the
variety of expression profiles which an activator of LAX3 may take, and so
any further conclusions are unlikely to be possible as long as any or all of
the regulators remain unidentified.
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Chapter 3
Auxin Inducible Auxin
Conjugation
3.1 Introduction and Model Formulation
The initial LAX3 expression model relies on the decay over time of an ini-
tial exogenous auxin signal to model the experimentally observed behaviour
of LAX3 mRNA following auxin treatment. However, as we saw in Section
2.2.4, the rate of decay of auxin on the experimental medium is insufficiently
rapid to account fully for the down-regulation of mRNAs following the ini-
tial auxin response within the timescale observed experimentally. Because
of this, it appears there may be at least one additional auxin homeosta-
sis mechanism endogenous to the plant, which we seek to simulate within
the single cell model. One such mechanism may be auxin conjugation, in
which cellular auxin is conjugated to amino acids, removing its signalling
capability (Ljung et al. 2002). A family of genes, the GH3s, have been
shown to have some members which conjugate auxin via enzymatic activity
(Staswick et al. 2005). In addition to this, GH3s are among the primary
response genes identified to be upregulated in response to auxin (Abel and
Theologis 1996).
In this section then, we add to the model the mechanism by which auxin
conjugation removes auxin from the active pool depending on the level of
the auxin conjugating GH3 genes present at any given time. These GH3
genes are themselves induced by an increase in cellular auxin. A simplified
gene network diagram for the conjugation model showing the key model
feedbacks is given in Figure 3.1. In Section 3.2 we fit this model to the qRT-
PCR data, while in Sections 3.3 and 3.4 respectively we investigate the effect
of different parameter values on model behaviour over time and at steady
state. In particular, parameter sets for which sustained oscillations in gene
expression occur are found, and key parameters affecting the agreement
between model and data are identified.
3.1.1 Model formulation
GH3 mRNA (Gm) is expressed as a primary auxin response gene in a similar
way as the other primary response genes. There is linear degradation pro-
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Figure 3.1: Model gene network with the inclusion of an auxin conjugating en-
zyme, which itself is induced by auxin (GH3). The conjugation of
auxin has a negative effect on cellular auxin by removing it from the
active signalling pool. As before there is a postive feedback on cel-
lular auxin following expression of LAX3, and a negative feedback
on activation by ARF7 following expression of IAA14.
portional to concentration of the mRNA and GH3 protein and the protein
is itself translated at a fixed rate proportional to the mRNA concentration:
∅
λgFg
−→ Gm
µgm
−→ ∅, ∅
δgGm
−→ G
µg
−→ ∅.
Additionally, GH3 can bind reversibly with auxin, and the complex of GH3
and auxin (Gr) can also disassociate to form conjugated auxin (auxinc) and
GH3:
G+ auxin
ga
⇋
gd
Gr
gm
→ auxinc +G.
This conjugating step is assumed to be irreversible, and once auxin is con-
jugated it is permanently removed from the pool of available signalling
molecules (Figure 3.2).
These reactions are then governed by the following dimensional equa-
tions for the new model quantities:
dG
dt
= δgGm − µgG− gaG auxin+ (gd + gm)Gr, (3.1a)
dGm
dt
= λgFtc
(
ARF
θga
,
AI
θgr
, ng
)
− µgmGm, (3.1b)
dGr
dt
= gaG auxin− (gd + gm)Gr. (3.1c)
In addition, the nondimensional equation for auxin previously given by
(2.14a) is changed to:
dauxin
dt
= (xaux0 + xaux(t))(αx + αlaxLAX)− µauxauxin
−paTIR auxin+ pdTIRa + gdGr − gaG auxin. (3.1d)
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Figure 3.2: Additional interactions included in the auxin conjugation model.
GH3 can bind reversibly with auxin, and GH3 bound auxin can
be conjugated to amino acids leaving free GH3 once more. GH3 is
itself activated by ARF which is repressed by IAA14, which is in
turn degraded by unconjugated auxin.
Here, in addition to the extra reactions with GH3, we differentiate between
the basal endogenous auxin concentration, xaux0, and any exogenous auxin
treatment, xaux(t).
Before combining with the previous LAX3 expression model we first
nondimensionalise where, as before, auxin is scaled with a nominal treat-
ment concentration, and similar rescaling factors as for previous mRNAs
and proteins are used, so that:
auxin =
auxin
xauxT
, G =
λgδg
µgµgm
G, Gr =
λgδg
µgµgm
Gr, Gm =
λg
µgm
Gm
where the bars represent the nondimensional quantities. We also introduce
the new non-dimensional parameters:
ηg =
λgδg
xauxTµgµgm
, ga =
gaxauxT
µim
, gd =
gd
µim
, gm =
gm
µim
,
µg =
µg
µim
, µgm =
µgm
µim
, α0 =
xaux0αx
xauxTµim
, αtr =
αx
xauxTµim
, αlax =
αlax
αx
.
Dropping the bar notation and combining with the simplified model given
by equations (2.14b)-(2.14g) then gives the non-dimensional model in ten
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variables:
dauxin
dt
= (α0 + αtrxaux(t))(1 + αlaxLAX)− µauxauxin
+ ηg(gdGr − gaG auxin), (3.2a)
dIAA
dt
=
−ηauxinIAA
QP +Qauxin+ auxinIAA
+ IAAm, (3.2b)
dIAAm
dt
= Ftc
(
K
θia(IAA+K)
,
IAA
θir(IAA+K)
, ni
)
− IAAm, (3.2c)
dXm
dt
= µxm
(
Ftc
(
K
θxa(IAA+K)
,
IAA
θxr(IAA+K)
, nx
)
−Xm
)
,
(3.2d)
dX
dt
= µx(Xm −X), (3.2e)
dLAXm
dt
= µlm
(
Ftc
(
X
θla
, 0, nl
)
− LAXm
)
, (3.2f)
dLAX
dt
= µl(LAXm − LAX), (3.2g)
dG
dt
= µg(Gm −G)− gaG auxin+ (gd + gm)Gr, (3.2h)
dGm
dt
= µgm(Ftc
(
K
θga(IAA+K)
,
IAA
θgr(IAA+K)
, ng
)
−Gm), (3.2i)
dGr
dt
= gaG auxin− (gd + gm)Gr. (3.2j)
Here we have the assumption that the binding of auxin and Aux/IAA
with the TIR1 receptors, and the binding of Aux/IAA and ARF is rapid
relative to the timescale of mRNA turnover and gene expression. Similarly,
if binding, unbinding and conjugation of GH3 and auxin is also assumed to
be rapid compared to mRNA decay, then a further approximation can be
made by neglecting the derivative in equation (3.2j). Rearranging and sub-
stituting for Gr, equations (3.2a) and (3.2h) can then be replaced resulting
82
in the model in eight variables given by:
dauxin
dt
= (α0 + αtrxaux(t))(1 + αlaxLAX)− µauxauxin− γG auxin,
(3.3a)
dIAA
dt
=
−ηauxinIAA
QP +Qauxin+ auxinIAA
+ IAAm, (3.3b)
dIAAm
dt
= Ftc
(
K
θia(IAA+K)
,
IAA
θir(IAA+K)
, ni
)
− IAAm, (3.3c)
dXm
dt
= µxm
(
Ftc
(
K
θxa(IAA+K)
,
IAA
θxr(IAA+K)
, nx
)
−Xm
)
,
(3.3d)
dX
dt
= µx(Xm −X), (3.3e)
dLAXm
dt
= µlm
(
Ftc
(
X
θla
, 0, nl
)
− LAXm
)
, (3.3f)
dLAX
dt
= µl(LAXm − LAX), (3.3g)
dGm
dt
= µgm(Ftc
(
K
θga(IAA+K)
,
IAA
θgr(IAA+K)
, ng
)
−Gm), (3.3h)
dG
dt
= µg(Gm −G), (3.3i)
where γ = ηggmga
gd+gm
.
3.2 Parameter Fitting Using Conjugation Model
To test whether either or both conjugation models (3.2) and (3.3) are able
to simulate the LAX3 and IAA14 data shown in Figure 1.9, the parameter
fitting algorithm was run for each model with a fixed increase of xaux from
0 to 1000 at t = 0. While the reduced model is able to show reasonable
agreement with the data (f = 0.095), with the ‘full’ conjugation model a
more precise fit is possible (f = 0.032). Plots of model time course and
data for both parameter sets are shown in Figure 3.3, with the parameter
values given in Table 3.1.
The fit for the reduced model is less precise than the initial conjugation
model, so this suggests the fit of the model with the data relies in part
on relatively slow binding of GH3 and auxin (ga), and a relatively slow
conjugation rate (gm). In addition, it is notable that the fits optimise the
rate of GH3-auxin disassociation (gd) and conjugation independent auxin
degradation (µaux) at or near zero. In other words once bound to GH3 auxin
remains bound until it is conjugated, and that this is the only way that
active auxin can be permanently removed from the cellular pool. If auxin
remains bound to GH3 and the conjugation rate is low, a rapid increase
in auxin will result in the available conjugating enzymes becoming rapidly
saturated. This will leave a surplus of auxin and strong upregulation of
the auxin responsive genes. Among these will be GH3 conjugating enzymes
which will subsequently damp down the response.
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(a) Best fit (solid lines) with LAX3 and IAA14 mRNA time course data (diamonds) using
conjugation model given by equations (3.2). For parameter values see Table 3.1.
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(b) Best fit (solid lines) with LAX3 and IAA14 mRNA time course data (diamonds) using
reduced conjugation model given by equations (3.3). For parameter values see Table 3.1.
Figure 3.3: Both the full (Figure 3.3(a)) and reduced (Figure 3.3(b)) conjuga-
tion models are able to match the data shown in Figure 1.9 rea-
sonably well. Closer agreement is possible with the full conjugation
model. In both cases a relatively slow accumulation of GH3 protein
allows for a transient peak of cellular auxin at around 10 hours post
treatment, and results in the experimentally determined mRNA ex-
pression profiles.
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Table 3.1: Best fitted non-dimensional parameters for the full conjugation
model (A) (f = 0.036), and the reduced conjugation model (B)
(f = 0.095).
P Q K ηgh3 ηiaa
(A) 4943 0.0125 0.0394 13739 10.7010
(B) 5677 4.6 x 10−5 0.0058 N/A 20.9215
ga gd gm γ α0
(A) 0.0102 0 0.6582 N/A 0.1172
(B) N/A N/A N/A 1224 0.0015
αtr αlax µaux ni θa
(A) 0.1172 15.5017 0 1.7274 0.1245
(B) 0.00021 15.4344 0.00026 2.6061 0.1194
θr µl µlm nl θla
(A) 4.4683 1.4427 4.7148 1.0006 2.1853
(B) 1.8447 1.5154 15.3352 1.9505 0.1736
µx µxm nx θxa θxr
(A) 0.9768 6.5433 1.0000 0.1043 0.2237
(B) 0.9884 9.2310 1.0636 0.1494 0.1748
µg µgm ng θga θgr
(A) 0.1444 0.0962 2.0000 0.0303 0.0294
(B) 0.0239 0.0086 3.9811 0.0303 0.0294
For both models, the required mRNA expression profile occurs as a re-
sult of a transient peak of cellular auxin centred around ten hours. This is
a result of increased auxin accumulation while LAX3 is expressed followed
by expression of GH3 resulting in increased conjugation and a removal of
auxin from the active pool. As we will see later on, this transient ‘pulse’ of
expression is in fact a damped oscillation about a steady state, and with dif-
ferent parameter values sustained oscillations of cellular auxin and mRNAs
is possible. The key point here is the relative timing in gene expression,
with GH3 peaking after LAX3, i.e. the negative feedback occurs after the
positive feedback. This will be discussed further in Section 3.3, where the
fitted parameter set given in Table 3.1 for the full model (3.2) will be used as
a basis for identifying key model parameters, and possible model behaviours
over longer timescales will be identified.
3.3 Time Course and Parameter Sensitivity
The parameter set used as the basis for investigation by altering one or more
parameters is given in Table 3.1, parameter set (A). Figure 3.4 shows model
LAX3 expression when changing both µg and µgm simultaneously. These are
the degradation rates of GH3 enzyme and and mRNA respectively (relative
to IAA14 mRNA degradation rate), and increasing them has the effect of
reducing the timescale over which the conjugating enzyme responds to a
change in auxin concentration. In other words, GH3 will respond more
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quickly to any change in transcription factor concentration, the larger µg
and µgm are. Changing these parameters should not, however, result in
any change to the final steady state expression, as can be seen by setting
the derivatives in (3.2h)-(3.2j) to zero. Instead, decreasing µg and µgm
results in damped oscillations of increasing magnitude and period about
the steady state. In the case of the fit to the data, the match with the time
points consists of one such damped oscillation, before settling on a steady
state later on in time. Increasing µg and µgm has the opposite effect and if
sufficiently large will damp out oscillations altogether (Figure 3.4).
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µg, µgm = fitted value x 16
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µg, µgm = fitted value / 2
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Figure 3.4: Model LAX3 and GH3 mRNA following a simulated auxin signal
with successive increases in µg (GH3 protein turnover) and µgm
(GH3 mRNA turnover). See legend for numerical parameter values.
Oscillations, damped or otherwise, appear to depend on the relative tim-
ing of LAX3 and GH3 expression. Specifically, if LAX3 peaks before GH3,
it appears that expression in both LAX3 and GH3 may oscillate with rel-
atively long periods, while if GH3 peaks first, simulated here by increasing
µg and µgm , the system shows an increasingly smooth increase in LAX3 ex-
pression toward its higher steady state. Conversely, GH3 expression shows
increasingly obvious damped oscillations, with shorter periods as µg and µgm
are increased. While changing the degradation rates of GH3 mRNA and
protein can introduce or remove damped oscillations to LAX3 expression,
increasing the rate of association between auxin and GH3 (ga) appears to
introduce a stable oscillatory steady state for the parameter set used (Figure
3.5). The existence of these stable limit cycles are confirmed and investi-
gated further in Section 3.4. Though in a different context to that modelled
here, relatively long period oscillations (around 15 hours) in the auxin re-
sponse have been observed biologically by De Smet et al. (2007) in the basal
meristem during the priming of lateral roots, so this model of competing
positive and negative feedback loops may provide an alternative hypothesis
to that presented by Middleton et al. (2010) as to how these oscillations
may arise from a persistent auxin signal.
Other important parameters are µaux, gd, and gm. The efffect of changing
each over orders of magnitude is shown in Figure 3.6. Increasing either gd
and µaux from their fitted values of near zero damps out oscillations in LAX3
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Figure 3.5: Model LAX3 following an initial auxin signal with successive in-
creases in ga (association rate of GH3 and auxin). See legend for
numerical parameter values.
expression, while reducing gm affects the period of oscillation. For the lowest
values of gm, expression appears to initially oscillate around a higher value
for LAX3 expression than for higher values of gm, before all return to similiar
steady states over longer time spans. The effect observed by increasing gd
and µaux may be expected as both decrease the effect of conjugation in
different ways. gd is the rate of disassociation of auxin and GH3, and
so a high rate of disassociation results in less bound auxin available for
conjugation. Increasing µaux has a similar effect but here this parameter
affects the linear degradation rate of auxin itself and so auxin is degraded
more quickly before binding with GH3 and conjugation. gm is the rate
of conjugation of bound auxin, and when both gd and µaux are set to a
low value so that the pool of GH3 for conjugation can be easily saturated,
changing the rate of conjugation of bound auxin will affect the period of
oscillations in the auxin available for signalling.
3.4 Steady State Analysis
To establish the existence of stable limit cycles for certain parameter sets
used in the model given by equations (3.2a)-(3.2j) the bifurcation diagram of
steady state LAX3 mRNA expression against ga was plotted using Xppaut
(Figure 3.7(a)). For the parameter set (A) in Table 3.1, with the auxin signal
set to be xaux = 1000 nM , LAX3 steady state decreases with increasing
ga from zero until reaching a Hopf bifurcation at ga = 193.9. Above this
value there is an unstable steady state, and a stable limit cycle where LAX3
expression undergoes sustained oscillations. This critical point depends on
xaux, as shown in Figure 3.7(b). Here, ga is set to the critical value for
xaux = 1000, and the steady states plotted for a range of values for xaux.
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Figure 3.6: Model LAX3 mRNA expression for varying values of the parame-
ters gd (top), gm (middle), and µaux (bottom) following an initial
auxin signal. Increasing gd and µaux from zero damps out oscilla-
tions in expression, while changing gm affects the period of damped
oscillations.
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(a) Bifurcation diagram showing LAX3 steady states with increasing ga.
Thick line represents a single stable steady state, solid dots represent
stable limit cycles, and the thinner line represents an unstable steady
state. At a critical value of ga there is a bifurcation, above which there
exists a stable limit cycle and an unstable steady state, and below which
there is a single steady state.
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(b) Bifurcation diagram for LAX3 steady state with increasing xaux
(extracellular auxin concentration). ga is set at the critical bifurcation
value for xaux = 1000. As with ga there is a critical value for xaux, above
which there exists a stable limit cycle and an unstable steady state, and
below which there is a single steady state.
Figure 3.7
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Again, there is a Hopf bifurcation at the critical value (xaux = 1000),
and prior to this LAX3 steady state increases with increasing xaux (auxin
signal) as expected. Above the critical value there are sustained oscillations
in expression. The critical values of ga and xaux are interdependent, as
shown in Figure 3.8(a) which shows the two distinct regions of parameter
space. For high ga and xaux the model system has a stable limit cycle and
an unstable steady state, while for low ga and xaux there is a single stable
steady state. In general, if ga is low xaux needs to be very high before
sustained oscillations will occur, and this critical value for xaux decreases
as the value of ga decreases. In the region of parameter space where stable
limit cycles cannot occur, there may still be oscillations but these will reduce
in magnitude over time and eventually be damped to reach a single stable
steady state.
The parameter set (A) in Table 3.1 used to produce the bifurcation
diagrams in Figures 3.7(a), 3.7(b) and 3.8(a) has the co-operativity of ARF
and ARF-Aux/IAA on the GH3 promoter ng = 2. Figure 3.8(b) shows hows
the critical value for ga changes as the co-operativity coefficient is reduced.
For values less than around 1.7 no sustained oscillations will occur, even
for high values of ga. If the co-operativity represents the number of binding
sites on the promoter, so that an integer value for co-operativity is generally
used, then only more than one binding site will result in oscillations in the
model.
The positive feedback due to active auxin transport by LAX3 is also
essential to produce oscillations. Plotting the LAX3 steady state for in-
creasing ga with αlax, the rate of LAX3 transport set to zero, shows that
there is no Hopf bifurcation for ga < 1000 (Figure 3.9(a)). In fact, testing
for ga < 10
7 shows there are no bifurcations within this range (not shown).
The same is not true for the negative feedback by IAA14. To remove
the Aux/IAA negative feedback from the model is not as straightforward as
removing the LAX3 feedback, since setting the rate of Aux/IAA expression
to zero would result in all ARF activated genes being expressed at their
maximum rate, regardless of the auxin concentration. However, if instead
of being auxin responsive, IAA14 mRNA is expressed at some constant rate
(βi), then the negative feedback is effectively removed. The function for
IAA14 transcription, as used in equation 2.14c then becomes:
Ftc(ARF,AI, n) = βi (3.4)
If the original model has a basal steady state expression of IAA14
mRNA, IAAm = IAAm
∗ before auxin treatment, substituting (3.4) into
(2.14c) and setting the derivative to zero at steady state gives:
βi = IAAm
∗ (3.5)
Using this value for βi will simulate removing the negative feedback loop
since IAA14 expression will remain constant and equal to the initial ex-
pression in the Aux/IAA inducible model. Setting IAA14 expression to be
constitutive and constant will still produce a Hopf bifurcation and stable
limit cycles for sufficiently high ga (Figure 3.9(b)).
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(a) Two-parameter continuation of locus of Hopf bifurcation for xaux
and ga. For high xaux and ga there is a stable limit cycle and and
unstable steady state, for low xaux and ga there is a single stable steady
state.
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(b) Two-parameter continuation of locus of Hopf bifurcation for ga and
ng (the co-operativity of the ARF binding site on the GH3 promoter).
Even for high ga an integer value less than 2 for ng cannot result in stable
oscillations.
Figure 3.8
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(a) LAX3 mRNA steady state for increasing ga with the removal of the
LAX3 negative feedback by simulating zero active auxin transport. Even
for very high values of ga there is no Hopf bifurcation or stable limit
cycles.
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(b) LAX3 steady state for increasing ga with the removal of the IAA14
negative feedback by simulating constant expression of IAA14. As before
there is a value of ga for which a Hopf bifurcation occurs, above which
stable limit cycles exist along with an unstable steady state.
Figure 3.9
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3.4.1 Pulses In LAX3 expression
Using the default parameter set (A) from Table 3.1, but increasing the
rate of active transport a hundred-fold so that αlax = 1550.17 and the co-
operativity in the transcription functions for X and LAX3 so that nx = 2
and nl = 2, so that the conditions for bistability in the initial model are met
(Section 2.1.3), can result in a pulse or repeated pulses in LAX3 expression
over time as the rate of ga, the association of auxin and GH3, is increased
(Figure 3.10(a)). For ga = 1 (low binding of auxin and GH3) there is only
a slight oscillation before LAX3 reaches a steady state of strong expression.
For higher ga(= 2) the oscillations are damped more slowly, with at least one
switch from high to low and back to high expression, before again settling
on a steady state of high LAX3 expression. For ga = 10 (close to our
fitted value) there are repeated pulses of strong expression. Here, LAX3
oscillates between periods of strong expression and close to zero expression.
Finally for the highest value of ga shown (= 1000), there is a single pulse of
strong LAX3 expression following the initial auxin signal, before expression
is effectively turned off once more for the rest of the time course.
Fixing ga = 1 and plotting the bifurcation diagram of steady state LAX3
mRNA shows that on increasing xaux from zero there is initially a single
steady state of low expression, followed by a region of stable limit cycles
or oscillations in expression at intermediate values of xaux before above a
critical value there is once more a single steady state, at a relatively high
level of expression (Figure 3.10(b)). Because of this neighbouring cells with
marginally different auxin concentrations may show (temporarily at least)
large differences in expression.
3.5 Discussion and Conclusions
The modelling and data presented in Chapter 2 suggest that there is some
endogenous mechanism in the plant root acting to provide auxin homeosta-
sis following exogenous treatment. In this chapter, the hypothesis that one
or more members of the auxin responsive GH3 gene family removes auxin
from the active signalling pool by conjugating it with amino acids, was
modelled and tested by comparison with the available data. It is possible
for the conjugation model to simulate the transient transcriptional response
seen in LAX3 and IAA14 over the 36 hours following treatment, and the fit
with the data appears very sensitive to some particular parameter values,
which lead to further biological questions.
Key Parameters
Firstly, in order to fit the experimental data, the GH3 independent auxin
degradation needs to be at or near zero. In other words conjugation needs
to be the primary pathway by which auxin is removed from the cell. If there
is a basal level of expression of GH3, which increases with increasing auxin,
this would ensure at least a basal rate of auxin turnover. However, setting
the model up in this way does not take into account the possibility of other
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(a) LAX3 expression against time following an initial increase in auxin
signal from zero to xaux = 1000 using the parameter set given in Table
3.1, with αlax = 1550.17, nx = 2 and nl = 2, for increasing values of the
parameter ga. For low ga there is a high steady state expression, followed
by damped oscillations as ga is increased, then repeated oscillations be-
tween high and low expression as ga is increased further, and finally a
single pulse of high LAX3 expression before reaching a steady state of
very low expression at the highest value for ga.
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(b) Simulated steady state LAX3 mRNA expression for increasing values
of xaux, the parameter corresponding to the concentration of extracellu-
lar auxin. Parameter values are as in Table 3.1 (A), but with with ga = 1,
αlax = 1550.17, nx = 2 and nl = 2. For low xaux there is a single steady
state of low expression, for intermediate xaux there are both stable limit
cycles around an unstable steady state, and for high xaux there is again
a single steady state at relatively high LAX3 expression. There is also
a range for xaux (between approx. 0.15 and 0.22)where there are both
stable and unstable limit cycles in addition to a stable steady state. Solid
lines represent stable steady states, dotted lines unstable steady states,
open circles unstable limit cycles, solid circles stable limit cycles.
Figure 3.10
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catabolic pathways for auxin, and so needs further biological justification.
Also important is the slow accumulation over the time-course of the
GH3 protein. While this appears to be in contradiction to the experimental
data, which shows GH3s are early auxin response genes (Abel and Theologis
1996), it may be possible for a slow turnover rate of GH3 protein to result
in a slow accumulation of the protein, in comparison to relatively rapid
turnover of mRNA giving an early response to the auxin signal. Even
if the timing of GH3 expression is not compatible with the model, there
may be other auxin inducible genes further downstream from the primary
response genes that affect homeostasis, such as genes involved in transport
or catabolism. If so, these genes could provide a similar mechanism in the
model as conjugation by GH3. In other words, the model as formulated
can provide a mechanism to fit the LAX3 and IAA14 mRNA data, but
the model may represent another mechanism in which auxin homeostasis
is maintained by inducing a gene which accelerates removal of auxin from
the cell. In a living cell, there may be several such mechanisms acting at
different times during the auxin response, and a more complex model for
homeostasis would need to take this into account.
The other key parameters appear to be the binding and unbinding rates
of auxin and the GH3 enzyme. Setting the rate of unbinding of GH3 and
auxin very low ensures the pathway by which auxin is conjugated is mostly
one way, as unless conjugated and removed from the pool entirely, once
bound to GH3 auxin remains bound. This means the GH3 enzymes may be
periodically saturated by auxin, allowing for an oscillatory effect. It is these
oscillations which allow for the fit between model and data. Increasing the
rate of binding between auxin and GH3 may result in stable limit cycles
in which gene expression oscillates indefinitely between states of high and
low expression. By adding the conditions needed for bistability identified in
Section 2.1.3, this can result in very sharp pulses of all or nothing expression
(Figure 3.10(a)). However, with the parameters set as they are, the period
of these oscillations are relatively long (days to weeks), and in the context
of cortical cells over lateral root primordia, it is probably not relevant to
consider gene expression much beyond the 36 hour dataset, since the auxin
source at the tip of the primordia will usually be fully emerged by this
time. However, oscillations over longer time-scales may be relevant to other
tissues where auxin influx transporters (or another inducible positive auxin
feedback) and auxin conjugating enzymes (or another inducible negative
auxin feedback) are induced.
Model Predictions and Comparison with previous models
Figure 3.11 shows the conjugation model (3.2a)-(3.2j) predictions for Aux/IAA
protein, tfX mRNA, tfX protein, and intracellular auxin, using the parame-
ter values given in Table 3.1, with a simulated auxin treatment of 1000 nM
at t=0. Also shown by way of comparison are the same model predictions
using the fit using the full model described in Section 2.2.2 (persistent auxin
model), and the fit using the reduced model with an exponential decay in
the auxin signal described in Section 2.2.4 (signal decay model).
The most obvious qualitative differences between the models is seen in
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Figure 3.11: Comparison of model predictions for IAA14 protein, tfX mRNA
and protein, and intracellular auxin, using the fitted parameter
sets for three model variations. Black lines: full model with per-
sistent auxin signal (Section 2.2.2. Blue lines: reduced model with
decay in exogenous auxin signal (Section 2.4.2). Red lines: conju-
gation model (Section 3.1).
.
the level of intracellular auxin over time. The conjugation model has a
relatively slow accumulation of intracellular auxin following the increase of
exogenous auxin, with the peak auxin in the cell not occuring until around
10 hours post-treatment. This will be due in part to the increase of LAX3
over this time. After about 10 hours sufficient GH3 has accumulated to
result in a net loss of auxin over the following 10 before settling at a relatively
low level. Though not neccessarily clear due to the scale of the figure, it
should be noted that the final steady state of auxin is still several-fold
higher than the basal level pre-treatment. In general this will always be the
case, increasing the exogenous auxin signal will increase the steady state
auxin level in the cell, even with increased conjugation. The conjugation
effectively narrows the range of steady state auxin concentration, while the
delay caused by the time taken for the GH3 protein to accumulate allows
for a temporal increase in cellular auxin, possibly far outside the range of
possible steady states. As we show above, it is even possible for oscillations
to occur indefinitely, but these oscillations will always be about an unstable
steady state auxin concentration higher than steady state before the increase
in exogenous auxin.
In the full model with unconstrained parameters auxin peaks at around
the same time as in the conjugation model, but remains relatively high
throughout the time course (over 200-fold greater than the basal level). This
is extremely unlikely based on the DII-VENUS data (Section 2.3), which
shows a recovery of DII-VENUS after around 10 hours corresponding to a
much lower level of intracellular auxin. In the model with an exponential
exogenous auxin decay, peak auxin occurs much sooner, and since the model
parameters were fitted to be consistent with the DII-VENUS, it is to be
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assumed that this profile for cellular auxin over time is likely to the most
biologically realistic.
All three models show a recovery in IAA14 protein following the initial
strong degradation. The biggest recovery is seen in the signal decay model,
where the combination of high levels of transcript and low auxin results in
a temporary abundance of protein over the second half of the time course.
In the persistent signal model, auxin remains high and so the recovery of
IAA14 protein is entirely due to an increase in transcript, rather than any
significant reduction in degradation rate due to a reduction in auxin. The
weakest recovery is seen in the conjugation model. Even though the levels of
IAA14 mRNA transcript over the time course are very similar for all models
(since they were all fitted to the same IAA14 mRNA data), and auxin is
relatively much lower than in the persistent auxin model, the IAA14 protein
does not recover above 50% of the basal level. This is because, for the
parameter sets used, the range of dose response of the Aux/IAA protein
degradation saturates at a much lower level of auxin in the conjugation
model than in the persistent auxin signal model. Even a relatively low
level of auxin compared to the simulated 1000 nM treatment will still cause
rapid degradation of the Aux/IAA. Despite this, the dose response of the
Aux/IAA protein predicted by the conjugation model (Figure 3.12) is still
not as sensitive to lower levels of auxin as is DII-VENUS (Figure 2.13(a)).
However, though we initially assume here that GH3 is regulated by IAA14, it
could be any auxin responsive Aux/IAA, and DII-VENUS itself uses domain
II of IAA28, and different Aux/IAAs may have different dose-responsiveness
and relative degradation rates.
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Figure 3.12: Response of Aux/IAA protein in the conjugation model using the
fitted parameters in Table 3.1, to different simulated auxin treat-
ments (see figure legend).
.
As discussed in Section 2.5 it is possible for a range of timings and magni-
tude of response for tfX mRNA and protein to result in the same expression
profile for LAX3 mRNA. Figure 3.11 shows that it is also possible for subtly
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different shapes in expression profile to produce the same LAX3 expression,
depending on the model for intracellular auxin used. All three models show
a similar initial response of tfX mRNA to auxin, but each remains at peak
expression for different time periods. The signal decay model is at peak ex-
pression for the shortest duration, followed by the persistent auxin model,
and finally the conjugation model has high tfX mRNA expression for the
longest time period.
Conclusions
The modelling shows that auxin inducible auxin conjugation is a possible
mechanism for auxin homeostasis following exogenous treatment. However,
when fitting with the LAX3 mRNA expression data, the predictions for in-
tracellular auxin and Aux/IAA protein are not entirely consistent with the
DII-VENUS data (Section 2.3). In addition, the qualitative behaviour of
the model is sensitive to relatively small changes to some parameter values,
meaning that the system may not be particularily robust to biological vari-
ation. For these reasons, in the discussion on more complex gene networks
(Chapter 4), we use the signal decay model described in Section 2.2.4 as a
simpler model for intracellular auxin following treatment. Despite this, the
range of possible behaviours of the conjugation model means that there is
scope for futher study, particularily when more biological data relating to
auxin conjugation or other homeostatic pathways become available.
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Chapter 4
Gene Regulatory Network
Model: Two Auxin Response
Factors (ARF7 and ARF19)
4.1 Biological Background
In previous chapters, only the case where a single ARF (nominally ARF7),
not transcriptionally responsive to increased auxin, activates a range of pri-
mary auxin response genes which feed back into the network model in vari-
ous ways was considered. However, ARF7 is just one of a family of 23 genes
which may affect the auxin response (Guilfoyle and Hagen 2007). Of these
23 ARFs, five gene products are believed to be transcriptional activators
(ARFs 5,6,7,8, and 19), while the remainder are thought to be transcrip-
tional repressors. Of particular importance to the lateral root emergence
network and the induction of LAX3 are the activators ARF7 and ARF19
(Okushima et al. 2007; Swarup et al. 2008), both of which have been shown
to interact with IAA14 (Fukaki et al. 2005). If, as the evidence suggests,
both ARF7 and ARF19 are involved in the LAX3 expression network, fur-
ther consideration is needed before we accept the assumption that the net-
work can be modelled by a single ARF.
Firstly, comparing the qRT-PCR expression data following auxin treat-
ment shown in Figure 4.1 for ARF7 and ARF19 suggests that they are dif-
ferentially regulated. ARF7 remains at a relatively constant expression level
following auxin treatment, while ARF19 is clearly upregulated by auxin. In
the arf7 mutant ARF19 expression is reduced, suggesting it is at least in
part activated by ARF7. In the ARF19 mutant however, ARF7 is not af-
fected, suggesting a stable pool of ARF7 independent of auxin treatment
and ARF19. Secondly, ARF19 has previously been thought to be an ac-
tivator similar to ARF7, so it may be expected that expression of ARF
activated genes is lower in the ARF19 mutant, as less activator is present
overall. However, IAA14 expression is similar, and LAX3 actually shows
increased expression in the arf19 mutant compared to wild type (Figure
4.1). Though ARF19 has previously been described as an activator similar
to ARF7, in the regulation of LAX3 it appears to act as a repressor.
This chapter begins by formulating a simple model where ARF19 is
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Figure 4.1: qRT-PCR time course data following 1 µM auxin treatment for
(a) ARF7, (b) ARF19, (c) IAA14, (d) LAX3 and (e) PG mRNAs
in wild type, lax3, arf7, and arf19 mutant backgrounds (Benjamin
Peret, personal communication). (f) Wild type LAX3 mRNA ex-
pression following treatment with 10 µM cyclohexamide (CHX),
1 µM auxin (IAA) and both CHX and IAA (Silvana Porco, per-
sonal communication).
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activated by ARF7 (Section 4.2), and this is used to show that depending
on parameter values ARF19 may either act as an trancriptional activator
or effectively as a transcriptional repressor. In particular, the parameter
values which allow ARF19 to act as a repressor are identified and linked
with the biological mechanism they represent (Section 4.2.4). Also shown
is a special case where the parameter values selected show that the model
with both ARF7 and ARF19 can approximate the model with ARF7 only
(Section 4.2.3).
Following this, we show that if ARF19 is an activator then an ARF19
inducible repressor can explain the temporal expression profile of LAX3,
but that to fit both the wild-type and arf19 mutant data, an additional
ARF19 independent repressor may be required. In addition we also show
that this model fails to account for the recovery in DII-VENUS observed
experimentally (Section 2.3), and that some homeostatic mechanism for
auxin is still needed.
Finally, by adding a decay in the exogenous signal to simulate the re-
quired auxin homeostasis, we investigate various models for both the tran-
scriptional regulation of ARF19, and the regulation of LAX3 transcription
by ARF19, and evaluate their ability to simulate the LAX3 expression data
in the wild type, and the arf19 mutant.
4.2 Simple ARF7 and ARF19 model
To begin comparing the models with and without the inclusion of ARF19
as an additional activator, we first consider a model network without the
added complication of positive feedback via LAX3 expression, with just
ARF19 and IAA14 expressed as primary auxin response genes (Figure 4.2).
We know from biological observation that IAA14 may bind with both
ARF7 and ARF19 (Fukaki et al. 2005), and so the model must take into
account both these interactions, and also the possibility that ARF19-IAA14
dimers may repress transcription as well as the ARF7-IAA14 dimers. We
keep the assumption that free ARF7 bound to a responsive promoter will ac-
tivate transcription, but in addition there is the possibility that free ARF19
bound to the promoter may act as an activator, making a total of four pos-
sible model species regulating transcription. It is conceivable that different
targets may be regulated by different combinations of these four regulatory
factors, but initially we consider the maximal model as shown in Figure 4.2.
4.2.1 Model Formulation
In this model both ARF7 and ARF19 are able to activate ARF19 and
IAA14, unless they are dimerised with IAA14, which both ARFs are able
to do reversibly. If either dimer is bound to a gene promoter transcription
is repressed, while if ARF7 or ARF19 monomers bind, transcription is ac-
tivated. ARF19 and IAA14 are induced by auxin, but ARF7 is not. All
model species compete for the same binding site(s). Using similar notation
and assumptions of mass action kinetics as for previous models, we have
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Figure 4.2: Network for ARF19 and ARF7 model. Auxin degrades IAA14
which binds to ARF7 and ARF19 repressing transcription of IAA14
and ARF19. When free from IAA14, both ARF7 and ARF19 acti-
vate transcription.
the dimensional model:
dTIR
dt
= −paTIR auxin+ pdTIRa, (4.1a)
dTIRa
dt
= paTIR auxin− pdTIRa
+ (qd + qm)TIRai − qaTIRa IAA, (4.1b)
dTIRai
dt
= −(qd + qm)TIRai + qaTIRa IAA, (4.1c)
dIAA
dt
= qdTIRai − qaTIRa IAA+ δiIAAm
− kaARF IAA+ kdAI − faA19 IAA+ fdAI19, (4.1d)
dARF
dt
= −kaARF IAA+ kdAI, (4.1e)
dAI
dt
= kaARF IAA− kdAI, (4.1f)
dIAAm
dt
= Fi(ARF,AI,A19, AI19)− µiIAAm, (4.1g)
dA19
dt
= −µaA19 + δaA19m − faA19 IAA+ fdAI19, (4.1h)
dA19m
dt
= Fa(ARF,AI,A19, AI19)− µamA19m, (4.1i)
dAI19
dt
= faA19 IAA− fdAI19, (4.1j)
TIR + TIRa + TIRai = tirT , (4.1k)
ARF + AI = arfT , (4.1l)
102
where:
Fi(ARF,AI,A19, AI19) =
λi1
(
ARF
θia
)ni
+ λi2
(
A19
φia
)ni
1 +
(
ARF
θia
)ni
+
(
AI
θir
)ni
+
(
A19
φia
)ni
+
(
AI19
φir
)ni ,
Fa(ARF,AI,A19, AI19) =
λa1
(
ARF
θaa
)na
+ λa2
(
A19
φaa
)na
1 +
(
ARF
θaa
)na
+
(
AI
θar
)na
+
(
A19
φaa
)na
+
(
AI19
φar
)na ,
Equations (4.1a)-(4.1g) are as in the earlier model (2.3b)-(2.3h), with
the addtional reactions for binding and unbinding with ARF19 included in
equation (4.1d), and the alternative function for transciption, Fi, replacing
Ftc in (4.1g). Equations (4.1h)-(4.1j) are added to model the evolution
over time of ARF19 protein (A19), ARF19 mRNA (A19m) and ARF19-
IAA14 dimers (AI19) respectively. As before, the conservation of bound
and unbound TIR1 and ARF is defined as in equations (4.1k) and (4.1l)
respectively.
The new functions for transcriptional activity are based on the assump-
tion that all model species compete for the same binding sites, with ARF7
and ARF19 activating (at different maximum rates reflected by the two
parameters λx1 and λx2) if bound, and that the ARF7-IAA14 and ARF19-
IAA14 dimers repress when bound. Auxin is a treated as a parameter,
effectively increasing the rate of degradation of Aux/IAA, rather than a
model variable, with the basal level defined as aux0.
Nondimensionalisation
Scaling TIR, TIRa, and TIRai with tirt, ARF , AI, A19 and AI19 with
arft, IAAm with λi/µim , A19m with λa/µam , and time with 1/µim gives the
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nondimensional model:
dTIR
dt
= −paTIR auxin+ pdTIRa, (4.2a)
dTIRa
dt
= paTIR auxin− pdTIRa
+ (qd + qm)TIRai − qaTIRa IAA, (4.2b)
dTIRai
dt
= −(qd + qm)TIRai + qaTIRa IAA, (4.2c)
dIAA
dt
= ηiaa(qdTIRai − qaTIRa IAA) + δiIAAm
− kaARF IAA+ kdAI − faA19 IAA+ fdAI19, (4.2d)
dARF
dt
= −kaARF IAA+ kdAI, (4.2e)
dAI
dt
= kaARF IAA− kdAI, (4.2f)
dIAAm
dt
= Fi(ARF,AI,A19, AI19)− IAAm, (4.2g)
dA19
dt
= −µaA19 + δaA19m − faA19 IAA+ fdAI19, (4.2h)
dA19m
dt
= µam(Fa(ARF,AI,A19, AI19)− A19m), (4.2i)
dAI19
dt
= faA19 IAA− fdAI19, (4.2j)
TIR + TIRa + TIRai = 1, (4.2k)
ARF + AI = 1, (4.2l)
where:
Fi(ARF,AI,A19, AI19) =
ARF
θia
+ λi
A19
φia
1 + ARF
θia
+ AI
θir
+ A19
φia
+ AI19
φir
,
Fa(ARF,AI,A19, AI19) =
ARF
θaa
+ λa2
A19
φaa
1 + ARF
θaa
+ AI
θar
+ A19
φaa
+ AI19
φar
.
For ease of notation, each variable and parameter has been replaced by its
non-dimensional equivalent as defined in Table 4.1. Scaling ARF , AI, A19
and AI19 with arfT enables us to compare binding parameters and peak
transcription rates in the function Fx(ARF,AI,A19, AI19) directly, and
make further model simplifications below.
Quasi Steady State Approximation
To simplify the model for steady state analysis and time course simulations
we can make further assumptions and approximations as detailed below.
Assuming the binding of auxin and Aux/IAA with the TIR1 receptors
happens on a rapid timescale means the derivatives of TIR, TIRa, and
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Table 4.1: Nondimensional parameters and variables from the model given by
equations (4.2a)-(4.2l), and relationship to dimensional parameters
and variables from equations (4.1a)-(4.1j).
Non-dimensional parameter Dimensional parameter equivalent
ηiaa
tirT
arfT
pa
paaux0
µim
pd
pd
µim
qa
qaarfT
µim
qd
qd
µim
qm
qm
µim
ka
kaarfT
µim
kd
kd
µim
fa
faarfT
µim
fd
fd
µim
θia
θia
arfT
θir
θir
arfT
φia
φia
arfT
φir
φir
arfT
λi
λi2
λi1
θaa
θaa
arfT
θar
θar
arfT
φaa
φaa
arfT
φar
φar
arfT
λa
λa2
λa1
δi
δiλi1
µim
2
δa
δaλa1
µamµim
µam
µam
µim
µa
µa
µim
auxin auxin
aux0
Non-dimensional variable Dimensional variable equivalent
TIR TIR
tirT
TIRa
TIRa
tirT
TIRai
TIRai
tirT
IAA IAA
arfT
ARF ARF
arfT
AI AI
arfT
IAAm
µimIAA
λi
A19 A19
arfT
A19m
µamIAA
λa
AI19 AI19
arfT
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TIRai can be neglected and the model simplified as follows:
dIAA
dt
=
−ηauxin IAA
QP +Qauxin+ auxin IAA
+ δiIAAm
−kaARF IAA+ kdAI − faA19 IAA+ fdAI19, (4.3a)
dIAAm
dt
= Fi(ARF,AI,A19, AI19)− IAAm, (4.3b)
dARF
dt
= −kaARF IAA+ kdAI, (4.3c)
dAI
dt
= kaARF IAA− kdAI, (4.3d)
dA19
dt
= −µaA19 + δaA19m − faA19 IAA+ fdAI19, (4.3e)
dA19m
dt
= µam(Fa(ARF,AI,A19, AI19)− A19m), (4.3f)
dAI19
dt
= faA19 IAA− fdAI19, (4.3g)
TIR∗ =
QP
QP +Qauxin+ auxin IAA
, (4.3h)
TIR∗a =
Qauxin
QP +Qauxin+ auxin IAA
, (4.3i)
TIR∗ai =
auxin IAA
QP +Qauxin+ auxin IAA
, (4.3j)
where Q = (qd+qm)/qa, P = pd/pm, η = qmηiaa and TIR
∗, TIR∗a and TIR
∗
ai
are the quasi-steady state values of TIR, TIRa, and TIRai respectively.
Further assuming that binding and unbinding in the dimerisation reac-
tions happens rapidly, and so neglecting the derivatives of ARF , AI, A19,
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and AI19 and rearranging gives:
dIAA
dt
=
−ηauxin IAA
QP +Qauxin+ auxin IAA
+ δiIAAm, (4.4a)
dIAAm
dt
= Fi
(
K
IAA+K
,
IAA
IAA+K
,A19,
A19 IAA
κ
)
−IAAm, (4.4b)
dA19
dt
= −µaA19 + δaA19m, (4.4c)
dA19m
dt
= µam(Fa
(
K
IAA+K
,
IAA
IAA+K
,A19,
A19 IAA
κ
)
−A19m) (4.4d)
ARF ∗ =
K
IAA+K
, (4.4e)
AI∗ =
IAA
IAA+K
, (4.4f)
AI19∗ =
A19 IAA
κ
, (4.4g)
TIR∗ =
QP
QP +Qauxin+ auxin IAA
, (4.4h)
TIR∗a =
Qauxin
QP +Qauxin+ auxin IAA
, (4.4i)
TIR∗ai =
auxin IAA
QP +Qauxin+ auxin IAA
, (4.4j)
where K = kd/ka, κ = fd/fa, and ARF
∗, AI∗ and AI19∗ are the quasi-
steady state values of ARF , AI and AI19 respectively.
4.2.2 ARF7 and ARF19 share parameter values
Intuitively, since ARF19 is an activator it is to be expected that adding it
to the model will result in a positive feedback. The situation is complicated
however, by the fact that it is also able to dimerise with Aux/IAA and form
repressors, which may at least in part offset the activatory effect (Figure
4.2). To test the degree to which the balance of repression to activation
may be altered by changing parameter values in the model we first look at
the special case where ARF7 and ARF19 behave identically in every way
other than their regulation.
Steady State Analysis
If we assume that ARF7 and ARF19 are similar in all ways other than their
regulation, so that they share binding and unbinding rates with Aux/IAAs
and gene promoters, and transcription rates are equal, then we assume
κ = K, all binding parameters are equal (θ), all co-operativity coefficients
are equal to one, and λi = λa = 1, so that:
Fi = Fa =
ARF + A19
θ + ARF + AI + A19 + AI19
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Using equations (4.2l), (4.4e) and (4.4g) and substituting for ARF + AI,
ARF and AI19 in the equation above gives:
Fi =
K
IAA+K
+ A19
θx + 1 + A19
(
IAA+K
K
) . (4.5)
At steady state all derivatives equal zero, so from 4.4a-4.4j we have:
IAAm
∗ =
ηauxin IAA∗
δi(QP +Qauxin+ auxin IAA∗)
, (4.6a)
IAAm
∗ =
K
IAA∗+K
+ A19∗
θ + 1 + A19∗
(
IAA∗+K
K
) , (4.6b)
A19m
∗ =
µa
δa
A19∗, (4.6c)
A19m
∗ =
K
IAA∗+K
+ A19∗
θ + 1 + A19∗
(
IAA∗+K
K
) , (4.6d)
where the ∗ superscript represents steady state values. To simulate the arf19
mutant we set A19 = 0 so that:
IAAm
∗ =
ηauxin IAA∗
δi(QP +Qauxin+ auxin IAA∗)
, (4.7a)
IAAm
∗ =
K
IAA∗+K
θi + 1
. (4.7b)
For a steady state to exist the two functions (4.7a) and (4.7b) must inter-
sect for some IAA∗ > 0. By inspection, equation (4.7a) is a monotoni-
cally increasing function of IAA∗, with IAA∗m = 0 when IAA
∗ = 0, and
IAAm
∗ → η
δi
as IAA∗ → ∞. Increasing auxin has the effect of decreasing
the value of IAA∗ at which half the maximum IAAm occurs (Figure 4.3).
In contrast, the expression on the right hand side of (4.7b) is monotonically
decreasing with increasing IAA∗, with IAAm
∗ = 1
θ+1
when IAA∗ = 0 and
IAAm
∗ → 0 as IAA∗ →∞. As shown graphically in Figure 4.3, this means
that in the absence of ARF19 the system will always have a unique steady
state.
When including ARF19 in the model, the steady state is more difficult
to find analytically. However, if we assume that for a given value for auxin,
a positive steady state for ARF19 exists (A19 = A19∗), then from (4.6b), we
have IAAm
∗ = 1+A19
∗
θ+1+A19∗
when IAA∗ = 0 and IAAm
∗ → 0 as IAA∗ → ∞.
Again, we show graphically in Figure 4.3 this must result in a unique steady
state for IAAm. However, in this case we must take into account that for
increasing values of auxin, so too will the steady state of ARF19 increase.
Nonetheless, for a given auxin concentration, assuming there is a unique
steady state for ARF19, the steady state IAAm expression will be greater
in the model with ARF19 than without if for all IAA∗ > 0:
K
IAA∗+K
+ A19∗
θ + 1 + A19∗
(
IAA∗+K
K
) > KIAA∗+K
θ + 1
,
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Figure 4.3: Equation 4.6a against IAA for three values of auxin (SS1), and
equation 4.6b with and without ARF19 (SS2). The intersections
between lines represent steady states for Aux/IAA mRNA and pro-
tein. For each value for auxin the mRNA steady state is unique,
and higher in the model with ARF19. ARF19 steady state is set to
1 or 1000. P, θ, η/δi = 1, Q,K = 0.1.
Table 4.2: Default nondimensional parameters for model defined by 4.4a-4.4j
Q = 0.1 P = 0.1 K = 0.1 κ = 0.1 η = 10
λi θia = 0.1 θir = 0.1 φia = 0.1 φir = 0.1
λa θaa = 0.1 θar = 0.1 φaa = 0.1 φar = 0.1
δa = 1 µa = 1 µam = 1 δi = 1
which can be shown by cross-multiplying the denominators as follows:
K
IAA∗ +K
(θ + 1) + A19∗(θ + 1) >
K
IAA∗ +K
(θ + 1) + A19∗.
In the above analysis we assume that ARF19 steady state exists, and
show that if it does, and all other things being equal, that genes activated
by ARF19 in addition to ARF7 will show higher expression levels than
those activated by ARF7 alone. Figure 4.4(b) shows the model IAA14
mRNA steady state against increasing auxin concentration for the default
parameter set given in Table 4.2. To simulate the arf19 mutant A19 is fixed
equal to zero and only equations (4.4a) and (4.4b) are used. Figure 4.4(a)
shows the time course solution using the same parameters for the model
with and without ARF19 as before, following a simulated increase in auxin
from initial steady state values at the lower value of auxin.
Looking at steady state, both models begin from zero expression at
zero auxin, and increase smoothly with increasing auxin up to a saturating
maximum steady state. The steady state for the model with ARF19 is
always higher than the model without. As expected, for the time course
there is a smooth transition between basal and auxin treated steady state,
and both low and high steady states decrease when ARF19 is removed
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(a) Model IAA14 mRNA against time, with (blue) and without (black) ARF19 as an
activator, from steady state following an increase in simulated auxin from 0.01 to 1. The
simulated IAA14 mRNA values are always greater in the model with ARF19 as an activator.
Parameter values for all interactions involving ARF7 and ARF19 are shared by both.
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(b) Model IAA14 mRNA steady state against auxin, with (black) and without (red,
dashed) ARF19 as an activator. For all values of auxin greater than zero, the steady
state is higher with ARF19 in the model. Parameter values for all interactions involving
ARF7 and ARF19 are shared by both.
Figure 4.4: Model time course and steady state using the parameter values in
Table 4.2 in equations (4.4a)-(4.4j). In both cases the arf19 mutant
is simulated by setting A19 = 0 and using just equations(4.4a) and
(4.4b).
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from the model. This difference can be magnified by changing parameter
values, but when parameters are equal for both ARF7 and ARF19, removing
ARF19 from the model will always reduce expression.
4.2.3 The ARF7 model can approximate the ARF7
and ARF19 model
While the previous sections shows that if ARF7 and ARF19 share param-
eter values, there will be quantitative reduction in expression in the model
without ARF19. Qualitatively however, model behaviour appears very sim-
ilar. Because of this, by changing parameter values in the ARF7 only model
relative to the ARF7 and ARF19 model, it is possible to approximate the
latter model with the former. From equation (4.5), and using the fact that
the maximum value for ARF = 1, the maximum steady state Aux/IAA
mRNA in the ARF7 and ARF19 model, for a given value for θ = θ1, is
given by:
IAAm1 =
1 + A19∗
θ1 + 1 + A19∗
,
where A19∗ is steady state ARF19. Similarly, from equation (4.7b) the
maximum steady state Aux/IAA mRNA in the ARF7 only model, for a
given value for θ = θ2, is given by:
IAAm2 =
1
θ2 + 1
.
If we then use θ2 =
θ1
1+A19∗
, with the peak value for steady state ARF19
expression for A19∗, the peak steady state expression should be similar for
the two models. This is demonstrated to be a reasonable approximation in
Figures 4.5(a) and 4.5(b).
4.2.4 ARF19 can act as a transcriptional repressor
The analysis in Section 4.2.2 demonstrates that assuming that the binding
and unbinding rates of ARF19 and IAA14 are the same as those for ARF7
and IAA14, that the peak rate of transciption is the same when ARF19
is bound as when ARF7 is bound to a promoter, and that bound or un-
bound ARF7 or ARF19 have the same affinity to promoters, steady state
gene expression will be greater in the model with both ARF7 and ARF19
than in the model with just ARF7. This may be intuitively obvious, but
in this section we show that by changing the parameters relating to the
assumptions given above, reduced expression can be seen when simulating
the ‘wild type’ in comparison to the arf19 mutant. In other words, differ-
ences in parameter values may cause ARF19 to behave as a repressor, as
seen experimentally, where there is an increase in LAX3 expression in the
arf19 mutant (equivalent to the ARF7 only model), compared to the wild
type (ARF7 and ARF19 model). To obtain solutions to the model given by
(4.4a)-(4.4j) that reflect this we must consider the more general case where
parameter values relating to ARF7 and ARF19 are different. By changing
three parameter values in particular it is possible to see greater expression
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(a) Model IAA14 mRNA against time, with (blue) and without (black) ARF19 as an acti-
vator, from steady state following an increase in simulated auxin from 0.01 to 1. Parameter
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ARF7-ARF19 model.
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
auxin
IA
A1
4 
m
R
N
A 
st
ea
dy
 s
ta
te
 
 
(b) Model IAA14 mRNA steady state against auxin, with (black) and without (red,
dashed) ARF19 as an activator. Parameter values are as in Table 4.2 except for in the
ARF7 only model θai, θar, φia and φia are all set equal to
θ1
1+A19∗
, where A19∗ is the
steady state ARF19 for auxin=1 in the full model using the default parameters, so that
the ARF7 only model is a good approximation of the ARF7-ARF19 model.
Figure 4.5: Model time course and steady state showing how the ARF7 model
may approximate the ARF7 and ARF19 model using the parameter
values in Table 4.2 (except where stated) in equations (4.4a)-(4.4j).
In both cases the arf19 mutant is simulated by setting A19 = 0 and
using just equations(4.4a) and (4.4b).
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of auxin responsive genes in the arf19 mutant model compared to the ‘wild
type’ model.
1. κ: Unbinding of ARF19-IAA14 dimers relative to binding.
Decreasing κ relative to K (unbinding of ARF7-IAA14 dimers relative
to binding) effectively means that ARF19 has a greater affinity with
the IAA14 repressors than does ARF7, and since we assume that this
binding and unbinding of dimers occurs on a rapid timescale relative
to gene expression, then when ARF19 is expressed the proportion of
repressors formed relative to activators is higher than when ARF19 is
not present. As shown by Figure 4.6a, reducing κ by a factor of two
is still insufficient to give significantly higher expression in the arf19
mutant relative to wild type, while reducing by a factor of ten can give
a difference closer to that observed experimentally. It may be possi-
ble to estimate a value of κ relative to K from the yeast two-hybrid
results given in Fukaki et al. (2005) for the binding of both ARF7 and
ARF19 with IAA14. While these results do appear to show in greater
affinity of IAA14 for ARF19 than for ARF7 as required, the given ex-
perimental value of ARF7-IAA14 dimers is approximately 80% that
of ARF19-IAA14 dimers. If we assume this is roughly equivalent to
the ratio of κ to K, this difference is not significant enough for the
model to account for the observed difference in expression.
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Figure 4.6: Fixing particular parameters relative to others, can result in higher
gene expression in the arf19 mutant relative to the wild type. κ
is the affinity of ARF19 to IAA14, φir is the binding threshold
of ARF19-IAA14 dimers with the promoter of tfX, and λi is the
activatory power of ARF19 relative to ARF7.
2. λi: Maximum activation due to ARF19 relative to ARF7.
The model has the assumption that when either ARF19 or ARF7 is
bound to a promoter, it increases the probability of RNA polymerase
binding to it, resulting in the gene being transcribed. Previously, it
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was assumed that this probabilty of transcription was equal for both
ARF7 and ARF19, by setting the value of the parameter λ for the gene
in question to 1. This parameter is effectively a measure of activatory
power of ARF19, and so a value of λ > 1 would simulate ARF19 being
a more effective activator than ARF7, while λ < 1 simulates ARF19
as a less effective activator. If λ = 0 ARF19 is entirely ineffective as
an activator; in other words by competing for the same binding site as
ARF7, when bound it will not result in transcription and so ARF19
is effectively a repressor. Because of this, reducing λi can result in
increased transcription in the arf19 mutant relative to wild type, as
shown in Figure 4.6b. Even for a value of λi = 0.1 the increased
expression in the arf19 mutant is marginal, and a parameter value this
low or lower would appear to contradict the assuption that ARF19 is
an activator at all.
3. φir: Binding threshold of ARF19-IAA14 repressors to pro-
moter.
The parameter φir can be thought of as representing the concentration
at which ARF19-IAA14 dimers begin to have a strong probability of
binding with the promoter and repressing transcription. If this value
is set low, compared to other binding parameter values, then the level
of ARF19-IAA14 may have a disproportionally large effect. Figure
4.6c demonstrates this using the model. However, if ARF19-IAA14
dimers are more likely to bind the promoter than ARF7 or ARF7-
IAA14 dimers, it might be expected that ARF19 monomers ought
also to bind preferentially, and if this is set to be the case by changing
the relevant parameter the effective repression by ARF19 is removed.
By changing the key parameters listed above, it is shown that the ob-
served increase in LAX3 expression in the arf19 mutant may be explained
by differences in interaction rates between ARF19, ARF7 and other sys-
tem components. In general though, these differences strongly reduce the
power of ARF19 as an activator in comparison to ARF7, and due to the
sequence similarity between ARF7 and ARF19 the differences in parame-
ter values needed may not be biologically realistic. For this reason in the
following sections we investigate the possibilty that ARF19 is activating an-
other transcription factor that acts as a repressor, and it is this that results
in the difference in expression of LAX3 in the wild type and arf19 mutant
backgrounds.
4.3 Models with ARF19 activated repressors
4.3.1 ARF19 activates a single repressor
Using the simple ARF7-ARF19 model in Section 4.2, it was shown in Section
4.2.4 that by changing one or more key parameters, ARF19 may be able
to act as a repressor of ARF7 responsive genes. In this way, the model
should be able to match qualitatively the increased expression of LAX3
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in the arf19 mutant compared to the wild type. This depends however, on
parameter values for ARF19 relative to ARF7 which may not be biologically
realistic. An alternative hypothesis to explain the difference between wild
type and arf19 is that ARF19 specifically activates a repressor of LAX3
that ARF7 does not. One set of candidate repressors are the negative
ARFs (Guilfoyle and Hagen 2007), which do not generally bind with the
Aux/IAAs (Vernoux et al. 2011), and may compete with the positive ARFs
for AuxRE binding sites. There is an AuxRE binding site on the LAX3
promoter which is a potential site for negative ARFs, and mutating this
site does not negatively impact LAX3 induction suggesting the positive
ARFs do not bind effectively (Larrieu 2011). The model network shown in
Figure 4.7 is therefore formulated in the following section and the resulting
predictions compared with the experimental data.
LAX3
ARF7
IAA14
auxin
‘X’
ARF19
ARFrep
Figure 4.7: Gene network using the single repressor model. ARF7 activates
ARF19 which activates an unknown repressor of LAX3.
Model Formulation
The model is formulated similarly to previous models, but with the addition
of the proposed negative ARF, ARFr, which is able to feed back negatively
on the expression of all the other genes. Also, with the exception of IAA14,
the protein and mRNA of the induced genes are modelled with a single
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equation. This gives the new model:
dIAA
dt
=
−ηauxin IAA
QP +Qauxin+ auxin IAA
+ IAAm, (4.8a)
dIAAm
dt
= Ftc
(
K
θia(IAA+K)
,
IAA
θir(IAA+K)
,
ARFr
θin
, ni
)
− IAAm,
(4.8b)
dX
dt
= µx
(
Ftc
(
K
θxa(IAA+K)
,
IAA
θxr(IAA+K)
,
ARFr
θxn
, nx
)
−X
)
,
(4.8c)
dLAX
dt
= µl
(
Ftclax
(
X
θla
,
ARFr
θln
, nl,m
)
− LAX
)
, (4.8d)
dA19
dt
= µa
(
Ftc
(
K
θaa(IAA+K)
,
IAA
θar(IAA+K)
,
ARFr
θan
, na
)
− A19
)
,
(4.8e)
dARFr
dt
= µr
(
Ftc
(
A19
θra
,
A19 IAA
θrr N
,
ARFr
θrn
, nr
)
− ARFr
)
, (4.8f)
dauxin
dt
= xaux(αaux + αlaxLAX)− µauxauxin, (4.8g)
where:
Ftc(ACT,REP1, REP2, n) =
ACT n
1 + ACT n +REP1n +REP2n
, (4.8h)
Ftclax(ACT,REP, n,m) =
(
ACT n
1 + ACT n
)(
1
1 +REPm
)
. (4.8i)
Time and auxin are scaled as before, IAAm, X, LAX, A19, ARFr are scaled
with λ/µ (ratio of peak transcription to decay) for each gene, and IAA is
scaled with λiδi
µ2im
.
The key features of the model occur in the form of the functions relating
to the transcription of the mRNAs. For simplicity, since as shown in Sec-
tion 4.2.3 the additional activation by ARF19 can be approximated in the
model by adjusting the affinity for ARF7, only ARFr is activated by ARF19
explicitly, while the other genes are activated by ARF7 only. In both cases
ARFr is able to bind the ARF binding site and repress transcription.
LAX3 is positively activated by the unknown TFx, and repressed by
ARFr, with both able to bind independently to different sites. For tran-
scription to occur we assume that both X must be bound to its binding
site, and that the ARF binding site is unoccupied. Otherwise transcrip-
tion is repressed. Because of this the transcription of LAX3 is modelled by
the product of the probability that the activatory site is occupied and the
probability that the ARF binding site is unoccupied.
Parameter Fitting
Using the parameter fitting algorithm described in Section 2.2, with the
above model (4.8a)-(4.8i) it is possible to fit the parameters to match the
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Table 4.3: Fitted parameter values for the model given by equations (4.8a)-
(4.8i) to the data in Figure 4.1. Co-operativity coefficients were
constrained between 1 and 3, and binding parameters between 0.01
and 100.
θia = 0.0589 θir = 0.0705 θin = 0.0576 ni = 2.9377 P = 0.784
θxa = 0.5936 θxr = 0.0497 θxn = 0.0169 nx = 1.1994 µx = 5.8473
θla = 0.1050 nl = 1.5557 θln = 0.0141 m = 1 µl = 0.6998
θaa = 0.0989 θar = 0.0534 θan = 0.7072 na = 3 µa = 0.0345
θra = 0.1034 θrr = 100 θrn = 1.1282 nr = 3 µr = 0.0682
αlax = 0.3837 µaux = 9.2349 Q = 0.0029 K = 0.0202 η = 13.2518
xaux0 = 0.1004 αx = 0.012
IAA14 and LAX3 qRT-PCR wild type data given in Figure 4.1, with the
fitted parameter values shown in Table 4.3). Figure 4.8(a) shows the model
fit, along with a prediction for ARFr mRNA against time. By peaking late
in the time course the additional repressor is able to reduce expression of
LAX3 and IAA14 over the second half of the time course. However, as may
be expected, when ARF19 is removed, the repressor is no longer induced
and the genes remain switched on (Figure 4.8(b)).
An additional result of including the additional repressor in the model is
seen in the steady state LAX3 expression with increasing exogenous auxin
(Figure 4.9(a)). In previous models, an increase in exogenous auxin will
result in an increase in steady state expression. Even in the conjugation
model where there may be stable oscillations, these will be about an un-
stable steady state which increases with increasing auxin signal. In the
repressor model however, we see that after increasing from zero auxin sig-
nal there may be a fixed value of exogenous auxin signal for which mRNA
expression peaks, before returning to at or near the initial zero auxin ex-
pression level for high levels of exogenous auxin. This means that both
very high and very low auxin treatments may result in low steady state ex-
pression of LAX3 mRNA, while an intermediate value for auxin will result
in a relatively high steady state expression. The steady state level intra-
cellular auxin concentration with increasing exogenous auxin signal shown
in Figure 4.9(b) demonstrates that the expression of the induced repressor
does not negatively affect the amount of auxin in the cell. In this case,
the key difference in model behaviour between high and low auxin treat-
ment is seen in the time course simulation (Figure 4.9(c)). Here, following
an initial increase from basal auxin level, low auxin treatment results in a
small and steady increase to a higher steady state expression, while inter-
mediate auxin treatment results in a qualitatively similar increase, but with
a much higher fold-change increase in steady state. For the highest auxin
treatment, there is temporary increase in expression many fold higher than
that seen at either the low or intermediate treatments, before over time the
increase in the induced repressor causes the expression level to drop to that
below that seen for the low auxin treatment.
The ARF19 activated repressor model describes a possible mechanism
by which at high auxin treatment LAX3 mRNA may be expressed tem-
117
0 5 10 15 20 25 30 35 40
0
10
20
30
40
50
60
70
80
time / hours
m
R
N
A 
/ s
te
ad
y 
st
at
e
 
 
model IAA14
model LAX3
model ARFr
IAA14 data
LAX3 data
(a) Simulated LAX3 and IAA14 mRNA against time using the model given by equations
(4.8a)-(4.8i) with the parameter values in Table 4.3, fitted to the wild type LAX3 and
IAA14 qRT-PCR data shown in Figure 4.1.
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(b) Simulated LAX3 and IAA14 mRNA against time using the model given by equations
(4.8a)-(4.8i) with the parameter values in Table 4.3, with ARF19 expression fixed equal to
zero. Removing ARF19 from the model, removes all repression, and so both IAA14 and
LAX3 remained switched on throughout the time course.
Figure 4.8
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(a) LAX3 mRNA steady state with increasing auxin signal (xaux).
Steady state expression is low at both low and high xaux, and peaks
at intermediate values.
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(b) Intracellular auxin steady state increases with increasing auxin signal.
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(c) Temporal differences in LAX3 mRNA expression following treatment
with low, intermediate or high auxin (see figure legend).
Figure 4.9: LAX3 mRNA (Figure 4.9(a)) and intracellular auxin (Figure 4.9(b))
steady state with increasing exogenous auxin signal, and example
time courses at low, intermediate and high auxin treatment (Figure
4.9(c)) using the repressor model (4.8a)-(4.8i) and the parameter
values in Table 4.3.
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porarily before being down-regulated once more. On its own however, it is
insufficient to explain the difference between the wild type and arf19 mu-
tant LAX3 expression, and removing ARF19 from the model removes all
downregulation (Figure 4.8(b)). A repression mechanism that may explain
this difference is investigated in Section 4.3.2.
4.3.2 Two Repressor Pathway Model
In Section 4.3.1 it is shown that a repressor, possibly a negative ARF, can
simulate the experimentally observed LAX3 expression profile of a peak be-
tween 10 and 15 hours followed by down-regulation for the remainder of
the time course. If this induced repressor is responsible for the shape of
the temporal expression profile, then a repressor must also be induced by a
pathway independent of ARF19, since this same profile (but with a larger
magnitude) is observed in the arf19 mutant plants. If this is the case the
effect observed in the arf19 mutant could be a result of a quantitative reduc-
tion in total repressor by knocking out the ARF19 specific pathway. This
leads to the formulation of a extended ARF7-ARF19 model as summarised
in Figure 4.10.
LAX3
ARF7
IAA14
auxin
‘X’
ARF19
ARFr1
Activator
ARFr2
Figure 4.10: Gene network for the two repressor model. As well as a repressor
activated by ARF19 which is activated by ARF7, there is also an
ARF19 independent repressor which represses LAX3.
Two more unknown genes are expressed in the model which we refer to
as A2 (activator 2) and R2 (repressor 2), which require the addition of two
new differential equations to the model given by (4.8a)-(4.8i):
dA2
dt
= µa2
(
Ftc
(
K
θa2a(IAA+K)
,
IAA
θa2r(IAA+K)
,
ARFr + r2
θa2n
, na2
)
−X
)
,
(4.9a)
dR2
dt
= µr2
(
Ftc
(
K
θr2a(IAA+K)
,
IAA
θr2r(IAA+K)
,
ARFr +R2
θr2n
, nr2
)
−X
)
.
(4.9b)
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A2, and R2 are scaled with λ/µ for their respective genes. Also, the
genes are now repressed by the total pool of repressors ARFr and R2, and
so ARFr is replaced in the functions for transcription in equations (4.8b)-
(4.8f) by ARFr +R2. For example:
dLAX
dt
= µl
(
Ftclax
(
X
θla
,
ARFr +R2
θln
, nl,m
)
− LAX
)
. (4.9c)
To simulate the arf19 mutant A19 is fixed equal to zero as before. Using
this model, and running the parameter fitting algorithm results in a pa-
rameter set which gives a good agreement between the model and both the
wild type and arf19 mutant LAX3 expression data (Figure 4.11(a)), and
a reasonable agreement with the wild type IAA14 and ARF19 data (Fig-
ure 4.11(b)). For parameter values see Table 4.4. This parameter set then
gives a prediction for the extra activator and both repressors as shown in
Figure 4.11(c). Both repressors peak late in the time course to provide the
characteristic expression profile for LAX3.
Table 4.4: Fitted parameter values for the two repressor model given by equa-
tions (4.8a)-(4.8i) and (4.9a)-(4.9b) to the wild type LAX3, IAA14
and ARF19, and arf19 mutant qRT-PCR expression data shown in
Figure 4.1. Co-operativity coefficients were constrained between 1
and 2, and binding parameters between 0.01 and 100.
θia = 0.0587 θir = 0.0687 θin = 0.0621 ni = 1.8962 P = 0.226
θxa = 1.1539 θxr = 0.1039 θxn = 0.017 nx = 1.9262 µx = 0.8652
θla = 0.173 nl = 1.1849 θln = 0.0142 m = 1 µl = 0.2818
θaa = 0.6738 θar = 0.5919 θan = 0.1799 na = 1.5735 µa = 5.3638
θa2a = 0.1489 θa2r = 0.0542 θa2n = 100 na2 = 2 µa2 = 2.9999
θra = 0.5225 θrr = 1.9578 θrn = 2.9371 nr = 1.1454 µr = 0.0307
θr2a = 0.1212 θr2r = 21.8627 θr2n = 2.7262 nr2 = 2 µr2 = 0.0431
Q = 0.0012 K = 0.0147 η = 9.3926 xaux0 = 0.0248 αlax = 0.2833
αx = 0.0042 µaux = 3.076
Figure 4.12 shows time course predictions for intracellular auxin and
Aux/IAA in the simulated wild type, and simulated lax3 and arf19 mu-
tants. In the lax3 mutant intracellular auxin increases smoothly to a higher
concentration following an increase in the auxin signal. In the wild type,
where LAX3 is present, auxin concentration is temporarily amplified due to
added auxin influx transport, before LAX3 is repressed again and auxin be-
gins to return toward the value seen in the lax3 mutant. In the arf19 mutant
this temporary amplification is increased in magnitude due to a reduction in
ARF19 dependent repressor causing an increase in LAX3 induction. These
changes in intracellular auxin are reflected in the predictions for Aux/IAA,
none of which show any significant recovery later on in the time course,
since in all three simulations auxin remains high and so despite the positive
feedback from increased Aux/IAA mRNA expression the Aux/IAA protein
is still rapidly degraded.
The lack of recovery of Aux/IAA over the latter half of the time course
in the two repressor model is contrary to the experimental evidence given
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(a) Model and qRT-PCR data for LAX3 in both wild type and arf19
mutant. The parameters are fitted so that ARF19 and IAA14 w.t.
expression data also matches the model.
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(b) Model and qRT-PCR data for ARF19 and IAA14 against time.
The parameters are fitted so that LAX3 w.t. and arf19 expression
data also matches the model.
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(c) Fitted ARF19, and predictions for the second activator and the
two proposed repressors. The parameters are fitted so that LAX3
w.t. and arf19, and ARF19 and IAA14 w.t. expression data matches
the model.
Figure 4.11: Fitted model wild type LAX3, ARF19, and IAA14 mNRA, and
arf19 mutant LAX3 fitted to the qRT-PCR expression data shown
in Figure 4.1, plus predictions for the unknown activator and re-
pressors using the two repressor model given by equations (4.8a)-
(4.8i) and (4.9a)-(4.9b).
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(a) Intracellular auxin against time, for simulated wild type, and lax3 and arf19 mutants.
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(b) Aux/IAA protein against time, for simulated wild type, and lax3 and arf19 mutants.
Figure 4.12: Prediction of the two repressor model given by equations (4.8a)-
(4.8i) and (4.9a)-(4.9b) for intracellular auxin (Figure 4.12(a)),
and Aux/IAA protein (Figure 4.12(b)) against time for the ‘wild
type’ (black lines), and arf19 (blue lines) and lax3 (red lines) mu-
tant simulations, using the parameter values in Table 4.4).
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by the 30 hour DII-VENUS data (Section 2.3), in which a recovery of DII-
VENUS levels is seen between 10 and 20 hours post-auxin treatment. Be-
cause of this, while the two repressor model may be a reasonable model
to simulate all the qRT-PCR data, the model prediction for intracellular
auxin is not compatible with the DII-VENUS data, and suggests some form
of auxin homeostasis is still needed.
4.4 ARF7-ARF19-LAX3 model with auxin
homeostasis
In the model given by equations (2.21a)-(2.21g) auxin homeostasis is ac-
counted for empirically by using decay of the exogenous auxin signal follow-
ing initial treatment as defined by equation (2.19c). For clarity, the model
is reproduced below:
dauxin
dt
= α0 + αtrxaux(t)− µauxauxin, (4.10a)
dIAA
dt
=
−ηauxinIAA
QP +Qauxin+ auxinIAA
+ IAAm, (4.10b)
dIAAm
dt
= µim(Ftc
(
K
θia(IAA+K)
,
IAA
θir(IAA+K)
, ni
)
− IAAm),
(4.10c)
dXm
dt
= µxm
(
Ftc
(
K
θxa(IAA+K)
,
IAA
θxr(IAA+K)
, nx
)
−Xm
)
,
(4.10d)
dX
dt
= µx(Xm −X), (4.10e)
dLAXm
dt
= µlm
(
Ftc
(
X
θla
, 0, nl
)
− LAXm
)
, (4.10f)
dLAX
dt
= µl(LAXm − LAX), (4.10g)
xaux(t) = (auxintr − auxin0)e
−µtrt, (4.10h)
where:
Ftc(ACT,REP, n) =
(ACT )n
1 + (ACT )n + (REP )n
. (4.10i)
In this section, the above model is used with the parameters in Table 4.5,
which are fitted to the IAA14 mRNA expression data in Figure 4.1 and
the DII-VENUS data discussed in Section 2.3, as a basis for investigating
ARF19 regulation and activity further.
In this model the only activator is ARF7 (substituted for by its quasi-
steady state value), and so if we consider that ARF19 is also regulating
LAX3 in some way, it may also be thought of as a model for the arf19
knockout mutant plant. For this reason, we first fit the existing model to
the arf19 mutant LAX3 data, and then evaluate several models for both
the expression of ARF19, and the regulation of LAX3 by ARF19, resulting
in a final network model which best describes all the available data.
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Table 4.5: Fitted model parameter values from Sections 2.3 and 2.4.1 used in
the model variants investigated in Section 4.4.
K µim ni θai θri µtr α0
0.1011 0.0915 1.7432 0.1179 0.0021 0.264 2.250
P Q η auxin0 αtr µaux λv
5.0006 0.6773 17.5942 0.2717 1.7252 8.2817 0.4229
4.4.1 Expression of LAX3 mRNA : arf19 mutant
In using the model given by equations (4.10) to simulate the arf19 mutant
we must make some further assumptions. First, that basal auxin in the
root is the same in both the wild type and arf19. Second, that the auxin
response machinery (i.e. the degradation of Aux/IAA in response to auxin)
works at the same rate and responsiveness in the two genotypes. Finally,
based on the PCR expression data we assume that expression of the main
repressor, IAA14, is similar in wild type and arf19 (Figure 4.1).
With the fitted parameters determined previously, this leaves 8 parame-
ters to be fitted to the LAX3 arf19 expression data (Figure 4.13). Repeated
application of the parameter fitting algorithm shows a consistent agreement
with the data, and fitting the model with the arf19 mutant data rather than
the wild type results in a much better fit. The model also gives a range of
predictions for tfX in the arf19 mutant background. There is clear varia-
tion in the magnitude of the auxin response of these predicted expression
profiles, but there seems to be some consistency in the relative timing in
expression. The best fits for the parameter values µx, µxm , θax, θrx, nx, µlm ,
θal, nl are given in Table 4.7 and used in subsequent models.
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Figure 4.13: Set of model fits of the LAX3 mRNA expression to the LAX3
arf19 mutant data shown in Figure 4.1, using the model given
by equations (4.10a)-(4.10i). Since ARF19 is not included in the
model but appears to affect LAX3 expression in the experimental
data, the model can be thought of as being of the arf19 mutant
genotype. The set of predictions for tfX differ in magnitude but
are consistent in timing.
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4.4.2 ARF19 Regulation Models
The PCR data gives evidence that ARF19 is auxin responsive, and at least
in part dependent on ARF7 (Figure 4.1). The precise regulation of ARF19
however is unknown. In this section we define four different models for
ARF19 regulation (Figure 4.14) and compare the best fits of each to the
data. In each case we assume that the downstream targets of ARF19 do
not themselves feedback and regulate ARF19 directly or indirectly.
Model 1: ARF19 is a primary response of ARF7 (Figure 4.14, top
left).
The simplest model for ARF19 regulation is direct activation by ARF7 only,
and repression by ARF7-IAA14 dimers. This requires just one equation in
addition to (4.10a)-(4.10i):
dARF19m
dt
= µam
(
Ftc
(
K
θaa(IAA+K)
,
IAA
θar(IAA+K)
, na
)
− ARF19m
)
,
(4.11)
with four extra model parameters, µam , θaa, θra, na.
Model 2: ARF19 is a primary response of ARF7, and also auto-
activated (Figure 4.14, top right).
If ARF19 is activated by ARF19 as well as ARF7, we need an additional
equation for ARF19 protein:
dARF19
dt
= µa(ARF19m − ARF19). (4.12a)
Due to the similarity of ARF7 and ARF19 we assume that the activatory
power of both ARF7 and ARF19 is equal, and that any co-operativity effect
acts on the combined pools of activators and repressors. We also assume
that ARF19 can bind with IAA14 to form repressors in a similar way as
ARF7 so that formation of ARF19-IAA14 dimers (AI19) is governed by:
dAI19
dt
= kaARF19 IAA− kdAI19. (4.12b)
If we use the same parameter values for ka and kd as for binding/unbinding
of ARF7-IAA14 dimers we can also assume these processes are relatively
rapid on our timescale of interest and make the steady-state approximation:
AI∗19 =
ARF19 IAA
K
This means that, with the addition of two new binding parameters θaa2 and
θar2 , ARF19 and the approximation for AI19 are added into equation (4.11)
as follows:
dARF19m
dt
= µam(Ftc
(
K
θaa(IAA+K)
+
ARF19
θaa2
,
IAA
θar(IAA+K)
+
ARF19 IAA
θar2K
,na
)
− ARF19m). (4.12c)
The complete model in nine variables is then defined by equations (4.10a)-
(4.10i), (4.12a) and (4.12c).
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Figure 4.14: Hypothetical regulatory models for ARF19. 1). ARF19 is a pri-
mary response of ARF7 (Section 4.4.2, Model 1). 2). ARF is
a primary response of ARF7 and is also auto-activated (Section
4.4.2, Model 2). 3). ARF19 is activated by both ARF7 and an
unknown ARF7 primary response in a feed-forward loop (Section
4.4.2, Model 3). 4). ARF19 is activated by both ARF7 and an un-
known ARF7 secondary response in a feed-forward loop (Section
4.4.2, Model 4).
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Model 3: ARF19 is activated by a primary auxin response gene
in addition to ARF7 (Figure 4.14, bottom left).
If instead of ARF19 there is an another ARF7 activated gene (A1) act-
ing as an additional activator of ARF19 equation, we need two additional
equations for A1 translation and transcription of its mRNA A1m:
dA1m
dt
= µ1m
(
Ftc
(
K
θ1a(IAA+K)
,
IAA
θ1r(IAA+K)
, n1
)
− A1m
)
, (4.13a)
dA1
dt
= µ1(A1m − A1), (4.13b)
with five new parameters µ1m , θ1a, θ1r, n1 and µ1. We have ARF7 and
A1 activating, and ARF7-IAA14 dimers repressing ARF19 so that (4.12c)
becomes:
dARF19m
dt
= µam
(
Ftc
(
K
θaa(IAA+K)
+
A1
θaa2
,
IAA
θar(IAA+K)
)
− ARF19m, na
)
,
(4.13c)
so that the model in eleven variables is defined by equations (4.10a)-(4.10i),
(4.12a) and (4.13a)-(4.13c).
Model 4: ARF19 is activated by a secondary auxin response gene
in addition to ARF7 (Figure 4.14, bottom right).
Finally, if the additional activator of ARF19 is a secondary auxin response
gene we have the extra two equations for A2 protein, whose mRNA A2m is
directly activated by A1:
dA2m
dt
= µ2m
(
Ftc
(
A1
θ2a
, 0, n2
)
− A2m
)
, (4.14a)
dA2
dt
= µ2(A2m − A2), (4.14b)
with the four new parameters µ2m , θ2a, n2 and µ2. Substituting A2 for A1
in (4.13c) so that:
dARF19m
dt
= µam
(
Ftc
(
K
θaa(IAA+K)
+
A2
θaa2
,
IAA
θar(IAA+K)
)
− ARF19m, na
)
,
(4.14c)
and the model in thirteen variables is defined by (4.10a)-(4.10i), (4.12a),
(4.13a)-(4.13b) and (4.14a)-(4.14c).
Parameter fitting
The parameter fitting algorithm was used to find the best fit of each of the
four ARF19 regulation models with the wild type ARF19 qRT-PCR mRNA
expression data shown in Figure 4.1. The resulting model predictions are
shown in Figure 4.15.
The simplest model (model 1) with ARF7 alone activating ARF19 does
not fit the data well. It can match the late timepoints (as shown here) or
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Figure 4.15: Best fit found to the ARF19 mRNA expression data for each of
the four hypothetical regulatory models in Figure 4.14. The best
fits are found with an additional transcription factor downstream
of ARF7 activating with ARF7 in a feed-forward loop.
the early timepoints, but not both with the same parameter set. Having
ARF19 feedback and activate itself (model 2) improves the fit slightly, but
the constraints of the model still limit the expression profile to a single peak.
Adding an ARF19 independent TF to the regulation model (models 3 and
4) allows for an expression profile with two maxima, and a much better
fit to the expression data. Model 4, where the activator is a secondary
auxin response gives a marginally better fit than model 3. While these
models need experimental validation before any biological conclusions can
be drawn, especially considering the possibility that adding extra variables
and parameters to the overall model may lead to over fitting the data, either
model 3 or 4 can be used to simulate the expression profile of ARF19 mRNA
and test the effect of ARF19 on potential downstream targets, as in Section
4.4.3.
4.4.3 Regulation of LAX3 by ARF19
The previous models have simulated expression of IAA14 (Section 2.4.1)
using fitted parameters from DII-VENUS quantification data (Section 2.3),
simulated expression of LAX3 mRNA in the arf19 mutant background using
the data in Figure 4.1 (Section 4.4.1), and simulated expression of ARF19
mRNA using the same data set (Section 4.4.2). To bring these sub-models
together we need to combine them and model the apparent negative effect
of ARF19 on LAX3 expression. We consider four main possibilities:
1. ARF19 can act as a repressor of LAX3 directly
2. ARF19 activates a repressor of LAX3 (ARFr)
3. ARF19 acts as a repressor of tfX directly
4. ARF19 activates a repressor of tfX (ARFr)
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Figure 4.16: Hypothetical gene regulatory networks extending the networks
shown in Figure 4.14 by including different possibilities for the
transcriptional repression of LAX3 by ARF19, as described in Sec-
tion 4.4.3. 1) ARF19 acts as a repressor of LAX3 by binding the
LAX3 promoter directly. 2) ARF19 activates in intermediate re-
pressor, ARFr, which binds and represses the LAX3 promoter. 3)
ARF19 acts as a repressor of LAX3 by binding the tfX promoter
directly, preventing LAX3 from being activated. 4) 2) ARF19 ac-
tivates in intermediate repressor, ARFr, which binds and represses
the tfX promoter, preventing LAX3 from being activated. In each
case, ARF7 and ARF19 activates their downstream targets in re-
sponse to auxin, and among ARF7 targets are ARF19 and tfX.
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Gene network diagrams of these four sub-networks are shown in Figure 4.16.
In each case, the models will have ARF7 and ARF19 activating their down-
stream targets in response to auxin, following the degradation of IAA14
which we assume binds to both of the ARFs. While the level of ARF7
remains constant, ARF19 is itself activated by ARF7 as discussed in Sec-
tion 4.4.2. tfX is activated by ARF7 in an auxin responsive manner. Each
model is a variant of Model 4 defined in Section 4.4.2 by equations (4.10a)-
(4.10i), (4.12a), (4.13a)-(4.13b) and (4.14a)-(4.14c). Each model variant is
defined in turn before attempting to fit each model to the LAX3 wild type
expression data.
ARF19 can act as a repressor of LAX3 directly
While ARF19 has previously been considered a transcriptional activator
(Guilfoyle and Hagen 2007), the simplest model for ARF19 regulation of
LAX3 has it repressing LAX3 directly by competing with the same binding
site as tfX. When ARF19 is bound to the LAX3 promoter in this model,
transcription is blocked. To include this repression we amend equation
(4.10f) as follows:
dLAXm
dt
= µl
(
Ftc
(
X
θla
,
ARF19
θlr
, nl
)
− LAXm
)
. (4.15)
Previously, the following function for transcription (equation (4.10i)) was
used:
Ftc(ACT,REP, n) =
(ACT )n
1 + (ACT )n + (REP )n
.
This is based on activator and repressor competing for the same binding
site. If instead, there are two binding sites we use the following function for
transcription:
Ftc2(ACT,REP, n) =
(
ACT n
1 + ACT n
)(
1
1 +REP n
)
. (4.16)
In this case the repressor can bind the LAX3 promoter and repress tran-
scriptional activity even when the activator tfX is bound to the other site,
and we consider both cases using Ftc and Ftc2 in the parameter fitting for
each different variation of the model given below.
Using model 3 or 4 from section for ARF19 mRNA, the profile of ARF19
protein relative to mRNA is free to vary according to a single parameter
value µa (ARF19 protein turnover rate). With the fitted parameter values
for model 4 from Section 4.4.2, Figure 4.17 shows two possible profiles of
ARF19 protein in relation to the the fitted mRNA profile for different µa.
Salmon et al. (2008) gives an experimentally determined half-life of 3.7 hours
for ARF1, which corresponds to a value of around µa = 0.20. If we use this
value as an estimate for ARF19 turnover this results in a relatively slow
accumulation of ARF19 protein over the time course, peaking between 15
and 20 hours following auxin treatment. A faster turnover rate results in a
profile of ARF19 which more closely matches the mRNA profile. If ARF19
is a direct repressor of LAX3, µa is a key model parameter.
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ARF19 activates a repressor of LAX3
Here there is an intermediate TF between ARF19, which is modelled by the
following two additional equations:
dARFrm
dt
= µrm
(
Ftc
(
ARF19
θra
,
ARF19 IAA
θrrK
,nr
)
− ARFrm
)
, (4.17a)
dARFr
dt
= µr(ARFrm − ARFr). (4.17b)
Again we use the quasi-steady approximation for ARF19-IAA14 repressor
dimers. ARFr is then substituted directly for ARF19 in equation (4.15),
replacing it with the following equation:
dLAXm
dt
= µl
(
Ftc
(
X
θla
,
ARFr
θlr
, nl
)
− LAXm
)
. (4.17c)
The dynamic nature of ARF19 means this gene can be activated in two
ways. At low auxin ARFr is repressed by ARF19-IAA14 dimers and so is
immediately auxin responsive when auxin is increased and Aux/IAA de-
graded. In addition though, any increase in ARF19, as seen following auxin
treatment, will also tend to increase transcriptional activity. The relative
import of these two processes is governed by one parameter value in particu-
lar, θrr, which is the affinity of ARF19-IAA14 dimers to the ARFr promoter
(Figure 4.17). For low θrr the dimers are more likely to bind the promoter,
and so the gene is more responsive to the initial auxin treatment. With a
higher value for θrr ARFr expression is less sensitive to the auxin signal,
and more responsive to the auxin induced increase in ARF19. Because of
this the expression profile of ARFr is sensitive to two key parameters, θrr
and the ARF19 turnover rate, µa (Figure 4.17).
ARF19 acts as a repressor of tfX directly
If ARF19 directly targets tfX for repression equation (4.17c) reverts to
equation (4.10f), and equation (4.10d) is replaced by:
dXm
dt
= µxm
(
Ftc
(
K
θxa(IAA+K)
,
IAA
θxr(IAA+K)
+
ARF19
θxr2
, nx
)
−Xm
)
.
(4.18)
ARF19 activates a repressor of tfX
In the final model ARFr represses tfX rather than ARF19, and so ARFr
is substituted for ARF19 in equation (4.18):
dXm
dt
= µxm
(
Ftc
(
K
θxa(IAA+K)
,
IAA
θxr(IAA+K)
+
ARFr
θxr2
, nx
)
−Xm
)
.
(4.19)
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Figure 4.17: Example expression profiles of ARF19 protein, a direct target of
ARF19, and a direct target of ARF7 using a range of parameters,
using the fitted model of ARF19 mRNA expression (for data, see
Figure 4.1). While both the ARF19 and ARF7 genes are auxin
responsive due to Aux/IAA degradation, the ARF19 gene has ad-
ditional feedback from upregulation of ARF19 itself. The param-
eter θr (the affinity of ARF19-IAA14 dimers to the promoter of
the target gene) affects the balance between these two activatory
components, while the parameter µa affect the timing of ARF19
translation, and so the timing of the target gene. In general the
ARF19 activated gene shows a broader range of expression profiles
than can the ARF7 activated gene. (a)Low µa, high θr. (b)High
µa, high θr. (c)Low µa, low θr. (d)High µa, low θr.
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Table 4.6: Best ‘fit value’ found using the hybrid genetic algorithm and di-
rectional local minima search for each model variation outlined in
Section 4.4.3. The fit value is defined as the sum of squared differ-
ences between model and data points, relative to the sum of squared
differences between the mean of data points and each data point.
Target Repressor Competitive Binding? Fit value
LAX3 ARF19 yes 0.391
LAX3 ARF19 no 0.441
LAX3 ARFr yes 0.295
LAX3 ARFr no 0.083
tfX ARF19 yes 0.564
tfX ARF19 no 0.571
tfX ARFr yes 0.329
tfX ARFr no 0.387
Parameter Fitting
To evaluate the different LAX3 regulatory models each was fitted with the
wild type LAX3 expression data shown in Figure 4.1, re-normalised relative
to the basal expression in the arf19 mutant. The parameter values fitted
in Section 4.4.1 and shown in Table 4.7 were used so that the arf19 mutant
data would always fit the model, with the differences being in the wild
type simulation relative to this. The best fits found for each of the model
permutations are shown in Figure 4.18.
In general there is a greater difference in the profiles of the fits between
the four main types (based on target and source of repression), than there
is between model subtypes (based on the number of binding sites). The
poorest fits appear for the model where ARF19 represses tfX directly, while
the best fit is for the model where a direct target of ARF19 (ARFr) represses
LAX3, with non-competitive binding with tfX on the LAX3 promoter. It is
difficult to differentiate between the other models. Most fit the data for at
least part of the time course, but do not match the basal expression of the
wild type relative to arf19. The goodness of fit is compared quantitatively,
by giving the value of the optimisation function for each case in Table 4.6.
The final set of fitted parameters is given in Table 4.7.
4.5 Discussion and Conclusions
Simple ARF7-ARF19 model
The experimental evidence points to ARF19 being partly induced by ARF7,
and so being auxin responsive. If ARF19 targets the same genes as ARF7,
it is expected intuitively that adding it to the model system will result in
greater expression of genes following an auxin signal. The mathematical
modelling of the ARF7-ARF19 system demonstrates that this is the case,
provided the parameter values relating to binding of gene promoters, mRNA
polymerase, and Aux/IAA repressors are shared between ARF7 and ARF19.
134
0 10 20 30 40
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
time / hours
m
R
N
A 
/ h
ou
rs
 
 
LAX3 wild type − Model A
LAX3 arf19
LAX3 wild type − Model B
LAX3 wt data
LAX3 arf19 data
0 10 20 30 40
0
1
2
3
4
5
6
7
time / hours
m
R
N
A 
/ h
ou
rs
 
 
LAX3 wild type − Model A
LAX3 arf19
ARF19 activated repressor − Model A
LAX3 wild type − Model B
ARF19 activated repressor − Model B
LAX3 wt data
LAX3 arf19 data
(a) Fits with the data of the model where ARF19 represses LAX3 by binding the promoter
directly (left), and the model where ARF19 activates a repressor which then binds LAX3
(right).
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(b) Fits with the data of the model where ARF19 represses LAX3 by binding the tfX
promoter directly (left), and the model where ARF19 activates a repressor which binds
the tfX promoter, effectively repressing LAX3 (right).
Figure 4.18: Best fits of the LAX3 mRNA expression data for each of the hy-
pothetical LAX3 regulatory models. The wild type LAX3 mRNA
expression data from Figure 4.1 is renormalised and plotted rela-
tive to the arf19 mutant. Model A: a repressor competes with the
activator for the same binding site. Model B: the repressor is able
to bind regardless of the presence of an activator (seperate bind-
ing site). The previously determined parameters for IAA14 and
ARF19 expression were used. The closest fit is found using the
model where ARF19 activates a repressor of LAX3 which binds to
a seperate binding site from tfX.
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If this is the case it can be shown that the steady state expression of the
auxin responsive genes will always be greater with both an inducible ARF19
and a stable ARF7 in the model than in the model with just ARF7.
As well as being induced by ARF7 and activating genes, ARF19 is able to
bind with Aux/IAAs and form genetic repressors (Fukaki et al. 2005). Since
we assume this binding and unbinding occurs at a much more rapid rate
than transcription, translation or mRNA/protein degradation, the model
predicts a separation of timescales so that increased expression of ARF19
activators is rapidly offset by the formation of more dimer repressors as a
proportion of the new ARFs bind with the remaining pool of Aux/IAAs.
For a stable auxin signal there is constant turnover of Aux/IAA as it is
degraded by auxin and replaced by translation of induced mRNA, giving
an equilibrium value for the amount of Aux/IAA present. The additional
presence of the ARF19-Aux/IAA dimers formed should not change this
equilibrium value. It is important to note that this is based on the assump-
tion that when bound to an ARF, the Aux/IAAs are unable to be targeted
for degradation by TIR1 and auxin. Because of the corresponding increase
of repressors along with the induction of ARF19 activators we are able to
show that in the absence of any co-operativity effects the ARF7-ARF19
model can be reasonably approximated by the ARF7 only model. Again,
this is assuming ARF19 and ARF7 share the same targets and parameter
values for all their interactions.
The mRNA expression data shows increased LAX3 expression in the
arf19 mutant, relative to the wild type expression (Figure 4.1). By chang-
ing key parameters in the model it is shown that the presence of ARF19 may
act as a repressor, by interfering with the activity of ARF7. In particular,
parameter values relating to three sets of biological reactions were identi-
fied as being important. First, a relatively low rate of unbinding between
ARF19 and IAA14 may result in an increased proportion of ARF-Aux/IAA
repressors in the wild type compared to arf19, limiting transcription rates.
Second, a lower rate of transcription ARF19 occuring when it is bound to the
promoter, compared to that when ARF7 is bound would reduce transcrip-
tion due to the competition for binding sites. Finally, an increased affinity
of ARF19-IAA14 dimers to gene promoters would again reduce transcrip-
tion via competition for binding sites with the activators, free ARF7 and
ARF19. Figure 4.6 shows that any of these mechanisms may be enough
to explain the difference in LAX3 between arf19 and wild type. However,
the relative fold changes in parameter values are so large in each case that
the necessary differences are likely to be biologically unrealistic. However,
it remains possible that in certain biological contexts ARF19 may lose its
activatory power and act as a repressor simply by competing for binding
sites with ARF7 or other ARFs.
ARF19-repressor model
A second hypothesis that may explain the observed increase in LAX3 ex-
pression in the arf19 mutant is the repression of LAX3 by an repressor
specifically activated by ARF19 and not ARF7. A good candidate for this
is a negative or repressing ARF, which may bind the binding site on the
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LAX3 promoter, as well as repressing the primary auxin response genes.
If this is the case, we see that it is possible for the repressor to cause the
observed temporal peak then repression seen in the qRT-PCR expression
profile, which was previously modelled by the inclusion of an auxin conju-
gation mechanism, or by exponentially degrading the initial auxin signal.
Without the conjugation mechanism, when ARF19 is removed from the
model to simulate the arf19 mutant, the downregulation is removed and
the auxin responsive genes remain switched on. Because of this, a single
repressor is insufficient to explain the observed data.
There are many negative ARFs, and if we suppose one or more is also
induced by an ARF19 independent, but ARF7 dependent pathway, then
this results in a two repressor model (Figure 4.10). Here, when ARF19 is
knocked out of the model, rather than a complete removal of repressor, there
is instead a quantitative decrease. This means that repressor is still induced
by auxin causing the characteristic expression profile, but the repression is
reduced so that there is consistently greater mRNA abundance, as observed
in the data. Relative timing of the genes is important, as we have LAX3
regulated positively by a primary auxin responsive gene (unknown tfX), and
negatively by a secondary gene, resulting in the required expression profile.
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Figure 4.19: Comparison of auxin against time for the repressor model and the
auxin conjugation model. In both cases the parameters are fitted
so that the model matches the wild type LAX3 expression data.
A key prediction is given by the amount of auxin within the cell over time
(Figure 4.19). In the repressor model an increase in auxin signal outside the
cell eventually results in a higher steady state auxin within the cell, with
a temporary amplification due to LAX3 expression. In other words, while
the expression of auxin responsive genes is transient due to the induction
of repressor(s), auxin remains high within the cell. By way of contrast, the
auxin conjugation model described previously predicts that auxin within
the cell will peak due to LAX3 expression, but the expression of the conju-
gating enzyme GH3 will have a homeostatic effect, and the extra auxin will
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eventually be removed from the cell. A similar, but opposite effect is seen
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Figure 4.20: Comparison of Aux/IAA against time for the repressor model and
the auxin conjugation model. In both cases the parameters are
fitted so that the model matches the wild type LAX3 expression
data.
when comparing Aux/IAA against time for the two models (Figure 4.20).
In both models, Aux/IAA is rapidly degraded following the auxin signal,
but while in the repressor model Aux/IAA remains low, in the conjugation
model Aux/IAA begins to accumulate once more towards the end of the
time course.
In summary, for a stable extracellular auxin signal, the repressor model
predicts auxin inside the cell will increase and remain high while gene expres-
sion (other than that of the repressors themselves) is eventually switched off,
while the conjugation model predicts that late expression of an auxin con-
jugating gene will eventually remove auxin from the signalling pool causing
down-regulation of auxin responsive genes. As shown by the 30 hour DII-
VENUS time course data (section 2.3), the observed recovery in DII-VENUS
between 10 and 20 hours post-auxin treament indicates that a recovery in
Aux/IAA levels would also be expected, as auxin is gradually removed from
the system. Becuase of this, while the two repressor model can simulate the
mRNA expression data, it is not consistent with the observations from the
DII-VENUS experiments, which show that some form of auxin homeostasis
is still needed.
ARF7-ARF19-LAX3 model with auxin homeostasis
A key qualitative observation from the initial LAX3 model (section 2.2.3)
is that given the initial assumption that the exogenous auxin signal from
the experimental medium remains constant, and that auxin remains high
within the cell, any auxin responsive genes that are upregulated will remain
upregulated for as long as the auxin signal persists (Figure 2.5). However,
if we instead assume that the auxin signal decays exponentially, the model
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can qualitatively match the experimentally observed qRT-PCR expression
profiles of upregulation followed by downregulation as shown in Figure 4.1.
By combining this signal decay mechanism with an ARF19 dependent LAX3
repression mechanism it is possible to fit the mRNA expression data in both
the wild type, and arf19 mutant plants.
In section 2.3 DII-VENUS was fitted to a model over a 30 hour time
course using an exponential decay in the initial auxin signal, giving us a
model for auxin within root cells over time following auxin treatment. While
feedback from LAX3 may play a role in the overall level of auxin, and will
affect auxin distribution spatially, if we have a good model for the auxin
input to the system we can omit the LAX3 feedback when trying to fit
the model quantitatively with data. This allows us to fit sub-models step
by step starting with IAA14 (section 2.4), then fitting LAX3 in the arf19
mutant(section 4.4.1), then ARF19 itself (section 4.4.2), then finally LAX3
in the wild type (section 4.4.3). This parameter fitting enabled us to select
a regulatory model for LAX3, with the best model fit found with an ARF19
activated repressor acting on the LAX3 promoter at a separate site to tfX.
The final model network is summarised in Figure 4.21. In addition to the
ARF19 activated repressor (ARFr), there are two further unknown model
components, the additional activators of ARF19 (A1 and A2). The addition
of A2 may not be necessary, but is included here for completeness. The final
model equations are as follows:
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dauxin
dt
= α0 + αtrxaux(t)− µauxauxin, (4.20a)
dIAA
dt
=
−ηauxinIAA
QP +Qauxin+ auxinIAA
+ IAAm, (4.20b)
dIAAm
dt
= µim(Ftc
(
K
θia(IAA+K)
,
IAA
θir(IAA+K)
, ni
)
− IAAm),
(4.20c)
dXm
dt
= µxm
(
Ftc
(
K
θxa(IAA+K)
,
IAA
θxr(IAA+K)
, nx
)
−Xm
)
,
(4.20d)
dX
dt
= µx(Xm −X), (4.20e)
dLAXm
dt
= µl
(
Ftc
(
X
θla
,
ARFr
θlr
, nl
)
− LAXm
)
, (4.20f)
dLAX
dt
= µl(LAXm − LAX), (4.20g)
dARF19
dt
= µa(ARF19m − ARF19), (4.20h)
dARF19m
dt
= µam
(
Ftc
(
K
θaa(IAA+K)
+
A2
θaa2
,
IAA
θar(IAA+K)
)
− ARF19m, na
)
,
(4.20i)
dA1m
dt
= µ1m
(
Ftc
(
K
θ1a(IAA+K)
,
IAA
θ1r(IAA+K)
, n1
)
− A1m
)
,
(4.20j)
dA1
dt
= µ1(A1m − A1), (4.20k)
dA2m
dt
= µ2m
(
Ftc
(
A1
θ2a
, 0, n2
)
− A2m
)
, (4.20l)
dA2
dt
= µ2(A2m − A2), (4.20m)
dARFrm
dt
= µrm
(
Ftc
(
ARF19
θra
,
ARF19 IAA
θrrK
,nr
)
− ARFrm
)
,
(4.20n)
dARFr
dt
= µr(ARFrm − ARFr), (4.20o)
xaux(t) = (auxintr − auxin0)e
−µtrt, (4.20p)
where:
Ftc(ACT,REP, n) =
(ACT )n
1 + (ACT )n + (REP )n
. (4.20q)
Since the fitting was done relative to the arf19 basal expression, if we
plot the model relative to the wild type using the same parameter values
there will be poor agreement between model and data. This is because
the model fits the fold-change response relative to a fixed point (either wild
type or arf19 expression at time zero). Changing the fixed point will change
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IAA14
ARF7
ARF19
auxin
tfX
LAX3ARFr
A1 / A2
Figure 4.21: Final model network based on the best fitting model variant with
the IAA14 wild type expression data, LAX3 wild type and arf19
expression data (Figure 4.1), and DII-VENUS time course fluo-
rescence data (section 2.3). Auxin accelerates the degradation of
IAA14, which frees the repression of ARF7 and ARF19. ARF7
then activates ARF19, IAA14, tfX and A1, which may activate
an addtional activator of ARF19, A2, or itself activate ARF19 di-
rectly. tfX activates LAX3, while ARF19 activates a repressor of
LAX3, ARFr. Auxin homeostasis is provided by an exponential
degradation of the exogenous auxin signal. The model is defined
by equations (4.20a)-(4.20q).
141
the magnitude of the response. If we refit all parameters directly affecting
LAX3 expression using the chosen model with the data renormalised to wild
type basal expression, we have a final set of model predictions (Figure 4.22)
and parameter values. Table 4.7 shows the fitted values for case when the
LAX3 data is normalised to the basal expression in the arf19 mutant and
the case when the LAX3 data is normalised to the basal expression in the
wild type. Most of the fitted values remain similar, only θxr, the affinity of
ARF7-IAA14 dimers to the tfX promoter, and θla the affinity of tfX to the
LAX3 promoter are changed. This may be expected since these are the key
parameters in determining the magnitude of the response of LAX3 mRNA.
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Figure 4.22: Best fit of model arf19 and wild type model LAX3 mRNA relative
to the wild type using the data shown in Figure 4.1. Also shown
are the fits to the IAA14 and ARF19 mRNA data using the same
set of parameter values (Table 4.7), and predictions for the other
model components.
The final model includes a secondary auxin response gene (A2 activated
by A1) feeding back on ARF19 expression, as this provided the best fit to
data. However, although constraints were placed on the parameter values,
as with any model increasing the number of parameters and the complex-
ity of the model will in general increase the likelihood of fitting the data
more exactly. With limited data, what appears to be a trend may just be
biological noise and in actual fact a simpler model may better describe the
biological reality. The inclusion of extra model components and parameters
can lead to over fitting. Nonetheless, the fitted model for ARF19 expression
was useful to investigate the effect of ARF19 activity.
Similarly, including a extra repressor between ARF19 and LAX3 also
adds more parameters to the model. Figure 4.17 shows how in general an
extra gene activated by ARF19 may show a wider variety of expression pro-
files than ARF7 depending on parameter values, giving more freedom to
fit the data. In this case however, there is more biological justification to
including the additional step due to ARF19’s predicted function as a tran-
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Table 4.7: Fitted parameter values for final network model given by equations
(4.20a)-(4.20q) to the wild type IAA14, ARF19 and LAX3 mRNA
and arf19 mutant LAX3 mRNA data shown in Figure 4.1. In the
column headed arf19, both wild type and arf19 LAX3 expression
data are normalised to the basal expression in the arf19 mutant be-
fore fitting and, in the column headed wild type, both wild type and
arf19 LAX3 expression data are normalised to the basal expression
in the wild type in before fitting.
Parameter arf19 wild type
Q 47.6939 47.6939
P 1.5723 1.5723
K 0.0015 0.0015
µaux 100 100
µtr 0.42 0.42
xaux0 1 1
xauxtr 6000 6000
η 16.667 16.667
β 8.3623 8.3623
µim 0.034 0.034
ni 1.2949 1.2949
θia 0.4058 0.4058
θir 9.0334 9.0334
µx 0.0928 0.0914
µxm 11.3317 12.0142
nx 1.0591 1.3444
θxa 0.1327 0.1152
θxr 4.8924 22.8311
µl 0.6805 0.4631
µlm 10.7725 11.2889
nl 1.2797 1.5265
θla 0.3013 0.1639
θlr 0.3225 0.3361
θnr 1.0 1.0
Parameter arf19 wild type
µ1 0.0319 0.0319
µ1m 0.4474 0.4474
n1 1.0906 1.0906
θ1a 0.2871 0.2871
θ1r 7.2674 7.2674
µ2 0.6476 0.6476
µ2m 0.4784 0.4784
n2 0.6956 0.6956
θ2a 0.3978 0.3978
µa 5.7685 5.9802
µam 0.5823 0.5823
na 1.3803 1.3803
θaa 1.62 1.62
θar 0.5355 0.5355
θaa2 0.6265 0.6265
µr 10.0 10.3263
µrm 9.319 9.3338
nr 1.0 1.0
θra 0.000013 0.000013
θrr 0.0022 0.0022
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scriptional activator (Guilfoyle and Hagen 2007), though it always possible
this may change following new experimental discoveries.
Fitting the 30 hour experimental DII-VENUS time course profile allows
us to make a prediction for cellular auxin, and so Aux/IAA. This in turn
allows us to predict the behaviour of other ARF7 / IAA14 responsive genes.
Using the parameter fitting algorithm with the simple ARF7 only model
gives a fit value with the LAX3 wild type data of f = 0.0724, and gives a
prediction for the expression profile of the unknown activator of LAX3 (tfX).
With the more complex model including ARF19 mediated repression the fit
improves to f = 0.0287. In addition, the more complex model demonstrates
how ARF19 activated genes may show more complex expression profiles
than genes activated by ARF7 only, and also gives a prediction for tfX,
along with the ARF19 activated repressor. Embedding these gene network
models into a multi-cellular context will give predictions for the spatial
distribution for key auxin regulated genes during lateral root emergence.
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Chapter 5
Tissue Scale Models of Lateral
Root Emergence
5.1 Introduction
5.1.1 Introduction and Biological Background
In the conceptual model published by Swarup et al. (2008) the all or noth-
ing expression pattern of LAX3-YFP is thought to be amplified by positive
feedback via increased auxin influx due to LAX3 expression in the specific
cells over lateral root primordia. In Chapter 2 it is shown using an ODE
model that this all-or-nothing expression pattern may be a result of bista-
bility caused by the LAX3 positive feedback, where small changes in local
auxin may result in large changes in gene expression in neighbouring cells.
To test this possibility directly in a spatial context, a multiscale model is
required, which will combine a tissue scale model of auxin transport and dif-
fusion with a gene network scale model of mRNA transcription and protein
translation in each individual cell (Chapter 6). Before this though, in this
chapter we formulate a model of auxin transport and diffusion in a realis-
tic cellular structure relevant to the spatial positioning of LAX3 expression
during lateral root emergence.
For simplicity, we initially consider a two-dimensional (2-D) cross-section
of the mature root in the plane perpendicular to the direction of primary
root growth, i.e. the plane in which the cell layers pericycle, endodermis,
cortex and epidermis are arranged as concentric rings of cells around the
central vascular tissue (Figure 5.1). The reasons for using this particular 2-
D cross-section are as follows. Firstly, if a 2-D representation must be used,
the radial cross-section is best able to show both the relative position of cells
in both the direction of growth of the LRP and the relative position of cells
within cell layers. Since the spatial structure of the mature root is mostly
conserved in the direction of primary root growth, each cell in the radial
cross-section can be considered a file of cells relative to the position of the
xylem pole pericycle (XPP) cells where new LRP are initiated. Secondly,
the cells are longer in the direction of primary root growth than in the other
two dimensions, and so the difference in physical distance between the centre
of adjacent cell files is generally much smaller than the distance between
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Figure 5.1: A) Original diagram of root cross section from Peret et al. (2009b),
and B) version captured manually in the .svg format for use in Open
Alea. The key allows cell types to be assigned automatically, and
the scale bar converts lengths of walls and areas of cells from pixels
and pixels2 to µm and µm2.
individual cells, and also the surface area in contact (via the apoplast)
between cells in adjacent cell files will be greater than that between cells
within a single file. If we keep the assumption that auxin concentration
within each cell is spatially uniform, the flux between cells ought to be
greatest where the shared surface area is greatest, and so if we simulate
the developing primorida as a fixed auxin source in the XPP the spread of
auxin ought to be more significant in the radial direction, in comparison to
that in the longitudinal direction.
After formulating the most general case of the auxin transport and
diffusion model (Section 5.1.2) based on the existing model published by
Perrine-Walker et al. (2010) and Band and King (2011) and detailing the
software implementation (Section 5.1.3), we look first at the case where
auxin is distributed within the root via diffusion only, to compare steady
state auxin between neighbouring cells, and in particular how these differ-
ences are affected by the rate of intracellular auxin turnover (Section 5.2).
Also investigated with the diffusion only model are the affect of adding
movement of auxin within the apoplast, in addition to movement between
cell and apoplast(and vice versa), and the affect of simulating the Caspar-
ian strip, which we assume to prevent all movement of auxin in specific cell
walls in the endodermis (Section 5.2.2). To compare the different models we
use simulations of two different scenarios, firstly treatment with exogenous
auxin, and then simulation of an LRP as producing a strong auxin source
from a single XPP cell.
Following the diffusion only model, we look at the affect of adding the
expression of auxin influx and eﬄux carriers to the tissue (Section 5.3).
Initially we use a fixed distribution of carriers (Section 5.3.1), before sim-
ulating dynamic expression of auxin transporters using a threshold model
(Section 5.3.2). In this model, once auxin within a cell passes a prescribed
value, influx or eﬄux carriers are ‘switched on’ in the model and feed back
on auxin fluxes. In both cases we may assign the localisation of the carri-
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ers to specific cell walls of the cell, but in the case of influx carriers (e.g.
LAX3) we assume the carriers are localised to all cell walls of an expressing
cell equally.
If a threshold model is also used to simulate the expression of a cell
wall remodelling enzyme (CWR) such as polygalacturonase (PG), provided
the threshold for the switching on of PG relative to that for LAX3 is high
enough, then the LAX3 threshold model shows that without the amplifica-
tion of cellular auxin due to increased influx via LAX3, that PG will not be
expressed. If the expression of CWRs is dependent on the amplification of
auxin by LAX3 expression, this provides a link between LAX3 expression
and lateral root emergence. Again, the model shows that a relatively high
intracelluar auxin turnover rate is a key parameter, this time in the power of
LAX3 to raise auxin levels relative to neighbouring cells that do not express
LAX3.
5.1.2 Model Formulation
The auxin transport model used in the following sections is based on that
developed by Band and King (2011) and Perrine-Walker et al. (2010). In
this model auxin is present in either a cellular space or in the apoplastic
space between two adjoining cells sharing the same cell wall. As described
above we use a 2-dimensional cross section to represent the tissue, with each
cell consisting of a polygon, each side of which represents a cell membrane.
Where two cell membranes meet, as is the case for all but the outer cell
membranes, there is an apoplastic space between the two adjacent cells
(Figure 5.2). Initially we assume auxin only moves from apoplast to cell
or from cell to apoplast, via either diffusion or active transport, with no
movement between adjacent apoplastic compartments (this latter possibility
is considered in Section 5.2.2). With a single class of influx carriers denoted
by LAX, and a single class of eﬄux carriers denoted by PIN , the initial
model is defined as follows:
dauxini
dt
= Vi
−1
(∑
n∈Wi
Si,n(J
+
n,i apoi,n − J
−
i,n auxini)
)
− µauxauxini + αi,
(5.1a)
dapoj,k
dt
= λ−1(J−j,k auxinj + J
−
k,jauxink − (J
+
j,k + J
+
k,j)apoj,k), (5.1b)
where:
J+p,q = A1Piaah + A2PlaxLAXq,p + A3PpinPINq,p, (5.1c)
J−p,q = B1Piaah +B2PlaxLAXp,q +B3PpinPINp,q. (5.1d)
Each cell in the model tissue is numbered, and so auxini denotes the con-
centration of auxin in cell i, and apoi,j denotes the concentration of auxin in
the apoplast adjoining cells i and j. In each case apoi,j = apoj,i, apoi,i = 0,
and, for non-adjoining cells k and l, apok,l = 0. The cell walls on the ex-
terior surface of the root are denoted apoi,0, where i is the index of the
cell with the external wall. The volume (represented in 2-D by an area) of
cell i is denoted Vi, and the surface area (represented in 2-D by a length)
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Legend:
Diffusion
Flux due to influx carrier
Flux due to efflux carrier
Figure 5.2: Schematic representation of the spatial arrangment of the boundary
between two cells in the tissue structure, showing an example of
the fluxes present (not to scale). To move from one cell to another,
auxin must pass through the apoplastic space. This can occur via
diffusion or active transport, with the rate of diffusion from the
apoplast into the cell much greater than vice versa. The main
direction of flux due to active transport depends on whether the
cell has influx or eﬄux carriers present at the membrane. In this
instance the upper cell is expressing an eﬄux carrier, and the lower
an influx carrier, but any other configuration is possible within the
model framework.
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between adjoining cells i and j is denoted by Si,j. As with the apoplastic
concentrations, Si,j = Sj,i, Si,i = 0, and for all non-adjoining cells k and l
Sk,l = 0. The surface area of the externally facing wall of an outer cell i is
denoted Si,0. λ denotes a uniform estimated width for the apoplast.
For each cell, i, there is an associated set of neighbouring cells denoted
Wi, and so the overall auxin flux for each cell is calculated by summing the
flux between the cell and each neighbouring apoplast. J+i,j represents the
flux from the apoplast between cell i and j into cell j, and J−i,j represents the
flux from cell i into the apoplast between cell i and j. Note that, since there
may be different transporter configurations on the membranes either side of
the apoplast dividing cell i and cell j, J+i,j and J
+
j,i are defined differently, as
are J−i,j and J
−
j,i. In addition, J
+
i,i = 0, J
−
i,i = 0, and for non-adjoining cells k
and l J+k,l = J
+
l,k = J
−
k,l = J
−
l,k = 0.
Each individual flux is calculated by summing the diffusive, influx and
eﬄux components. The diffusive component is proportional to the pas-
sive permeability Piaah, the influx component is proportional to the influx
permeability Plax and the amount of influx carrier present in cell i at the
membrane facing cell j (denoted LAXi,j), and the eﬄux component is pro-
portional to the eﬄux permeability Ppin and the amount of eﬄux carrier
present in cell i at the membrane facing cell j (denoted PINi,j). It is im-
portant to note that, in general, PINi,j is not equal to PINj,i, and LAXi,j
is not equal to LAXj,i. The differences in flux depending on the direction
of auxin movement, either from apoplast to cell or vice versa, is reflected by
the proportionality constants A1, A2, A3, B1, B2 and B3. Estimated values
for these constants are derived in Perrine-Walker et al. (2010). In the case
of diffusion the rate of movement across cell membranes from apoplast into
cells is significantly greater than movement from cell to apoplast, and so
A1 > B1. For active transport, for both eﬄux and influx there is movement
in both directions across the cell membrane, but for eﬄux carriers move-
ment from cell to apoplast is favoured so that B3 > A3, while for influx
carriers movement from apoplast to cell is favoured so that A2 > B2.
The final processes within each cell are the intracellular degradation of
auxin at rate µaux, and possible production within any cell i at rate αi.
Estimates of these two parameters were not found in the literature, and
so investigating their effect on model behaviour is a key component of the
work. In addition to cellular production and degradation, the presence of
an exogenous auxin source is represented by a fixed concentration of auxin,
auxin0 = ω which can enter the apoplastic compartments on the outer
surface of the root, so that:
dapoi,0
dt
= λ−1(J−i,0 auxini + J
−
0,iω − (J
+
i,0 + J
+
0,j)apoi,0). (5.2)
A summary of the default parameter values used is given in Table 5.1,
along with a brief description, and source from where the estimate was
taken, where appropriate.
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Table 5.1: Estimated default parameter values for the auxin transport model
given by 5.1a-5.1d, with a brief description and source for the esti-
mate where appropriate. Source references: [1] Perrine-Walker et al.
(2010), [2] Band and King (2011), [3] Kramer et al. (2007)
Parameter Estimate Description Source
Piaah 2016 µm hour
−1 Passive membrane perme-
ability
[1], [2]
Plax 2016 µm hour
−1 Membrane permeability due
to LAX3 or AUX1 influx
carriers
[1], [2]
Ppin 1008 µm hour
−1 Membrane permeability due
to PIN eﬄux carriers
[1], [2]
A1 0.24 Apoplastic proportion of
protonated auxin
[1], [2]
A2 3.57 Relative influx from LAX3
or AUX1 carriers
[1], [2]
A3 0.034 Relative influx from PIN
carriers
[1], [2]
B1 0.004 Cytoplasmic proportion of
protonated auxin
[1], [2]
B2 0.045 Relative eﬄux from LAX3
or AUX1 carriers
[1], [2]
B3 4.68 Relative eﬄux from PIN
carriers
[1], [2]
Dcw 115200
2 µm hour−1 Diffusion coefficient in the
apoplast
[3]
λ 0.2 µm Apoplast thickness [3]
µaux 100 hour
−1 Intracellular auxin turnover
rate
αi 0 µM hour
−1 Intracellular auxin produc-
tion rate
αp 100 µM hour
−1 Intracellular auxin produc-
tion rate in primordium
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5.1.3 Implementation
To represent mathematically the geometry and topology of the root cell
structure, the open source software package OpenAlea was used
(http://openalea.gforge.inria.fr). This includes a set of Python modules
which can take a vector graphic image file produced in a specific .svg format
and convert it to a ‘topomesh’ structure (Figure 5.3), within which ODE
models can be run. In this case, the image file was traced manually from a
diagram of a radial cross section of an Arabidopsis root (Peret et al. 2009b),
using the open source software package Inkscape (www.inkscape.org) (Fig-
ure 5.1). A radial cross section was selected initially, as this would allow
for movement of auxin between cells within the same layer, as well between
different layers. However, the OpenAlea framework allows for any 2D cell
structure to be represented in this way, and so once a model is formulated
and implemented in one tissue, it is straightforward to apply it to another.
The scale of the visual representation of the tissue is included in the .svg
file and used to calculate realistic cell wall lengths and 2-D areas.
Figure 5.3: Visual description of the topomesh data structure. Walls are de-
scribed by pairs of points, which in turn represent the cell geometry.
Each wall separates two cells, which each have an associated set of
points and walls. The relationship between cells is also recorded as
a directed graph, with cells as nodes, and walls as edges.
The topomesh data construct consists of points, walls, and cells. The
points constitute the geometric description of the vertices in the tissue, and
each point is associated with a number of walls leading from it. The walls
represent the separation between the cells, and each has two points describ-
ing its physical location and length, and the two cells which it separates.
The cells have a set of associated points and walls, which describe both its
topological relationship to other cells, and its physical area. In addition to
this, the software creates a directed graph of the relationship between cells
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in the tissue, with the nodes representing the cell centres, and the edges
representing cell membranes. Using a combination of the graph and the
topomesh data structure allows for physical properties, such as auxin or
LAX3, to be assigned to each cell, or in the case of auxin to walls, and
the evolution of each over time can be governed by the ODE models devel-
oped here. The ODEs are solved using the ‘odeint’ function in the Python
package Scipy (http://www.scipy.org/). The resulting simulations are visu-
alised using the viewer within OpenAlea or the python package Matplotlib
(http://matplotlib.sourceforge.net/), and numerical solutions can be output
to a text file. The whole simulation exists as a python object referred to as
a Tissue Database, which contains the spatial and topological structure, as
well as all the user-defined properties assigned to the tissue.
5.2 Auxin distribution: diffusion only
In this section we investigate the effect of diffusion alone on the distribution
of auxin within the tissue, with either treatment with exogenous auxin (Sec-
tion 5.2.1), or an auxin source from a developing lateral root primoridium
(Section 5.2.3). In Section 5.2.2 we investigate adding the further move-
ment of auxin between apoplastic compartments via diffusion, and also the
blocking of apoplastic diffusion that will take place in the Casparian strip.
5.2.1 Simulation of auxin treatment
To simulate treatment of roots with exogenous auxin, we set ω, the con-
centration of auxin in the space surrounding the outer cells of the root to
be non-zero. If auxin is subject to diffusion only, we set PINi,j ≡ 0 and
LAXi,j ≡ 0 for all i, j so that:
J+p,q = J
+
q,p = A1Piaah, (5.3a)
J−p,q = J
−
q,p = B1Piaah (5.3b)
for all adjoining cells p and q.
Figure 5.4 A,C,E shows, using log-log axes, the mean steady state auxin
concentration in each cell layer with increasing ω, at three values for the key
parameter µaux, the rate of intracellular auxin turnover (0.1, 1.0, 10.0 hour
−1).
In each case there is a linear relationship between exogenous auxin and the
concentration in each cell layer, with the rate of increase with increasing
ω decreasing with each layer closer to the central stele. In addition, as
the rate of intracellular auxin turnover increases so does the relative steady
state difference in auxin between cell layers. This is also demonstrated in
Figure 5.4 B,D,F which shows a colour map of the auxin in each cell in the
tissue relative to the mean auxin concentration in the epidermis, at each of
the three values for µaux. Clearly, the lower the value for µaux, the more
evenly the auxin from the exogenous treatment is distributed between all
the cell layers.
This relationship between µaux and the relative auxin concentrations in
each cell layer is shown more explicitly in Figure 5.5. As the intracellular
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Figure 5.4: Log-log plots of mean steady state auxin by cell layer with increas-
ing exogenous treatment to all outward facing cell walls in the epi-
dermis, at three increasing intracellular auxin turnover rates, µaux
(A,C,E), using the model defined in Section 5.1.2 with the concen-
tration of all auxin carriers fixed to zero. Colour map showing the
auxin in each cell, relative the the mean value in the epidermis,
for three values of µaux (B,D,F). The higher the value of µaux, the
greater the relative difference between cell layers, and the shallower
the increase of intracellular auxin with increasing signal.
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auxin turnover rate increases so the ability of auxin at the root surface to
penetrate to the centre of the root decreases. Also affected by the auxin
turnover rate is the time taken following treatment for auxin within each
cell to reach steady state. Figure 5.7 shows model time courses of mean
cortical auxin following simulated 1000 nM exogenous auxin treatment with
three values for µaux. For the lowest value µaux = 0.1 hour
−1 it takes
between 3 and 6 hours to reach half the final steady state value, while for
µaux = 10 hour
−1 and µaux = 1000 hour
−1 it takes less than 10 minutes and
less than 10 seconds respectively. These response times are similar for a
given µaux for every cell layer (Figure 5.8). Given that in Band et al. (2012)
a response in DII-VENUS degradation is seen within 2 minutes, possibily
accelerating up to about 10 minutes, this would appear to put a lower bound
on the value of µaux = 10 hour
−1. However as we see in Figure 5.4, at this
value of µaux with the assumptions made in the simulation auxin does not
significantly penetrate the innermost layers of the root. This is in contrast
to the experimental observation that DII-VENUS appears to be degraded
at a similar rate in all cell layers in the mature part of the root following
1000nM auxin treatment (Band et al. 2012). This may be due in part
to the presence of auxin carriers, which are not simulated here yet, and
will be investigated further in Section 5.3. In addition, the assumption that
auxin only enters the inner layers of the root from the epidermis may not be
valid, as auxin may enter the stele from either the root tip, or from upper
parts of the seedling which are also exposed to auxin during treatment.
This can be easily simulated by adding an auxin source in the stele during
the simulation. A final explanation is that diffusion of auxin within the
apoplast will add to the penetration of auxin into the interior of the root.
This apoplastic diffusion, along with the presence of the Casparian strip
which blocks the apoplastic pathway in the endodermis, is added to the
model in Section 5.2.2.
5.2.2 Apoplastic diffusion and Casparian strip
Apoplastic Diffusion
In the previous sections the auxin transport model only considers auxin
diffusion between apoplast and cell, and at a much slower rate between cell
and apoplast. However, the lack of penetration into the inner cell layers
of the root seen when simulating exogenous auxin treatment suggests that
adding movement of auxin between adjacent apoplastic compartments may
provide a more realistic model, by simulating an apoplastic pathway for
diffusion within the root (Figure 5.6). In the new model, auxin can diffuse
freely between any adjacent apoplastic compartments or, in the OpenAlea
terminology, between any adjacent wall compartments, which meet at the
vertices or points of the tissue structure. After Band and King (2011), in
addition to the existing apoplastic compartments, the auxin concentration
in a small compartment representing each vertex is calculated at each step
and used to calculate the flux between adjacent wall compartments. The
diffusion takes place in the direction of higher to lower gradient in auxin
concentration, proportional to a fixed diffusion coefficient, Dcw. The value
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Figure 5.5: Log-log plot of mean steady state auxin by cell layer with increasing
intracellular auxin turnover rate (µaux). The exogenous source of
auxin, ω, is set = 1000. As µaux increases, the penetration of auxin
into the inner cell layers decreases more rapidly than in the outer
cell layers.
of Dcw used is taken from Kramer et al. (2007), which estimates Dcw =
3.2 × 10−11 m2 s−1 or Dcw = 115200 µm
2 hour−1. Equation (5.1b) is then
replaced by:
dapoi,j
dt
=
Si,j
Vi,j
(
J−i,j auxini + J
−
j,iauxinj − (J
+
i,j + J
+
j,i)apoi,j
)
+
λ
Vi,j
(
Jaij1 + J
a
ij2
)
,
(5.4a)
where Vi,j is the volume of the apoplastic compartment between cell i and
cell j, and the diffusive flux either end of the apoplastic compartment is
given by:
Jaijk =
2Dcw
Si,j + λ
(avi,j,k − apoi,j) . (5.4b)
The term avi,j,k is defined as the auxin concentration in the small com-
partment representing the vertices, k = 1, 2, either end of the apoplastic
compartment dividing cells i and j. The volume of each of these point com-
partments is the square of the apoplast width (λ2), and an equal proportion
of this volume is subtracted from each of the apoplastic compartments that
meet at that point. In most cases, there are three apoplastic compartments
meeting at each vertex, and so simplifying the notation by way of illustra-
tion, if av is the auxin concentration at a vertex, and a1, a2 and a3, and
S1, S2, and S3 are the auxin concentrations and lengths respectively of the
three adjoining compartments we have the following differential equation
for av:
dav
dt
=
2Dcw
λ
(
a1 − av
λ+ S1
+
a2 − av
λ+ S2
+
a3 − av
λ+ S3
)
. (5.4c)
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(A)
Legend:
Diffusive fluxes
(B)
(C)
(D)
Cell wall
Boundary between 
apoplastic compartments
Figure 5.6: Schematic representation of the diffusive fluxes present when
apoplastic diffusion is added to the model. The apoplast is divided
into compartments, one compartment per wall in the data struc-
ture, plus small compartments at each vertex or point. The auxin
in these small compartments is assumed to be at quasi-steady state
and is approximated at each time step to calculate the flux between
each apoplastic space meeting at that point. When n walls meet at
a point in the mesh, there are n compartments in addition to the
point compartment, and an equal proportion of the small volume
of the point compartment is removed from each of the n walls. As
before, from each apoplastic compartment, there is diffusion into
the two cells it divides (or single cell in the case of an external
wall), and a much slower rate of diffusion from the two cells in the
apoplast. In addition, auxin can diffuse freely between each of the
apoplastic compartments that meet at each point.
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For small values of λ we can neglect the derivative in equation (5.4c) and
rearrange, giving the following expression for av:
av =
a1
λ+S1
+ a2
λ+S2
+ a3
λ+S3
1
λ+S1
+ 1
λ+S2
+ 1
λ+S3
. (5.4d)
Similarly, for vertices with just two compartments, the expression for av
is the same as equation (5.4d), with just the first two terms in both the
numerator and denominator. More generally, using the earlier notation we
can write:
avi,j,k =
∑
(p,q)∈Wijk
(
apop,q
Sp,q+λ
)
∑
(p,q)∈Wijk
(Sp,q + λ)−1
, (5.4e)
where Wijk is a list of apoplastic compartments in the form of (p, q) pairs
denoting the cells they divide.
Casparian strip
A realistic model of the apoplastic pathway in plants is further complicated
by the presence of the Casparian strip, an impermeable barrier in the endo-
dermis, which will act to block the diffusion and carrier mediated transport
of auxin in the cell walls where it is present. In the model this is simulated
by fixing auxin in the walls between pairs of endodermal cells to zero, and
preventing any auxin flux in or out of these walls. These zero flux walls are
indicated on the diagram in Figure 5.9.
Figure 5.7 compares time courses of mean auxin in the cortical cell lay-
ers following a simulated exogenous auxin treatment of 1000 nM , with and
without both apoplastic auxin diffusion and the Casparian strip, at three
values of µaux. As we have already seen, increasing µaux has the effect of re-
ducing steady state auxin in the cortex, and also reducing the time taken to
reach steady state. In addition, as may be expected, adding the apoplastic
diffusion pathway to the model increases steady state auxin in the cortex,
compared to the model without. Furthermore, the comparative effect of the
apoplastic pathway is magnified as µaux increases, so that the relative dif-
ference in steady state auxin with and without apoplastic diffusion is much
greater for µaux = 1000 than for µaux = 0.1. The presence of the Caspar-
ian strip only has a very slight effect on cortical cell auxin concentration
when the apoplastic pathway is present, with a very slight increase when
the Casparian Strip is present due to a small amount of auxin being pre-
vented from moving into the interior of the root via the apoplastic pathway.
Clearly, removing the apoplastic pathway altogether will remove this effect
and so there is no apparent difference with or without the Casparian strip
when the apoplastic pathway is not included.
The effect of the Casparian strip following simulated auxin treatment
can be seen more clearly in the inner cell layers (Figure 5.8). The peri-
cycle in particular shows a clear reduction in steady state auxin when the
Casparian Strip is included in the model, as would be expected as the only
pathway by which auxin can enter the pericycle cells is via diffusion out
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Figure 5.7: Time course of mean cortical auxin, with a simulated exogenous
treatment ω = 1000, at three values of auxin turnover, µaux. For
each plot the model is solved both with and without apoplastic
diffusion, and with and without a simulated Casparian strip. In-
creasing µaux reduces the time taken to reach steady state from
zero auxin, and increases the relative importance of the apoplastic
diffusion pathway. The presence of not of the Casparian strip has
a limited effect on cortical auxin with the exogenous auxin source
simulated at the outer epidermal cell walls.
of the endodermis. A slight reduction is seen in the endodermis when the
Casparian strip is present as it has the effect of reducing the surface area of
the cells around which auxin is able to flow freely.
Also shown in Figure 5.8 is the effect of increasing the diffusion coefficient
Dcw, which has the effect of further increasing the penetration of auxin into
the centre of the root. When the Casparian Strip is present however, even
with a four-fold increase in Dcw, auxin is unable to enter the pericycle cells
to any significant degree.
Clearly, the addition of apoplastic diffusion of auxin to the model in-
creases the spread of auxin throughout the tissue, and increasing the diffu-
sion coefficient within the apoplast increases the degree of penetration from
the outer cell layers to the inner of the root when simulating an auxin source
at the roots surface. As would be expected, simulating a barrier for auxin
in the endodermal cell walls, to represent the Casparian Strip, is able to
block most of the auxin reaching the inner cells in the pericycle and stele.
5.2.3 Simulation of primordium auxin source
To simulate an auxin source in the developing primordium, we set αi > 0
in one of the central xylem pole pericycle (XPP) cells either side of the
stele, or by way of comparison all three XPP cells on one side are set to
produce auxin. The model is then run to steady state, under the effect of
diffusion only, and the steady state auxin in each of the eight cortical cells
compared relative to each other, and to the primordia source cell. Figure 5.9
shows the numerical key used to identify each of the cortical cells, and the
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Figure 5.8: Time course of mean auxin in each of the four outer cell layers,
with a simulated exogenous treatment ω = 1000, for µaux = 100.
For each plot the model is solved both with and without apoplastic
diffusion, with and without a simulated Casparian strip. The model
solution is also shown with double and four times the apoplastic dif-
fusion coefficient, Dcw, again with and without the Casparian strip.
For the three outer cell layers, epidermis, cortex, and endodermis,
the key determinant in the steady state auxin value is the value
of Dcw. With no apoplastic diffusion Dcw = 0, and this results in
the lowest values of intracellular auxin, and as Dcw increases so too
does the steady state auxin in each of the three outer cell layers.
In addition, the relative effect of the apoplastic pathway increases
towards the centre of the root. The Casparian strip has the great-
est effect towards the centre of the root as it blocks auxin in the
endodermal cell layer.
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position of the XPP set to be the auxin source for most of the simulations.
Initially the model has apoplastic diffusion of auxin and the Casparian strip
(Section 5.2.2), but later the effect of removing one or both of these model
components is investigated.
8
76
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3 2
1
Cell walls with 
Casparian strip
Primordium 
auxin source
Figure 5.9: Schematic view of the root cross section, showing the location of
the XPP cell primed as the auxin source representing a LRP used
in most of the simulations, the cell walls set to have zero auxin flux
to represent the Casparian strip, and the labelling of the cortical
cells used in Figures 5.10 and 5.11.
The initial purpose of the simulation is to investigate the auxin levels in
cortical cells relative to their spatial position in the tissue to a primordium
auxin source. The conceptual model for LAX3 mediated lateral root emer-
gence (Swarup et al. 2008) has positive feedback from LAX3 auxin influx
acting to focus auxin in specific cortical cells close to the LRP. However,
the positive feedback on those cells must act on some initial asymmetry in
auxin distribution in order to be effective. Clearly, the asymmetry will be
due to the spatial positioning of the cortical cells nearest to the primordium
source, which are likely to receive more auxin than those cells further away.
In the cross section used in Figure 5.9, it is to be intiutively expected that
cells 4 and 5 will receive the most auxin from the primordium source cell,
while cells 1 and 8 would get the least. The initial aim of the primordium
simulation then, is to quantify the relative differences in auxin between cells
in the cortex that may occur due to diffusion alone (either trans-cellular or
apoplastic).
Looking at the diffusion only model in isolation from a model in which
LAX3 is expressed in response to auxin and feeds back on the system is
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further justified by considering the timescales on which auxin diffusion and
LAX3 expression are taking place. While it takes at least 5 to 10 hours for
LAX3 mRNA to be expressed following an increase in auxin signal (Fig-
ure 4.1), for all but unrealistically low rates of intracellular auxin turnover
(µaux), auxin is redistributed to steady state within the tissue within min-
utes or even seconds of the introduction of an auxin source. Because of this,
for realistic values of µaux, it is expected that the diffusion only simulation
of a primordium auxin source represents the establishment of an initial spa-
tial auxin distribution on which future expression of influx or eﬄux carriers
may act.
Effect of intracellular auxin turnover (µaux)
Figure 5.10 shows the relative steady state level of auxin in each of the
eight cortical cells against µaux, using a value of αi = 100 in the central
XPP cell to the left of the stele (as in Figure 5.9). The values for each
of the cells is given relative to the ‘dominant’ auxin receiving cell, cell 5,
and the model includes both trans-cellular and apoplastic diffusion, and the
simulated Casparian Strip.
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Figure 5.10: Steady state intracellular auxin in each of the eight cortical cells
1-8 (see Figure 5.9 for cell labels) with increasing auxin turnover
rate, µaux (log x-axis), relative to the steady state value in cell
5, following the introduction of an auxin signal in a single cell in
the pericycle representing a primordium. The primordium cell is
as indicated in Figure 5.9, with the strength of the auxin source,
αi = 100. Both apoplastic diffusion and the Casparian strip are
included in the model. The distribution of steady state auxin by
cortical has a narrow distibution in auxin for µaux < 0.01, where
each cell has more than 50% of the value of the greatest cell (cell
5), and a much broader distribution of auxin for µaux < 10, with
all but the cell adjacent to cell 5 (i.e. cell 4), having less than 40%
of the auxin in cell 5.
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The rate of intracellular auxin turnover (µaux) has a clear effect on the
relative auxin distribution in the cortex, with a smaller range between the
highest and lowest auxin containing cells seen at low µaux than at higher
values. Below around µaux = 0.01 the distribution between cells is similar
for all values of µaux, with the cell with the least auxin containing more
than 50% that of the cell with the most. Above around µaux = 100, there
is also a consistent distribution between the cells, but with a much greater
range of auxin concentrations. Here, the cell with the least auxin has less
than 0.2% that of the cell with the greatest. For 0.01 < µaux < 100 there is
a transistion between the two modes of auxin distribution.
Of particular interest is the comparison between the two cells receiving
the most auxin (cells 4 and 5, Figure 5.9), and their nearest neighbours (cells
3 and 6, respectively). This is because of the observed expression pattern
of LAX3 (Swarup et al. 2008), following which it would be predicted that
cells 4 and 5 would express LAX3, while cells 3 and 6 do not. Since LAX3
is expressed in response to auxin, it follows then that there is sufficient
auxin in cells 4 and 5 to trigger LAX3 expression, while in cells 3 and 6
there is either insufficient auxin to ever trigger LAX3 expression, or that
LAX3 accumulates more rapidly in cells 4 and 5 and the positive feedback
on their auxin levels depletes auxin in the neighbouring cells so that LAX3
is not expressed. Either way, a greater difference between the two cells
with the most auxin and their neighbours will result in greater robustness
to biological variation, and help restrict LAX3 expression to the specific
observed expression pattern. In the simulation, the auxin in the neighbour
cells (cells 3 and 6) relative to the main cortical cells (cells 4 and 5) ranges
from 0.87 and 0.77 respectively at µaux = 0.01 to 0.35 and 0.12 respectively
at µaux = 100. This means that for µaux in the upper range there may be
between 3 and 8 times as much auxin in the two main cortical cells compared
to their nearest neighbours, giving a fairly broad spatial distribution of auxin
on which the positive feedback due to LAX3 expression may operate. This
range of µaux is also consistent with the minimum estimate for the true value
of µaux based on the time taken for auxin to reach steady state following
exogenous treatment discussed in Section 5.2.1.
A key point to make is that, as well as increasing the difference in auxin
between neighbouring cells in the cortex, increasing µaux also greatly in-
creases the difference between auxin in the cortical cells with greatest auxin
and the auxin producing primordium cell. Using αi = 100, for the low range
of µaux auxin in the main auxin receiving cell (i.e. cell 5) is around 0.14
times the value in the primordium, while for µaux = 100 auxin in cell 5 is
less than 5.0 × 10−6 times the primordium value (Figure 5.11). Increasing
αi to 1000 or decreasing it to 10 has little or no effect on these relative
values. Similarly, there is little or no difference when comparing the values
of auxin in the different cortical cells relative to cell 5 at αi = 100, to those
for either αi = 1000 and αi = 10, for all values of µaux used.
Model variations
Figure 5.11 shows the relative auxin in each of the eight cortical cells against
µaux, for the model with both apoplastic diffusion and the Casparian strip as
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Figure 5.11: Steady state auxin in each of the cells 1-8 (see Figure 5.9 for
cell labels) against turnover rate µaux (log x-axis), following the
introduction of an auxin signal in a single cell in the pericycle
representing a primordium. The primordium cell is as indicated
in Figure 5.9, with the strength of the auxin source, αi = 100.
The values in cell 5 are shown relative to the value in the pri-
mordium, and the other cells are shown relative to the value in
cell 5. Each plot shows the model with and without apoplastic
diffusion (APO/NO APO), and with and without the Casparian
strip (CASP / NO CASP). The plot for cell 5 demonstrates that
as well as the distribution of auxin within the cortex widening
with increasing µaux, as µaux increases the value of auxin in the
cell 5 drops rapidly relative to the value in the primordium.
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in Figure 5.10, but also showing the effect of removing one or both of those
model components. The values of auxin shown for each cell are relative
to the value in cell 5, which generally receives the most auxin, with the
exception of the values for cell 5 itself which are shown relative to the value
in the primordium. The results are qualitatively very similar, regardless of
the model used, though there are some subtle differences, in particular in
the relative values of cell 4 and cell 5. Looking at the values for cell 5 gives
a measure of how much auxin is reaching the cortex in each case, with the
most auxin seen in the model with apoplastic diffusion, but no Casparian
strip, and the least when both apoplastic diffusion and the Casparian strip
are present. In the latter case the block on the apoplastic pathway in the
endodermis prevents as much auxin reaching the cortical cells. In any case,
the choice of model appears to have less effect on distribution in the cortex
than the value of µaux, and so in future we use the model which best reflects
the biological reality and keep the apoplastic diffusion and Casparian strip
in all further simulations.
To test the importance of the physical size of the auxin maximum, the
simulations were repeated with all three of the left-hand XPP cells set as the
primordium source, rather than just the central cell (Figure 5.12). Looking
qualitatively, differences between the simulated one cell auxin source and
three cell auxin source are not visible at low and intermediate values of
µaux. At high µaux, there does appear to an increased spread of auxin in
the cortex with the three cell auxin source, and a slight increase in some
epidermal cells. However, these changes in the relative values are much less
significant than the changes seen by varying µaux itself. In addition, to test
whether the results were unique to the choice of XPP cell, the simulations
were also repeated with the opposite central XPP cell set as the primordium
source (Figure 5.12(C)). The results were qualitatively very similar as for
the other XPP (Figure 5.12(A)), though further repetition on a range of
cross sections would provide further corroboration.
The implication of the above results is that for the current parameter
values used in the auxin transport model, in the range of primordia signal
strengths tested, the relative spatial auxin distribution depends mainly on
the rate of intracellular degradation, and not on the rate of auxin production
within the primordium. In addition, for µaux > 10, which was estimated
previously as a lower bound for the true value of µaux, there is a relatively
large spread of values of auxin within the cortex (several fold-change in
auxin between each cortical cell and its nearest neighbour). However, as
µaux increases the relative amount of auxin that reaches any of the cortical
cells is greatly reduced.
If we use an estimated value of µaux = 100 hour
−1, so that steady state
is reached quickly and there is close to a maximum range of relative auxin
distribution in the cortex, when αi = 100 µM hour
−1, the steady state
concentration of auxin in the primordium is just under 1 µM . This just
below the lower end of the range estimated by Petersson et al. (2009) of 1 to
50 µM auxin concentration within the cells near the root tip, and so these
estimates appear to be reasonable estimates to use as a basis for further
investigation. With these estimates however, the value of auxin in the two
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Figure 5.12: Colour maps of the steady state distribution of auxin in the cortex
and epidermis following the introduction of an auxin signal in
one or more cells in the pericycle. Each colour map is shown for
low, intermediate and high values of the auxin turnover rate µaux,
relative to the value in the cortical cell with most auxin. For
clarity, auxin is not shown in the endodermis, pericycle or stele,
except for those cells set to be auxin sources. (A) auxin source in
central left-hand XPP cell, (B) auxin source in all three left-hand
XPP cells, (C) auxin source in central right-hand XPP cell.
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cortical cells that would be expected to ultimately express LAX3 (i.e. cells
4 and 5) is 3.34 × 10−6 µM and 4.28 × 10−6 µM , which may be too low
to produce an auxin response. As discussed above, one way of increasing
cortical auxin is to simulate a fold-change increase in primordium signal
strength, which will produce an equivalent fold-change increase in cortical
auxin. However, increasing auxin in the primordium much beyond 1 µM
may take it outside of a realistic physiological range. An alternative solution
may be to investigate the effect of adding auxin influx and eﬄux carriers to
the model, as in the following Section (5.3.1).
5.3 Modelling of influx and eﬄux carriers
5.3.1 Fixed distribution of influx and eﬄux carriers
To test the effects of the presence of fixed auxin carriers in the tissue, various
configurations were added to the tissue (Figure 5.13), by setting the terms
LAXq,p and/or PINq,p equal to one for specific values of p, q corresponding
to the required cells and cell membranes. For each configuration, with
parameter values µaux = 100 and αi = 0 except in the primordium cell
as indicated in Figure 5.9, where αi = 100, the model was run to steady
state, and the final auxin concentrations compared to the results with no
carriers present as shown in Figure 5.14. The various carrier configurations
are discussed in more detail below.
Influx carriers in stele
The first configuration has influx carriers on every face of the stele (Figure
5.13a) since, for simplicity, the stele is modelled throughout as a single cell,
rather than modelling each individual cell. The presence of influx carriers
in the stele is based on the experimental observation that the auxin influx
carrier LAX3 has been observed to be expressed in the stele (Swarup et al.
2008). While the precise localisation of the carriers within the individual
cells in vascular tissue is unclear, we approximate their presence by setting
influx carriers around the circumference of the stele.
With this configuration, the stele retains more auxin than without car-
riers, with a direct effect that less auxin remains in the pericycle cells,
marginally restricting the spread of auxin in the pericycle layer (Figure
5.14). This has a knock on effect in the endodermis and cortex, where the
spread of auxin relative to the cells that receive most is also slightly reduced.
AUX1 in primordia / pericycle
There is also experimental evidence that the auxin influx carrier AUX1 is
expressed in the developing primordia (Marchant et al. 2002). This is simu-
lated in the model in two ways. Firstly, AUX1 is localised to all membranes
of the central, auxin producing XPP cell (Figure 5.13b), and secondly AUX1
is localised to all membranes of all three XPP cells on the side where the
auxin source is located (Figure 5.13c). The former arrangement results in
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Location of efflux carriers with direction of transport
Location of influx carriers with direction of transport
Figure 5.13: Schematic diagrams of the various configurations of fixed auxin
carriers tested with the model. a) Influx carriers are expressed in
the stele and localised to each cell wall facing the pericycle. b)
Influx carriers in stele, plus in each of the walls of the primordium
cell. c) Influx carriers in stele, plus in each of the walls of the
three XPP cells. d) Influx carriers in stele, plus eﬄux carriers
in pericycle localised to each cell wall facing the endodermis. e)
Influx carriers in stele, plus eﬄux carriers in primordium localised
to each cell wall facing the endodermis. f) as e), plus influx carriers
in each of the walls of the three XPP cells.
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Figure 5.14: Relative steady state distribution of auxin in the pericycle, endo-
dermis, and cortex, with simulated auxin source in a single peri-
cycle cell (cell 353) and µaux = 100, for each of the fixed carrier
configurations shown in Figure 5.13, plus the values with no car-
riers. For cell id’s see diagram in top right of figure.
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only a marginal reduction in the spread of auxin in the endodermis and
cortex, relative to the case with no carriers (Figure 5.14), with the latter
arrangement showing slightly more restriction in the spread of auxin in the
cortex, relative to the cell receiving most auxin (i.e. cell 340).
PIN in pericycle / primordia
In the cases above, and the case without any carriers at all, the absolute
value of auxin that reaches the cortex relative to the concentration in the
primordium is very low. To assist the spread of auxin from inner to outer cell
layers, the effect of adding PIN eﬄux transporters in the pericycle cell layer
was investigated. This was done in two ways. Firstly, by localising PINs to
the outward facing (relative to the centre of the root) cell membranes of all
cells in the pericycle (Figure 5.13d), and secondly by localising PINs to the
outward facing membranes in just the primordium auxin source cell (Figure
5.13e). In both cases we retain the influx transporters in the stele.
In both cases when PINs are added to the pericycle, there is around
a fifty-fold increase in the absolute quantity of auxin reaching the cortex,
when compared to the the values without the PINs. When PIN is expressed
throughout the pericycle, there is a marginal increase in the spread of auxin
within cortex, relative to the case when the only carrier is AUX1 in the stele
(Figure 5.14). This is most likely due to the PINs in the pericycle aiding
the spread of auxin radially around the root, as well as from inner to outer
cell layers. For the case where PIN is only expressed in the primordium,
however, there is reduction in the spread of auxin in the cortex, as more
auxin is focused into the cortical cells closest to the primordium (Figure
5.14).
AUX1 and PIN in primordia cells
In the final case, PIN is localised to the outward facing membranes of the
central primordium cell, and AUX1 is localised to all membranes of all
three XPP cells on the side with the primordium, and to the stele. With
this arrangment, there is not only significantly more auxin reaching the
cortical cells than when the PINs are not present, but the relative spread of
auxin within the cortex is the most restricted of all the carrier arrangements
tested, with the value in the cell with the third most auxin out of the eight
cortical cells (.e. cell 344) receiving less than 20% of the auxin that the cell
with the most (i.e. cell 340) receives (Figure 5.14).
Though in relative terms the differences in auxin in the cortical cells
are marginal between the different carrier configurations, in general adding
fixed auxin carriers to the tissue in the experimentally observed locations
generally increases the difference between the auxin in the two cortical cells
which are expected to express LAX3, with that in their neighbours. If
LAX3 is expressed in a switch like manner, increasing the differences in
auxin between adjacent cells ought to widen the range of concentrations in
which LAX3 may be expressed, so leading to greater robustness to biological
variability. In addition, the presence of PINs in the tissue has a significant
effect on increasing the absolute quantity of auxin reaching those cells, which
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means they will not need to be as sensitive to the presence of very low levels
of auxin.
5.3.2 Threshold model for expression of LAX3
In the previous section, it was shown that adding fixed auxin carriers to
the model, based on experimental evidence, can subtly change the relative
distribution of auxin between cells in the cortex. In this section, a threshold
model for LAX3 expression is used so that when auxin in either cortical or
epidermal cells exceeds a prescribed value, LAX3 is localised to all mem-
branes of the cell, resulting in an increased auxin influx rate to that cell.
The model given in 5.1.2 is amended so that for all cell ids, i, in the cortex
or epidermis, if:
auxini > θlax, LAXi,j = 1, ∀ j ∈ Wi,
where θlax is the threshold for activation of LAX3 expression.
Given that it takes several hours following the auxin signal for LAX3
to be expressed, and that with a sufficiently high value for µaux, the model
predicts that auxin within the tissue will re-equilibrate following a pertur-
bation in auxin signal within minutes or seconds, we assume that auxin
within the tissue is at steady state before any expression of LAX3 occurs.
For this reason the model is run to steady state for a given parameter set
first, with all LAX3 switched off, with a fixed auxin signal in the pericycle
to represent a primordium. The model is then run from steady state, with
LAX3 expressed in the cells above a given auxin threshold, as described
above. The LAX3 is localised instantly at the beginning of each time step if
auxin is above the required threshold. Clearly in reality the transcription,
translation and localisation of mature LAX3 will all take time, and this will
be considered further in Chapter 6. For the time being however, the model
will give a prediction on the effect LAX3 has on intracellular auxin pre- and
post-expression.
Using the default parameter values µaux = 100 and αi = 100 in the
primordium the model was run for three increasing values of θlax, selected
so that 3, 2 and 1 cortical cells are triggered to produce LAX3 immediately
after an initial timestep. As shown in Figure 5.15, in all three cases, after
LAX3 is switched on, auxin in the cortex quickly finds a new steady state
within less than 6 minutes. The values of auxin shown in the figure are
relative to the auxin at time zero in the cell receiving most auxin before
LAX3 is triggered (cell A). Clearly, if θlax is greater than this value, LAX3
will not be triggered for expression in any of the cells.
When θlax is set such that three cells are triggered, cells A, B, and C
produce LAX3, and their auxin concentration is increased due to the extra
influx rate. Cell A eventually has almost double its original value, while
cell B’s auxin is increased to greater than that of cell A before the LAX3 is
added.
This is critical when considering the effect LAX3 may have on the
production of CWREs such as PG. In the conceptual model published in
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Swarup et al. (2008), the expression of CWREs is dependent on the focus-
ing of additional auxin in specific cells via the positive feedback on auxin
caused by the expression of LAX3. This hypothesis is supported by qRT-
PCR data, which in the wild type shows late induction of PG, following
the expression of LAX3. In the lax3 mutant this induction is impaired
(Figure 4.1). A robust biological system would seek to limit the expression
of CWREs only to very specific cells in order to maintain the integrity of
the root’s cellular structure. One way to ensure this is the presence of a
genetic switch, in which only cells with very high auxin will ever express
PG. In the context of the threshold model described here, the threshold for
PG expression ought to be higher than that for LAX3 expression, so that
only the additional auxin influx caused by LAX3 expression is sufficient to
trigger PG, and the remodelling of cell walls. In the lax3 mutant, the lack
of additional influx means that PG is not expressed.
In Figure 5.15 we see that if θlax is in the range such that both cells A and
B express LAX3, the result is that both of these cells end up with more auxin
than either had previously, possibly within the threshold for PG expression.
However, even if the threshold for LAX3 expression is sufficiently low so that
cell C also expresses LAX3, the resulting increase of auxin in that cell is
not enough to reach the level of cell A or B pre-LAX3 expression. Since we
assume that the auxin needs to exceed this level in order for PG expression
to occur, this helps ensure that PG is not expressed outside of a narrow
spatial domain.
For a given value of µaux there is a range of values for θlax for which
LAX3 is expressed in the two cortical cells nearest the primordium as per
the observed spatial expression pattern. Figure 5.16 shows how the relative
breadth of this range changes as µaux varies, and also how the final steady
state auxin in each of the four nearest cells to the primordium varies with
µaux, for θlax in each of the three ranges.
The range of auxin concentrations for which one or two cortical cells
express LAX3 broadens as µaux increases. In addition, as µaux increases
the range of values for which three of more cells express LAX3 decreases,
relative to the maximum auxin at t = 0. In general, the broader the range
of auxin that produces the desired expression pattern, the more robust the
system ought to be to biological variation. Again, a relatively high value for
µaux would appear to be desireable. This is also the case when looking at
the steady state values as µaux varies. The lower the value of µaux, the lower
the proportional increase in intracellular auxin after LAX3 is triggered. For
high values of µaux, when θlax is set so that LAX3 is triggered in cells A and
B, there is almost a doubling in auxin concentration post-LAX3 induction
in the affected cells, while as µaux is lowered this proportion is reduced,
to the extent that for the lowest value of µaux there is only a 3% increase
in auxin in cell A, and cell B only attains 99% of the value of cell A pre-
LAX3 induction. If a significant increase in auxin post-LAX3 expression is
required to further trigger the expression of CWRs such as PG, a relatively
high value for µaux will be most effective. A final point is that should θlax
be low enough so that a third cell is triggered to express LAX3 (i.e. cell C),
as µaux increases the steady state value of auxin this cell attains post-LAX3
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Figure 5.15: Model time courses for the cortical cells labelled A,B,C,D (bot-
tom left) from steady state with a single cell primordium auxin
source following the expression of LAX3 after an initial time step.
Depending on the value of θlax, 1 (bottom left), 2 (top right), or 3
(top left) cortical cells begin to express LAX3. Intracellular auxin
turnover, µaux = 100. In each case there is a clear increase in
auxin in cell A to almost or more than double the initial value
within around 5 minutes. If cell B is triggered to express LAX3
(two top plots), its auxin level increases over a similar time-frame,
and eventually exceeds the initial value in cell A pre-LAX3 ex-
pression. Even if the threshold for LAX3 is such that LAX3 is
triggered in cell C, the increase of auxin in that cell is not suffi-
cient to exceed the initial values in either cells A or B. This lack
of overlap in the range of auxin concentrations in cells A and B,
and the other cells, may help restrict the expression of CWRs to
the two cells nearest the LRP only.
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Figure 5.16: Top left: Ranges of the the values θlax may take, relative to the
value in cell A at steady state pre-LAX3 expression, so that 1, 2
or 3 or more cells are triggered to express LAX3 in the threshold
model with a simulated single cell primordium auxin source (see
Figure 5.9 for location), for increasing values of µaux, the auxin
turnover rate. Top right, bottom left, bottom right: Respective
steady state auxin values after θlax is set so that 3, 2, and 1 cells
are triggered to express LAX3 in each of the cells A,B,C,D, for
increasing values of µaux. As µaux increases the range of auxin
values for which two cells are triggered to express LAX3 increases,
and so too does the fold-change increase in auxin increase following
LAX3 expression. See Figure 5.15 for the position of cells A-D in
the tissue.
173
expression drops relative to the other two LAX3 expressing cells (A and B).
Again, a high value for µaux increases robustness, by reducing the chances
that a high concentration of auxin will occur in any cortical cell other than
the two closest to the primordium.
5.4 Discussion and conclusions
Analysis of the LAX3 model at the network scale shows that it is possible to
have switch-like behaviour of LAX3 mRNA expression with an increasing
auxin signal (Chapter 2). Depending on key parameters relating to pro-
moter co-operativity and the strength of positive feedback on auxin due to
LAX3, the switch from low to high expression can occur gradually over a
relatively broad range of auxin concentrations, rapidly over a very narrow
range of auxin (ultra-sensitivity), or the switch can be bistable (i.e. there
is a range of auxin at which both high and low steady states can occur).
Moving from the network scale into the tissue scale, it is observed that only
the specific cortical cells over lateral root primordia express LAX3 during
emergence. For this expression pattern of LAX3 to occur, there needs to
be either a large difference in auxin concentration between adjacent cells in
the cortex, or a sharp switch in LAX3 expression with the threshold value
for change from low to high tuned precisely between the auxin values in the
adjacent cells. While it is unlikely that this latter mechanism alone will be
robust to biological variation, a combination of the two mechanisms ought
to provide a much more reliable system to ensure that only specific cells
express LAX3 and so go on to express the CWRs needed for lateral root
emergence. A key purpose of the tissue scale model then is to investigate
how auxin is spatially distributed radially within the root, in particular in
the cortex in response to a source in the pericycle simulating a LRP, and
what factors or parameter values affect that distribution.
Initially the model was used to simulate an exogenous source of auxin
around the circumference of the root, with just diffusion between cell and
apoplast. The intracellular turnover of auxin (µaux) was identified to be a
key parameter in the steady state distribution of auxin between cell layers,
with the difference in concentration between adjacent layers increasing as
the turnover rate increases. Adding diffusion of auxin between adjoining
apoplastic spaces was shown to significantly increase the penetration of
auxin into the root. In the interests of adding biological realism to the
model, the apoplastic diffusion is therefore retained in future simulations,
along with a simulated barrier in the endodermis to represent the Casparian
strip. Though the lack of penetration of auxin to the centre of the root shows
that attempting to simulate auxin treatment by restricting the auxin source
to the outer surface of the root may be unrealistic, the model clearly shows
the importance of the intracellular auxin turnover rate and the apoplastic
diffusion pathway on the auxin distribution in the radial root cross-section.
An alternative method to better simulate exogenous auxin treatment is
given in Chapter 6.
The lateral root primordia is simulated in the model by a fixed source of
auxin in one of the central XPP cells. As with the exogenous auxin treat-
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ment simulation, the key parameter in determining the relative auxin dis-
tribution is the intracellular auxin turnover. At high turnover rates there is
more than double the auxin in the two cortical cells nearest the primordium
than in their nearest neighbours, while at low turnover values the auxin is
distributed much more evenly around the ring of cortical cells, with the
auxin in the neighbouring cells receiving around 80% of the auxin of the
two main cells. These relative values are subtly changed by removing either
or both of apoplastic diffusion and the Casparian strip, but neither have as
significant an effect on the relative values as µaux. If there is a switch in
LAX3 activation with increasing auxin signal, the greater difference in auxin
at high µaux in adjacent cells allows for a less sharp switch, and greater ro-
bustness to biological variability. At low µaux however, the switch will need
to be much sharper and more precisely tuned, in order to see the observed
all or nothing LAX3 spatial expression pattern. It is important to note that
increasing µaux reduces the amount of auxin reaching the cortex, relative to
primordium concentration, though the difference between primordium and
cortex can be reduced by adding PIN transporters to the primordium, or
pericycle layer. Adding a fixed distribution of auxin carriers in the stele
and XPP has the effect of slightly increasing the difference in steady state
auxin between the two main cortical cells and their two nearest neighbours.
If LAX3 expression is set to be triggered when auxin in any cortical
or epidermal cell exceeds a pre-defined threshold, it is possible to see the
effect the feedback LAX3 has on the final steady state auxin post-LAX3
expression by changing the value of the threshold so that specific cells in
the cortex are triggered. By looking at the steady state auxin distribution
pre-LAX3 expression, it is shown that the threshold values resulting in 1, 2
or 3 cortical cells to be triggered are much closer together at low µaux than
at high µaux. In addition, at high µaux, when the threshold is set so that just
the main two cortical cells are triggered, there is nearly a doubling of auxin
in those two cells post-LAX3 expression, with both cells ultimately receiving
more auxin than either pre-LAX3 expression. This latter point is important
when considering the proposed conceptual model for CWRE expression in
the cortex, where LAX3 is required to amplify auxin in specific cells in order
for them to be able to express the CWREs. If the CWREs also have switch-
like activation with increasing auxin, it would be expected that the threshold
for CWR expression is greater than that for LAX3, preventing the unwanted
expression of CWREs. The higher this threshold for CWRE expression, the
more robust the system to small changes in auxin concentration. At low
µaux, the triggering of LAX3 results in a relatively small fold-change in
steady state auxin, with the cell with the second most auxin pre-LAX3
expression failing to exceed the value of the cell with the most pre-LAX3
expression. In other words, in order for both these cells to express CWREs,
the auxin threshold for CWRE expression would need to be similar to that
for LAX3, meaning that the amplification of auxin by LAX3 is not required.
In this case, it would be expected that removing LAX3, as in the case of
the lax3 mutant, would have little or no effect on CWRE expression, which
is not the case for the expression of the CWRE PG (Figure 4.1).
In general, the tissue scale model shows that with a high rate of intra-
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cellular auxin turnover, the spatial arrangement of cells in the cortical cell
layer relative to a primordium auxin source provides a wide distribution
of auxin between adjacent cells in the cortex. Following the introduction
of the auxin source, the action of diffusion, via both apoplastic and tran-
scellular pathways, results in a steady state redistribution of auxin within
minutes. The experimental evidence indicates that it takes several hours
before LAX3 is expressed and so this steady state distribution represents
the initial conditions for the production of the LAX3 expression pattern.
A broad distribution of auxin in the cortex then provides an effective basis
on which a switch-like expression of LAX3 can operate. In addition, a high
auxin turnover rate increases the power of LAX3 expression to raise the
auxin level of cells in which it is expressed, consistent with the conceptual
model that the magnification of auxin by LAX3 is required for the expres-
sion of CWRs. The current model does not, however, take into account
the timing of gene expression events, or demonstrate that a range of auxin
signals may produce the same LAX3 expression pattern. To do this the tis-
sue scale auxin transport model needs to be coupled with the network scale
models for LAX3 expression (Chapters 2-4), as described in the following
chapter (Chapter 6).
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Chapter 6
Multi-scale Models of Lateral
Root Emergence
In the previous chapter (Chapter 5), a tissue scale model of auxin transport
within a mature Arabidopsis root cross section was used to show the auxin
distribution following both simulated auxin treatment and the introduction
of an auxin source in a single pericycle cell to represent a LRP. The first
step in linking the tissue scale model to a gene network scale model is made
by modelling the relationship between cellular auxin and the degradation
of Aux/IAA within each cell. Initially this is done using a simpler model
of the DII-VENUS sensor, which is expressed constitutively and does not
feedback on its own expression rate (Section 6.2), and then by explictly
modelling the expression of Aux/IAA mRNA in response to the level of
Aux/IAA protein (Section 6.3). Next, the secondary auxin response gene
LAX3 is modelled in Section 6.4. LAX3 is able to feedback on cellular
auxin levels by increasing the rate of transport into the cell. Finally, the
expression of a tertiary response gene, hypothesised to be the CWRE PG, is
modelled in Section 6.5. A schematic digram of the gene network is shown
in Figure 1.10. In the model PG is only expressed in the cortical cells which
have elevated auxin concentration due to the expression of LAX3, matching
experimental observation. Before developing the multiscale model, however,
we return to the problem of simulating exogenous auxin treatment in the
multicellular context (Section 6.1).
6.1 Initial conditions for auxin transport sim-
ulations
6.1.1 Exogenous auxin treatment
In Section 5.2 exogenous auxin treatment of Arabidopsis roots was sim-
ulated by setting a fixed concentration of auxin at the boundary of the
tissue. Using this method it is seen that the intracellular auxin turnover
rate is a key parameter in determining the degree of penetration of auxin
from outer to inner cell layers, with a higher turnover rate resulting in a
greater decrease in auxin concentration between adjacent cell layers as the
auxin passes from the epidermis to the central stele. Further analysis of the
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model shows that significant auxin turnover within cells is necessary both
to provide a sufficient gradient of auxin between cells in the cortex so that
the domain of expression of LAX3 may be restricted (Section 5.2.3), and to
provide a significant fold-increase in auxin in cells when LAX3 is expressed,
compared to the level without LAX3 expression (Section 5.3). However,
the predicted gradient of auxin from outer to inner cell layers seen in the
exogenous auxin simulation when using a high turnover of cellular auxin is
not consistent with experimental observations using the auxin sensor DII-
VENUS. When treating roots with exogenous auxin the degradation of the
DII-VENUS sensor in the mature part of the root appears to occur equally
and simultaneously in all cell layers, with the possible exception of the epi-
dermis, which may actually show less DII-VENUS degradation (Band et al.
2012).
This indicates that rather than a sharp negative gradient in auxin from
outer to inner cell layers following exogenous treatment, as predicted by the
earlier simulation, in reality the increase in cellular auxin following treat-
ment is fairly uniform, save in the epidermis where less auxin is detected.
A possible explanation for this uniform increase is that rather than being
restricted to entering the cross-section used in the simulation via the surface
of the root, the auxin from the experimental medium enters via every possi-
ble pathway, including the vascular tissue. Simulating exogenous treatment
in this way, should result in a uniform increase of auxin throughout the
cross-section. The reduced response of DII-VENUS in the epidermis may
be due to an increased auxin turnover rate in those cells compared to other
cell layers, possibly as a protective mechanism for the outer cell layer, but
this question is left to future study.
To approximate the uniform increase in auxin due to exogenous treat-
ment, rather than using a fixed auxin concentration at the tissue boundary
as previously, the production rate in each cell, αi, as defined in the model
given by equations (5.1a), (5.1c), (5.1d), (5.4a), (5.4b) and (5.4e), is in-
creased such that the resulting steady state concentration in each cell for
a given auxin turnover rate is approximately equal to the treatment con-
centration. The values for αi for each treatment are given in Table 6.1. It
is important to note that though using these parameter values results in
dimensional auxin concentrations in the cells roughly equal to the treat-
ment concentrations, this is not necessarily the case biologically. However,
as shown in Chapter 5, the absolute values of cellular auxin are less impor-
tant in the model than the relative values between cells and cell layers, and
choosing the parameters in this way is convenient to give some reference to
known treatment concentrations.
Figure 6.1 shows the time course of mean intracellular auxin in the tissue
cross section for the first six minutes post-auxin treatment, for the range
of treatments and corresponding estimates for αi given in Table 6.1. As
discussed in Section 5.3.1, there is a fixed distribution of influx carriers
surrounding the outer faces of the stele to simulate the stele acting as a
sink for auxin, but the influx carriers in the stele still only produce a very
slight differential in auxin between inner and outer cell layers of less than
one percent (not shown). The model is run from the steady state values
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Table 6.1: Values for αi in every cell in the auxin transport model given by
(5.1a), (5.1c), (5.1d), (5.4a), (5.4b) and (5.4e), with the default pa-
rameters in Table 5.1, used to approximate the given range of auxin
treatments, or no auxin treatment (n.t.). The no treatment or basal
value for αi was determined by parameter fitting (Section 6.2)
Treatment concentration (nM) αi
n.t. 0.06256
1 0.1
5 0.5
10 1.0
100 10.0
1000 100.0
using the estimated basal rate for αi determined in the following Section
(6.2). In each case the new steady state is reached within 6 minutes (0.1
hours), with half the new steady state reached within around 30 seconds.
This is consistent with the rapid response of DII-VENUS within two minutes
following auxin treatment seen by Band et al. (2012). This simulation of
exogenous auxin treatment is used to model the response of DII-VENUS in
the multicellular model in Section 6.2.
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Figure 6.1: Mean intracellular auxin in the model tissue versus time for the
range of exogenous auxin treatment simulations and parameter val-
ues given in Table 6.1. In each case the model given by (5.1a),
(5.1c), (5.1d), (5.4a), (5.4b) and (5.4e) is run from the basal steady
state or no treatment value as given in Table 6.1 and determined
in Section 6.2.
6.1.2 Simulation of LRP auxin source
An estimate for cellular auxin concentration near the maxima found at the
root tip of between 1 and 50 µM is given in Petersson et al. (2009). Using a
179
value of αi = 5000 in the cell representing the primordium, and a turnover
rate of µaux = 100, results in the concentration in the primordia within
this estimated range, with a steady state concentration of around 17 µM .
Figure 6.2 shows the cellular distribution of auxin in the tissue relative to
that in the primordia using this value for the primordium auxin production,
with the value of αi in the others cells remaining at the basal level given
in Table 6.1. In addition, as in Section 5.3.1, influx carriers are fixed to all
membranes of the three XPP cells near the primordium, and eﬄux carriers
are fixed to the membranes of the primordium facing the endodermis.
1
2
3
4
0.0 1.00.50.25 0.75
auxin / auxin in primordium
Figure 6.2: Steady state cellular auxin distribution using a value for αi = 5000
in the simulated primordium, αi = 0.06256 elsewhere, and µaux =
100, using the model given by (5.1a), (5.1c), (5.1d), (5.4a), (5.4b)
and (5.4e) with the value of all auxin carriers fixed to zero. Auxin in
the primordium cell is around 17 µM , and the auxin turnover rate,
and acid trapping mechanism prevents widespread distribution of
auxin in this high concentration range. Instead, auxin in the cortical
cells labelled 1 to 4 is in the nanomolar range with cell 1 = 0.84 nM,
cell 2 = 5.8 nM, cell 3 = 4.2 nM and cell 4 = 1.6 nM, in comparison
to the basal level of around 0.63 nM.
Clearly the intracellular auxin turnover and preferential diffusion of
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auxin from apoplast to cell rather than vice versa prevents a wide spread
of auxin throughout the tissue, with only the cells immediately adjacent to
the primordium showing a visible elevation of auxin with the colourbar scale
used. However, looking at the numerical values of steady state auxin in the
cortex shows that the cells labelled 2 and 3 in the figure have increased
in auxin from around 0.6 nM to around 5.7 nM and 4.1 nM respectively.
Auxin in the neighbouring cortical cells, 1 and 4 only increased to 0.83 nM
and 1.6 nM respectively, so that there is more than double the auxin in the
two cortical cells nearest the LRP compared to their nearest neighbours.
In addition, based on the data from the DII-VENUS sensor these values
are in the physiological range in which an auxin response may be expected
(Band et al. 2012). To see an all-or-nothing response however, a non-linear
response of the target gene to cellular auxin concentration would be needed.
In the following Sections 6.2-6.4 an ODE model is used to show that the
auxin distribution shown in Figure 6.2 can be used as the basis for the
experimentally observed LAX3 expression pattern, and reinforced by the
positive feedback from LAX3 influx transporter activity.
6.2 Multiscale model of the DII-VENUS auxin
sensor
Before adding LAX3 expression and feedback to the model in Section 6.4,
the link between auxin and the auxin response must be first added. This is
provided by the expression of Aux/IAA mRNA and translation of Aux/IAA
protein as described in Section 6.3. First however, in this section the auxin
transport model is linked with the model for DII-VENUS and parameter
values found for which the model is able to approximate to the DII-VENUS
data from Chapter 2 and Band et al. (2012) in the multi-cell context. These
parameters can then be used as an estimate to model the auxin dose re-
sponse of Aux/IAA protein.
The equation used to model the level of DII-VENUS is of a similar form
to that given in Section 2.3, but with β = 1 so that:
dDIIi
dt
= 1 +
−ηauxiniDIIi
QP +Qauxini + auxiniDIIi
− λvDIIi, (6.1)
where the subscript i denotes the concentration in cell i. This equation is
then coupled with equations (5.1a), (5.1c), (5.1d), (5.4a), (5.4b) and (5.4e)
to give a multicell model for the level of DII-VENUS dependent on the level
of cellular auxin.
Using a fixed value for auxini effectively reduces the model to a single
cell model, behaving as one would expect each cell in the multicell model
to behave for that value of auxin. Doing this enables model parameters in
the single cell model to be fitted using the fitting algorithm described in
Section 2.2, so that the multicell model then approximates the DII-VENUS
data without fixing the level of auxin, but instead using the values for αi
for each concentration as given in Table 6.1. Setting the αi and µaux so
that the cellular concentration is approximately the same as the treatment
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concentration means that auxini can be set equal to 0.001, 0.005, 0.01, 0.1,
and 1.0, to represent 1, 5, 10, 100 and 1000 nM treatments respectively, and
fitted with the experimental data. αi for the non-treated data is set as an
additional parameter to be fitted using the algorithm.
The response of the multicell model using the parameter set given in Ta-
ble 6.2 is shown in Figure 6.3. Figure 6.3(a) shows mean intracellular model
DII-VENUS versus time for the first two hours following a range of auxin
treatments, and Figure 6.3(b) a colourmap of the steady state distribu-
tion of model DII-VENUS for the same range of treatment concentrations.
Comparison of the time course plots with the data shown in Figure 2.13(a)
shows that both the timing and the dose response of the multicell model are
a good approximation to the data, and the the colourmap plots show that,
as would be expected, the distribution of DII-VENUS for a given simulated
auxin treatment is uniform throughout the tissue.
The precise strength of the auxin signal from the developing LRP re-
mains unknown. However, using the model it should be possible to predict
the expected distribution of DII-VENUS for a given signal strength, which
can then be tested experimentally (Figure 6.4). At the lowest value for the
auxin production in the primordium (αp) there is little or no degradation of
DII-VENUS save in the cells immediately adjacent to the LRP cell, while
at the highest value for αp there is clear degradation in all of cells in the
stele, pericycle, and endodermis, and most of the cells in the cortex and
epidermis to the left hand side of the cross-section. At the intermediate
values of αp, the greatest degradation in the two outer cell layers is seen
in the two cortical cells nearest the LRP. In particular, for αp = 5000,
there is strong degradation of DII-VENUS in these two cells, but low to
intermediate degradation in the neighbouring cells. Using the assumption
that the degradation of DII-VENUS is an approximation for the degrada-
tion of Aux/IAA, this suggests that with this primordium signal strength
there would be a strong auxin response in the two nearest cortical cells, and
a lower auxin response in the adjacent cells. This, in conjunction with a
switch-like or non-linear transcriptional response to auxin, could provide a
basis for the spatial expression pattern of LAX3.
6.3 Primary auxin response: expression of
Aux/IAA
Though DII-VENUS is a mutated domain II of IAA28, and so both the
timing and auxin dose response of the degradation of IAA14 may be different
to that of DII-VENUS, in the absence of other data the parameters found
in Section 6.2 remain the best estimate of how IAA14 may respond to
auxin. The key difference when modelling an Aux/IAA such as IAA14 to
modelling DII-VENUS is the induction of IAA14 mRNA in response to
auxin, rather than constitutive expression as with DII-VENUS. Following
the single cell model described in Section 2.2.3, the expression of IAA14
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Table 6.2: Default gene network parameter values used in equations (6.2a)-
(6.2j), in conjunction with equations (5.1a), (5.1c), (5.1d), (5.4a),
(5.4b) and (5.4e), and the default parameter values for auxin trans-
port given in Table 5.1 describing the complete multiscale model.
parameter default estimate description
Q 34.9898 balance between binding and unbinding
of Aux/IAA and TIR1
P 0.0254 balance between binding and unbinding
of auxin and TIR1
η 177.6257 maximum rate of IAA14 protein decay
auxin0 0.0006256 basal intracellular auxin concentration
(nM)
K 0.0914 balance of binding and unbinding of
IAA14 and ARF
µim 0.1153 turnover rate of IAA14 mRNA
θia 1.98 binding of ARF to IAA14 promoter
θir 0.9646 binding of ARF-IAA14 dimers to
IAA14 promoter
ni 3.3849 co-operativity coefficient of binding on
IAA14 promoter
µx 1.0 turnover rate of tfX protein
µxm 2.0 turnover rate of tfX mRNA
θxa 0.05046 binding of ARF to tfX promoter
θxr 10.367 binding of ARF-IAA14 dimers to tfX
promoter
nx 4.0 co-operativity coefficient of binding on
IAA14 promoter
µl 1.0 turnover rate of LAX3 protein
µlm 0.2 turnover rate of LAX3 mRNA
θl 1.0 × 10
−8 binding of tfX to LAX3 promoter
nl 4.0 co-operativity coefficient of binding on
IAA14 promoter
µpa 4.0 turnover rate of PGa
na 4.0 co-operativity coefficient of binding on
PGa promoter
θaa 0.05046 binding of ARF to PGa promoter
θar 10.367 binding of ARF-IAA14 dimers to PGa
promoter
µpb 0.1 turnover rate of PGb
θb 3.0 × 10
−8 binding of PGa to PGb promoter
nb 4.0 co-operativity coefficient of binding on
PGb promoter
µpg 0.2 turnover rate of PG
θp 0.65 binding of PGb to PG promoter
np 4.0 co-operativity coefficient of binding on
PG promoter
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Figure 6.3: (a.) Mean multicell model DII-VENUS against time using the pa-
rameters in Tables 5.1, 6.1 and 6.2, for simulated treatment with
1, 5, 10, 100, and 1000 nM exogenous auxin, using the model given
by equations (5.1a), (5.1c), (5.1d), (5.4a), (5.4b), (5.4e) and (6.1).
(b.) Colour maps showing DII-VENUS in each cell for basal or non-
treated (n.t.) tissue, and the simulated treatment concentrations.
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Figure 6.4: Predictions for DII-VENUS distribution in the model given by equa-
tions (5.1a), (5.1c), (5.1d), (5.4a), (5.4b), (5.4e) and (6.1) relative to
basal steady state with a fixed auxin source representing a LRP in
the left-hand central XPP cell, and increasing values for the signal
strength in that cell, αp. (a.) αp = 5, (b.) αp = 50, (c.) αp = 500,
(d.) αp = 5000, (e.) αp = 50000. The other parameter values are
as shown in Tables 5.1, 6.1 and 6.2.
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protein and mRNA is therefore governed by the following two equations:
dIAAi
dt
=
−ηauxiniIAAi
QP +Qauxini + auxiniIAAi
+ IAAmi, (6.2a)
dIAAmi
dt
= µim
(
Ftc
(
K
θia(IAAi +K)
,
IAAi
θir(IAAi +K)
, ni
)
− IAAmi
)
,
(6.2b)
where the subscript i refers to the concentration in cell i, and:
Ftc(ACT,REP, n) ≡
(ACT )n
1 + (ACT )n + (REP )n
. (6.2c)
The default parameters shown in Table 6.2 were selected to replicate the
timing and magnitude of the early part of the IAA14 mRNA time course
expression profile as shown in Figure 1.9. Figure 6.5a shows the model time
course response from basal steady state of IAA14 protein and mRNA for the
first 20 hours post 1000 nM simulated auxin treatment. The IAA14 protein
is rapidly degraded to its minimum value within two hours, before recovering
very slightly in response to increased mRNA expression, while the mRNA
begins to be up-regulated almost immediately, gradually increasing over the
early part of the time-course before plateauing near its maximum value after
around ten to fifteen hours post-treatment. The apparent homeostasis of
the auxin response seen experimentally is discussed in Chapters 2 and 3,
but without a homeostasis mechanism as is the case here, IAA14 mRNA
will remain upregulated as long as the increase in auxin signal persists.
This is not initially investigated further as the first objective is to obtain
parameter estimates for the early response of IAA14 which may be applied
to the simulation of the auxin signal from a LRP. The steady state response
of IAA14 mRNA and protein in the model using the parameter estimates in
Table 6.2, with a simulated LRP of auxin signal strength αp = 5000 is shown
in Figure 6.5b. The distribution of IAA14 is similar to that of DII-VENUS
at the same primordia signal strength, but with a smaller relative magnitude
of degradation due to the feedback on protein levels from increased mRNA
expression. There is a clear induction of IAA14 mRNA throughout the
pericycle, greater in magnitude on the side of the root near the primordium,
while there is strong induction in half of the endodermal cells, and the two
cortical cells nearest the LRP, and weaker induction in the adjacent cells.
This expression pattern ought to be indicative of what may be expected
for primary auxin response genes. For secondary response genes, such as
LAX3, the relative expression between cells may be sharper depending on
the relationship between the auxin activated transcription factor and the
downstream target gene.
6.4 Secondary auxin response: expression of
LAX3
Following the single cell model described in Chapter 2, the expression of
LAX3 is activated by the unknown activator tfX, which is itself a primary
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Figure 6.5: (a.) Mean cellular IAA14 mRNA and protein following simulated
1000 nM auxin treatment using the parameters given in Tables 6.1
and 6.2 in the model given by equations (6.2a)-(6.2c), (5.1a), (5.1c),
(5.1d), (5.4a), (5.4b) and (5.4e). (b.) Steady state distribution of
IAA14 mRNA and protein using the same model and parameters,
but with a simulated LRP auxin source (αi = 5000) in the left-hand
central XPP cell.
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auxin response gene. Using the same notation as in previous models the
evolution over time of LAX3 and tfX mRNA and protein is governed by the
following equations:
dXmi
dt
= µxm
(
Ftc
(
K
θxa(IAAi +K)
,
IAAi
θxr(IAAi +K)
, nx
)
−Xmi
)
,
(6.2d)
dXi
dt
= µx(Xmi −Xi), (6.2e)
dLAXmi
dt
= µlm
(
Xnli
θnll +X
nl
i
− LAXmi
)
, (6.2f)
dLAXi
dt
= µl(LAXmi − LAXi), (6.2g)
where as before the subscript i refers to the concentration in cell i, and Ftc
and the parameters are defined as previously. In contrast to auxini, DIIi,
IAAi and IAAmi which are defined for all cells in the tissue, Xmi, Xi,
LAXmi and LAXi are only defined for cells within the cortex and epidermis.
When this model for LAX3 expression is used in conjunction with the auxin
transport model given by equations (5.1a), (5.1c), (5.1d), (5.4a), (5.4b)
and (5.4e), and the model for IAA14 expression given by (6.2a)-(6.2c), the
feedback of the level of LAX3 on cellular auxin is included by setting LAXi,j
= LAXi for all i in equation (5.1d), so that LAX3 is localised to every cell
membrane of the cell where it is expressed. In biological reality, there may
be a delay to this localisation process and the relationship between expressed
mRNA and membrane bound protein may even be non-linear, but this is
left to future study.
The parameters governing the magnitude and auxin sensitivity of tfX
mRNA expression, θxa, θxr, and nx, are selected so that steady state tfX
mRNA increases with increasing auxin within the range of auxin expected
in the cortical cells near the developing LRP (Figure 6.6, for parameter
values see Table 6.2). The timing of the tfX mRNA and protein response
depends on the parameters µxm and µx, and to ensure a relatively rapid
response of tfX we set µxm = 2.0 and µx = 1.0. The equation for LAX3
mRNA expression includes a Hill function setting the rate of transcription
for a given value of tfX protein. By setting the co-operativity coefficient (nl)
sufficiently high, and the value of half maximum expression (θl) between the
value for tfX when auxin is in the range expected in the two cortical cells
nearest the LRP and the value for tfX when auxin is in the range expected
in the two neighbouring cells, the steady state expression of LAX3 mRNA
has a sigmoidal shape with increasing auxin, as shown in Figure 6.6. The
default parameters used are given in Table 6.2.
The temporal response of a single cell in the model in response to sim-
ulated auxin treatment can be tested by fixing auxini to the basal value
of 0.000625 µM , running to steady state, and then changing auxini to the
fixed treatment value of 1.0 µM . The time course solution of the model for
the first 40 hours post-treatment is shown in Figure 6.7. The mRNA of tfX
is the first model species to peak after around two hours, before settling
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Figure 6.6: Steady state tfX and LAX3 mRNA using the parameter values in
Table 6.2 in the model given by equations (6.2) for increasing fixed
values of auxini in every cell.
at a lower, though still many-fold greater than basal, steady state level
between 10 and 20 hours post-treatment, with tfX protein following the
mRNA with a 2 to 3 hour delay. The drop in tfX expression following the
initial peak may be due to increased IAA14 protein levels. LAX3 mRNA
begins to be expressed as the tfX protein is produced, but in the absence of
a homeostasis mechanism continues to climb up to between 10 and 20 hours
post-treatment. The timing of this accumulation of LAX3 may be altered
by changing the value of the parameter µlm , but using the default value of
µlm = 0.2 produces a result roughly comparable with the early timing of
LAX3 mRNA accumulation seen experimentally (Figure 4.1). As with tfX
there is a delay in the time course profiles between mRNA and protein, but
in the case of LAX3 a value for µl = 0.2 results in a delay of several hours
between the mRNA and protein. This is again consistent with experimen-
tal observations of the time taken post-auxin treatment for LAX3-YFP to
be visible (Silvana Porco, personal communication), compared with the up-
regulation of the mRNA, though it may be that part of that delay is taken
up by the localisation and maturation of the LAX3-YFP protein.
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Figure 6.7: Time course of tfX and LAX3 mRNA and protein using the the
model given by equations (6.2), using the parameter values in Table
6.2, following a change in the fixed value value of auxini in every
cell from the basal value of 0.000625 to auxini = 1.0, to simulate
treatment with 1 µM exogenous auxin.
Transferring the model to the multi-cellular context by using the pri-
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mordium simulation as described previously results in the time-courses and
spatial distributions of model species as shown in Figures 6.8 and 6.9. The
addition of the auxin signal results in the rapid increase in cellular auxin
in each of the four labelled cortical cells, with a much greater fold-change
seen in the two central cells (labelled 2 and 3). This increase in auxin is
manifested by a decrease in IAA14, and up-regulation of the primary re-
sponse genes. Again, this up-regulation is much greater in cells 2 and 3, and
furthermore the recovery of IAA14 protein resulting from the up-regulation
of the mRNA is proportionally greater in the two outer cells (labelled 1 and
4) further limiting the steady state expression of auxin responsive genes in
those cells. The non-linear auxin dose response of tfX widens the difference
in expression between the two outer and two inner cells, and this is further
magnified in the expression of LAX3, where there is clearly strong expres-
sion in cells 2 and 3 and little to no expression in cells 1 and 4. Once LAX3
is expressed, the positive feedback on auxin further widens the difference
in expression between the two central cortical cells and two neighbouring
cells. The increase of auxin in cells 2 and 3 is such that the final level of
auxin in both those cells is greater than that following the inital increase
caused by the introduction of the auxin signal in the LRP. This elevation
of cellular auxin by LAX3 will become important when modelling the ex-
pression of the cell wall remodelling enzyme (CWRE) PG, as described in
the following section.
6.5 Tertiary auxin response: expression of
PG
Though little is yet known about the regulation of polygalacturonase, in
Swarup et al. (2008) it is shown to be expressed in the cortical cells near
developing LRP, depend on LAX3 for this induction, and to be induced by
auxin. Its role as a CWRE (Kim et al. 2006) provides a link between the
expression of LAX3 and the the expression of PG and normal lateral root
emergence. The qRT-PCR data shown in Figure 4.1 shows a long temporal
delay of between 3 to 5 hours post-auxin treatment before PG begins to be
expressed. This time delay leads to the hypothesis that PG may be at least a
tertiary auxin response gene, i.e. a primary auxin gene is regulated directly
by the interactions of ARFs and Aux/IAAs, which activates a secondary
response gene, which then activates PG. If we denote the primary auxin
response (PGa) in cell i by PGai, the secondary response (PGb) in cell i as
PGbi, along with PG in cell i (PGi) they can be modelled by the following
equations:
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Figure 6.8: Timecourses of each model species in the model given by equations
(5.1a), (5.1c), (5.1d), (5.4a), (5.4b), (5.4e) and (6.2a)-(6.2g) for each
of the four cortical cells nearest the simulated LRP (labelled 1-4 at
bottom right of figure, the red cell is the cell with the auxin source)
for the first 30 hours following the switching on of the auxin signal
(αi = 5000) in the source cell. In each case the plots are shown
relative to the basal steady state at t = 0. LAX3 protein is only
strongly expressed in the two central cells (2 and 3), and results in
elevation of auxin levels in both these cells greater than that caused
by the initial signal from the LRP alone. For parameter values see
Tables 5.1 and 6.2.
191
IAA14 protein tfX mRNA LAX3 mRNA auxin
5 h
10 h
15 h
20 h
25 h
30 h
Figure 6.9: Spatial distribution of IAA14 protein, tfX mRNA, LAX3 mRNA,
and auxin at 5 hour intervals after the introduction of an auxin
source simulating a LRP at time = 0.0 using the model given by
equations (5.1a), (5.1c), (5.1d), (5.4a), (5.4b), (5.4e) and (6.2a)-
(6.2g) run from basal steady state. The primordium is simulated
by increasing αi to 5000 in the central XPP cell on the left-hnad
side of the cross-section. Each colour map is scaled relative to the
maximum value seen for each model species within the cortex. For
parameter values see Table 6.2.
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dPGai
dt
= µpa
(
Ftc
(
K
θaa(IAAi +K)
,
IAAi
θar(IAAi +K)
, na
)
− PGai
)
,
(6.2h)
dPGbi
dt
= µpb
(
PGai
nb
θnbb + PGai
nb
− PGbi
)
, (6.2i)
dPGi
dt
= µpg
(
PGbi
np
θ
np
p + PGbi
np
− PGi
)
, (6.2j)
where we keep the convention that the µ parameters refer to turnover rates,
the θ parameters binding thresholds, and n parameters co-operativity coe-
ficients, and the subscripts a, b and p refer to the genes PGa, PGb and PG
respectively. For simplicity, the mRNA and proteins of PGa, PGb and PG
are combined into single equations for each gene, with the assumption that
any delay between the expression of mRNA and protein can be accounted
for by the values of the parameters µpa, µpb and µpg.
The parameter values for the PG model are selected so that there is
a switch in expression with increasing auxin steady state, with expression
kept as low as possible for values of cortical auxin seen before the feedback
from LAX3 is present, and high expression for the values of fixed auxin
seen in the cells following LAX3 expression. The default parameter values
chosen are given in Table 6.2, and the steady state expression of PG and
activators with increasing auxin is shown in Figure 6.10.
There is very low steady state PG expression when auxin is fixed below
the maximum level seen in the cortex pre-LAX3 expression (0.0057 µM),
and a rapid switch to higher PG expression for auxin above that level.
Because of this, strong PG expression would only be expected to be seen in
cells which also express LAX3 strongly, as the positive feedback on auxin
from LAX3 is required to elevate auxin sufficiently for PG expression to
occur. If the lax3 mutant is simulated by switching off the expression of
LAX3 in the model, PG expression would be expected to be greatly limited.
Also shown in Figure 6.10 is the predicted time course of PG mRNA
for simulated 1 µM auxin treatment. The parameter values are chosen so
that the timing of expression is roughly comparable with that seen experi-
mentally (Figure 4.1), with little or no PG expression seen before 5 hours
post-treatment, and then gradual accumulation of PG mRNA up to around
20 hours. As with the other genes, in the absence of a homeostasis mech-
anism the level of expression remains high throughout the time course, in
contrast to the experimental data where PG expression appears to be re-
turning to the basal level at the final 36 hour time point.
To test whether the model can simulate the lack of PG expression in
the lax3 mutant in comparison to the wild type, where PG expression is
strong but restricted to the specific cortical cells over LRP, the primordium
simulation was run with LAX3 set equal to zero in every cell, and compared
with the ‘wild type’ simulation with LAX3 expressed normally as described
previously. The model time courses for PG mRNA for the two cortical
cells nearest the LRP, in both wild type and the simulated lax3 mutant,
are shown in Figure 6.11, which also shows colour maps at regular time
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Figure 6.10: Top left, top right, bottom left: Steady state PGa, PGb and PG
with increasing auxin in the range seen in the four cortical cells
nearest the LRP in the primordium simulation, using the param-
eter values given in Table 6.2 in the model given by equations
(6.2a)-(6.2j) for increasing fixed values for auxini. Bottom right:
Model PG mRNA expression against time using the same param-
eter values following an increase in the fixed value of auxini to
simulate treatment with 1 µM exogenous auxin.
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points showing the level and spatial distribution of PG in both the simulated
genotypes.
Expression of PG is very close to zero in all but the two cells for which
the time courses are shown (cells 2 and 3). For the first 5 hours following
the introduction of the LRP signal there is little to no PG induction in
either simulated wild type or lax3 mutant. Between 5 and 10 hours there
is a similar induction of PG in both genotypes, with slightly higher PG
expression in cell 2 than in cell 3. After 10 hours the difference between
the wild type and lax3 mutant becomes clearer. While in the wild type PG
expression continues to rise in both cells up to the end of the 40 hour time
course, in the lax3 mutant, the final level of PG expression in much lower
in both cells compared to the wild type. Though the auxin signal from
the primordium is sufficient to trigger transient expression of PG, the lack
of positive feedback on cellular auxin provided by LAX3 expression means
that that expression is not sustained as is the case in the wild type, where
the sustained induction results in strong PG expression in both the cortical
cells nearest the LRP.
For the time-course simulations above, the auxin signal in the LRP is
fixed at an estimate of αp = 5000. In Figure 6.12 the effect of changing
this parameter on steady state expression of LAX3 and PG is tested. With
increasing αp there is a clear switch from low to high LAX3 expression
in the two cortical cells nearest the LRP between around αp = 1000 and
αp = 3000, with expression in cell 2 switched on at a slightly lower signal
strength than that in cell 3. Above αp = 10000 LAX3 expression in cell 4
is switched on, but expression in cell 1 remains low even at the maximum
value for αp simulated. As expected, a higher auxin signal is required to
switch on PG, with the switch from minimum to maximum expression in
cells 2 and 3 between around αp = 2000 and αp = 6000, with expression in
cell 4 not switched on below αp = 15000. Because of this, even when the
primordium signal strength is sufficiently high to switch on expression in
three cortical cells, this is not enough to switch on expression of PG outside
of the region required for lateral root emergence.
In the absence of LAX3, as in the lax3 mutant simulation, the expres-
sion of PG is clearly not switched on in both cells 2 and 3 until a higher
primordium signal strength is reached than in the wild type simulation.
With the estimate for αp = 5000, as used for the time course simulations,
expression in cell 3 remains very low, while in cell 2 expression of PG is
only around a quarter of the value seen in the wild type. If high expression
of PG is needed in both of the two cortical cells nearest the primordium for
normal emergence to occur, this will clearly be impaired in the lax3 mutant.
6.6 Discussion
By embedding a version of the single cell LAX3 expression model from
Chapter 2 into a muticellular framework it is possible to show that pro-
vided there is a sufficiently sharp switch in LAX3 expression with increasing
auxin signal, it is possible to simulate the experimentally observed expres-
sion pattern of LAX3 in the specific cortical cells over the developing LRP.
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Figure 6.11: (a.) Time course of model PG mRNA in the two cortical cells
nearest the LRP, following the introduction of an auxin signal in
the primordium cell, for both the simulated wild type and lax3
mutant. In the lax3 mutant, LAX3 is set equal to zero in every
cell. The locations of the cells annotated cell 2 and 3, and the pri-
mordium cell are as shown in Figure 6.8. (b.) Spatial distribution
of PG expression in both the wild type and lax3 mutant simu-
lations at eight hour intervals following the introduction of the
LRP auxin signal. The model is given by equations (5.1a), (5.1c),
(5.1d), (5.4a), (5.4b), (5.4e) and (6.2a)-(6.2j) and the parameter
values are as shown in Tables 5.1 and 6.2.
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Figure 6.12: Steady state LAX3 mRNA (top), PG mRNA in the wild type
simulation (middle), and PG mRNA in the lax3 mutant simulation
(bottom) in each of the four cortical cells labelled 1-4 in Figure
6.8, with increasing primordium signal strength αp. The absence
of LAX3 as in the lax3 mutant clearly impairs the expression
of PG at lower auxin signal strength. The model is given by
equations (5.1a), (5.1c), (5.1d), (5.4a), (5.4b), (5.4e) and (6.2a)-
(6.2j), the parameter values are as shown in Tables 5.1 and 6.2 and
the locations of the cells annotated 1 to 4, and the primordium
cell are as shown in Figure 6.8.
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Furthermore, by changing the signal strength of the auxin source in the cell
simulating the LRP it is seen that a broad range of auxin concentrations
in the primordium will replicate this expression pattern. The model is also
able to show the same spatial pattern for PG, with expression limited to the
two cortical cells nearest the LRP. In addition, with the parameter values
used, there is a range of primordium signal strengths for which expression
of PG is dependent on the positive feedback from LAX3 on intracellular
auxin, so that in the lax3 mutant simulation the expression of PG is clearly
impaired. If PG is required for emergence, the simulation demonstrates
that without LAX3 then emergence may be impaired.
While there is likely to be biological variability in the strength of auxin
signal from the primordium, the model system ensures that even at an
extremely high auxin signal such that LAX3 is expressed outside of the
expected two cells in the cortex, the spatial expression pattern of PG can
remain restricted to the two cells between which the growing primordium
is expected to pass. This robustness of the PG spatial expression pattern
to high primordium signal strength may help protect the root from the un-
wanted softening of cell walls outside of the region necessary for emergence.
By a similar argument, in the lax3 mutant an unusually high signal strength
may still result in high PG expression in the cells necessary for emergence,
despite the lack of positive feedback from LAX3. However, as observed in
Swarup et al. (2008), emergence is impaired rather than blocked entirely in
the lax3 mutant, and so there is a possibility that PG may still be intermit-
tently expressed correctly in the lax3 mutant, as is the case in the model
simulation for a high primordium signal strength.
In addition to replicating the steady state spatial expression pattern for
LAX3 and PG expression over a realistic range of auxin concentrations, by
comparison with experimental data the model is also able to replicate the
timing of the key events leading to the expression of LAX3 and PG, which
ultimately leads to lateral root emergence. The most rapid event is the
redistribution of auxin following a change in source signal or carrier distri-
bution which over a time scale of seconds to a few minutes, consisitent with
the rapid early response of DII-VENUS seen in response to auxin treatment
(Band et al. 2012). The DII-VENUS is also used to approximate the tem-
poral and dose response of Aux/IAA protein to different auxin distributions
in the multicellular context, which as the key regulator of auxin responsive
genes partly determines the rapidity of response of mRNA expression of
the hypothetical primary response genes tfX and PGa, and of the known
primary response gene IAA14 mRNA. While the level of Aux/IAA is set to
change from one steady state to another following a redistribution of auxin
within around 2 hours, depending on the turnover rates the response mR-
NAs may change to a new level quickly within a few hours, or as in the case
of IAA14 accumulate more slowly before reaching a peak in expression after
ten hours. The secondary response genes are delayed further with LAX3
continuing to accumulate for 15-20 hours, and the tertiary response genes
may be delayed further still.
By working with the hypothesis that PG is a tertiary response gene, its
expression is delayed by the time taken to transcribe and translate the two
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precursors needed for its expression. With the parameter values used, there
is little or no expression of PG for five hours following the introduction of
the auxin signal, and following this it takes 10 or more hours before it is
strongly expressed. In addition, the nonlinear regulation of the intermedi-
ate genes may be a mechanism to sharpen the switch-like response of PG
expression, to produce the all-or-nothing spatial expression pattern, and
limit its expression in order to maintain the integrity of the root structure.
Regulating PG in this ways ensures that a strong persistent auxin signal is
required in order for the CWRE PG to be expressed, and prevents small
transient fluctuations in auxin resulting in the major changes in cell wall
structure seen during emergence.
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Chapter 7
Concluding Remarks
7.1 Bistability in LAX3 mRNA expression
The single cell model of LAX3 mRNA expression described in Chapter 2 is
able to show hysteresis when changing the value of auxin signal, so that at
low auxin signal there is a stable steady state of low expression of LAX3, at
high auxin signal there is a stable steady state of high expression, and for
an intermediate range of auxin signal there is bistability, where both high
and low stable steady state expression may occur. Though in the bistable
region there is an additional steady state at which LAX3 is expressed at in-
termediate values, this steady state is unstable and so persistent expression
at intermediate values is very unlikely. In the plant, LAX3 protein appears
to be strongly expressed only in a small number of cells directly over lateral
root primordia, with no expression visible in the adjacent cells. The model
shows that this observed all or nothing LAX3 expression pattern may be
formed and maintained by the jump from low to high expression as auxin
in the cortical cells increases closer to a lateral root primordium.
Based on the biological evidence that LAX3 is a secondary auxin re-
sponse a transcriptional activator of LAX3 (tfX), itself a primary auxin
response, is included in the model. Study of a model in which LAX3 is
instead a primary auxin response may help establish a biological function
for tfX if it is shown that the additional downstream transcription factor
is required for bistability in the model, or at least broadens the range of
key parameters needed for bistability. If this is the case the extra step
between primary auxin response and LAX3 expression may have a role in
sharpening the response of LAX3 to a range of auxin signals. Furthermore,
if tfX can be identified, this could possibly be tested experimentally by
expressing LAX3-YFP under the activation of the tfX promoter in a lax3
mutant background. If the additional step sharpens the expression pattern
of LAX3, expressing it as a primary auxin response ought to broaden its
domain of expression. More directly, a marker for tfX expression, once iden-
tified, can be compared with the LAX3 expression pattern. Identification
of tfX will also allow study of the number of ARF binding sites (AuxREs)
on its promoter, and the possible binding sites for tfX on the LAX3 pro-
moter. A large number of binding sites would support the bistable model
since a high co-operativity of transcription factor binding on both the tfX
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and LAX3 promoters are shown to be important parameters in introducing
bistability to the model. Again, this could be tested further experimentally
by mutating binding sites and observing any resulting differences in LAX3
expression. At the time of writing a strong candidate for tfX has been iden-
tified and the results of experiments currently underway will hopefully form
the basis of ongoing collaboration.
7.2 Sources of auxin homeostasis
An initial qualitative observation drawn from the qRT-PCR data is that the
induction of LAX3 and other mRNAs following exogenous auxin treatment
is transient, i.e. there is an initial up-regulation of mRNA before the expres-
sion level peaks and returns in time to around the basal level of expression.
However, if we assume that the exogenous auxin signal is persistent over
time the initial model is unable to capture this behaviour. In contrast, intro-
ducing a decay to the auxin signal, distinct from the intracellular turnover
rate, allows the model to fit the qRT-PCR data quantitatively and results
in the prediction that as the level of cellular auxin and mRNA drops there
is a matching recovery in the level of Aux/IAA as its rate of degradation
returns to the basal level. Experimental evidence for this recovery is given
by quantification of DII-VENUS over a 30 hour time period in which a sim-
ilar recovery is seen. Two possible explanations for the apparent reduction
in cellular auxin over time following an initial increase post-treatment are
the degradation in light of the auxin in the experimental medium and some
endogenous mechanism by which the plant is able to maintain auxin home-
ostasis. The former was tested by measuring the rate of decay of auxin in
the medium due to exposure to light alone. While significant degradation
of auxin does occur, adding this rate of decay to the auxin signal in the
model is insufficient to match the recovery in the DII-VENUS data over
the 30 hour time course. The prediction of the model that the measured
rate of decay is too slow to explain may be tested further by repeating the
DII-VENUS quantification at a range of auxin treatments.
The second hypothesis explaining the transient response of DII-VENUS
and ARF target mRNAs to auxin treatment is the presence of an endoge-
nous auxin homestasis mechanism. One possible mechanism was modelled
in Chapter 3, in which a member of the primary auxin responsive gene fam-
ily GH3 increases the rate of intracellular auxin turnover by binding with it
and conjugating it with amino acids. A combination of positive feedback to
auxin from LAX3 expression and negative feedback to auxin from GH3 can
result in damped or persistent oscillations in gene expression depending on
model parameter values, and parameter sets exist in which the model can
match the LAX3 and IAA14 mRNA expression data via one such damped
oscillation. However, the oscillations in expression depend on a slower ac-
cumulation of GH3 protein in response to auxin relative to that of LAX3,
which, since GH3 is a primary auxin response gene and LAX3 is at least a
secondary response gene may be biologically unrealistic. Experimental data
relating to the GH3 conjugation model is currently limited. Useful data to
test the model further would include qRT-PCR following auxin treatment
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of the GH3s which are involved in auxin conjugation, and LAX3 mRNA
expression data in plants missing one or more functional GH3s. If GH3 has
a role in reducing cellular auxin post-treatment it is expected that auxin
induced expression will remain higher for longer in mutant plants when
compared to wild type. It may be necessary to create mutants missing mul-
tiple GH3s to observe any effect due to genetic redundancy. Another line
of investigation is to look at the long term behaviour of DII-VENUS in gh3
mutant plants. Here it would be expected that the recovery of DII-VENUS
over time following its initial degradation post-auxin treatment would occur
more slowly in the mutants.
Though the GH3 based auxin homeostasis model requires experimental
validation it seems likely that the degradation of auxin in the experimental
medium is unable to account fully for the apparent removal of excess auxin
from the cell, and that a combination of decay in the medium and some
as yet unconfirmed endogenous homeostasis mechanism acts to produce a
transient genetic auxin response post- exogenous treatment.
7.3 The role of ARF19 in LAX3 expression
The question of how ARF19 may act as a repressor of LAX3 was addressed
in Chapter 4. Firstly, several parameters determining the behaviour of
ARF19 were identified that, when the values used were sufficiently different
relative to the equivalent values for ARF7, allowed it to repress transcription
of target genes. These included the strong binding of ARF19 to IAA14, so
that though the total level of ARF19 is increased following auxin treatment,
its strong affinity with IAA14 means a large proportion of this is bound
with the Aux/IAA and so acts as a transcriptional repressor. Some work
has been done to establish that IAA14 binds with both ARF7 and ARF19
in a yeast two hybrid system (Fukaki et al. 2005), but further experiments
are needed to establish the relative importance of these interactions in the
plant. For example, how does mutating domains III and IV of ARF19 affect
gene expression? These domains are thought to facilitate dimerisation of
ARF19 with Aux/IAAs and so blocking this interaction ought to prevent
formation of repressors, and an increase in LAX3 expression relative to wild
type may give evidence of the importance of the interaction between IAA14
and ARF19 in repressing LAX3. Another important parameter determining
the relative expression of target genes in the wild type and arf19 mutant
simulations is the relative power of ARF19 to activate transcription relative
to that of ARF7. A low value for this parameter means that regardless
of whether or not an Aux/IAA is bound to it, if ARF19 is bound to a
gene promoter transcription is very unlikely to be activated. In this way
an increased pool of ARF19 will act to repress transcription by occupying
binding sites which may otherwise be occupied by ARF19. An experiment
to test this would be to observe the affect of replacing domain II in ARF19
with that of ARF7, or otherwise mutating it to remove its function. If
this domain determines the activatory (or repressive) power of ARF19, and
is more effective in ARF7, replacing it with the ARF7 domain II should
increase expression of target genes.
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The remainder of Chapter 4 presents a number of hypothetical gene
regulatory networks for the ARF19 mediated repression of LAX3, and the
ability of each to fit the available data is tested using the parameter fitting
algorithm. In general terms, the best models appear to need an unidentified
transcription factor, activated by ARF19, binding to the LAX3 promoter
and repressing its transcription, in addition to a decay over time in the
auxin signal. Some models with additional regulatory components may im-
prove the fit of model to data, but it is unclear whether this is due to a
closer reflection of the biological reality or simply a result of adding more
components and parameters. The use of some method to stastically com-
pare the goodness of fit of the different models (e.g. Akaike information
criterion) would help in model selection. Despite differences between regu-
latory models, a common prediction is the relatively flat time course profile
of the protein repressing LAX3 (whether this is an ARF19 activated gene
or ARF19 itself), possibly due to slow turnover of the protein, low respon-
siveness to auxin, or a combination of the two. This observation then leads
to the possibility that the auxin responsiveness of the LAX3 repressor may
not be required at all to obtain the observed wild type expression profile of
LAX3. The hypothesis can be tested using the model by fixing a constant
level of ARF19, rather than having it induced by auxin, and experimentally
by having ARF19 expressed constitutively in an arf19 mutant background,
though there may be confounding effects from ARF19 being expressed in
this way. A follow on question then is, if ARF19 does not necessarily need
to be auxin inducible to mimic wild type expression of LAX3, is the up-
regulation of ARF19 by auxin important in the normal expression of other
genes? Additionally, what is the biological role of ARF19 mediated re-
pression of LAX3? One possibility is that it helps spatially restrict LAX3
expression only to cells where it is required, a hypothesis that may be tested
in future using the multicellular modelling framework developed in Chapters
5 and 6.
7.4 Multiscale Model and Ongoing Challenges
Simulating the diffusion of auxin from a primordium source cell in the per-
icycle throughout a root cross-section using the multicellular framework
described in Chapter 5 gives predictions for the cellular auxin distribution
that may be present in a living root. A key parameter affecting this distri-
bution is the rate of intracellular auxin turnover, with a low rate resulting
in smaller relative differences between cells, and a high rate producing much
larger relative differences in auxin concentrations between cells. In the lat-
ter case the greater difference in auxin signal between adjacent cells in the
cortical cell layer means that any switch-like response of LAX3 to auxin
would need to be much less finely tuned than for a low intracellular auxin
turnover rate. The intracellular auxin turnover rate also affects the power
of LAX3 to amplify the relative level of auxin within cells, with a high
turnover rate resulting in a much greater fold-change increase in intracellu-
lar auxin concentration post-LAX3 expression than that seen in the model
with a low auxin turnover rate. This is important since if the extra auxin
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in cells due to LAX3 is required to switch on the expression of CWREs, a
larger difference in cellular auxin pre and post-LAX3 expression will help
to further focus the auxin in the local region only into those specific cells
expressing LAX3.
A key problem with the model with a high auxin turnover rate is that the
difference in auxin concentration between the primordium source cell and
in the cortical cells nearest to it varies by around two orders of magnitude,
so that if auxin in the source cell is around 1 µM , the maximum auxin in
the cortex is around 1 pM , which may not be enough to trigger an auxin
response. This relative difference is partly reduced by including apoplastic
movement of auxin in the model, but this transport route may in reality be
blocked by the presence of the Casparian strip in the endodermis. Further
investigation of lateral root emergence in mutants defective in Casparian
strip formation may help determine the relative importance of this pathway.
Adding PIN transporters directing auxin from pericycle to endodermis also
reduces the relative auxin difference between pericycle and cortex, and so
better determining the usual configuration of PINs in the radial cross-section
using either existing or new images will help produce a more realistic model.
In particular, this should include modelling the individual cells and PIN and
auxin distribution within the stele, for which data is available suggesting
that auxin is directed by PINs towards opposing xylem poles (Bishopp et al.
2011), which may help reinforce the maxima in primordia in the pericycle.
Finally, it is always possible that another mechanism, such as diffusion
through plasmodesmata, which would enable movement of auxin between
cells without traversing cell walls, may allow greater movement of auxin
from the primordium source to the overlying cortical cells, and this should
be considered in future models.
In Chapter 6, the asymmetry in cortical auxin distribution relative to
a pericycle auxin source is used in conjunction with switch-like expression
of tfX and LAX3 to produce very strong expression of LAX3 in only the
two cells nearest the primordium, matching the experimentally observed
expression pattern. The positive feedback on auxin in these two cells from
LAX3 active transport reinforces the spatial expression further, and in-
creases auxin in these two cells sufficiently so that the CWRE polygalactur-
onase (PG), which is modelled as a tertiary auxin response gene, is eventu-
ally expressed. The high auxin threshold required for the switching on of
PG ensures that if LAX3 is removed from the model, as when simulating
the lax3 mutant, PG expression is all but removed, matching experimental
observation. Furthermore, in the wild type simulation, even if the auxin
signal in the primordium is greatly increased so that LAX3 is switched on
in more than two cells, the expression of PG is still restricted only to the
two cells nearest the primordium.
In addition to matching the observed spatial expression patterns of PG
and LAX3, the model also gives predictions for the spatial distribution of
IAA14 and DII-VENUS protein in response to a simulated auxin source
in the primordium. A key experiment then is to obtain and quantify DII-
VENUS data for root cross-sections at various stages during primordia de-
velopment and emergence and compare with model predictions. One diffi-
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culty that will arise from this highlights a limitation of the model, specifi-
cally that over the full time scale of emergence (30 to 40 hours) the model
tissue strucure remains static, while over the same time period the lat-
eral root primordium undergoes major cell division and growth, with corre-
spondingly large changes to the overlying tissue structure as the new root
emerges. However, the data and modelling suggests that the spatial distri-
bution of both auxin and DII-VENUS should respond relatively quickly to
the introduction of the primordium auxin signal, so the static tissue is still
a useful comparison with data for the early stages of emergence.
Adding cell division and growth to the tissue structure of the model
presents a significant technical challenge. Currently both processes can be
modelled using the OpenAlea framework, but must be uncoupled from the
ODEs governing gene expression and auxin transport, so that the ODE
model is run for a time step, the results of which can be used as a decision
to divide cells according to some defined rule, and then the cells of the tissue
are able to grow according to another set of rules, after which the state of the
tissue at that time is used as the initial condiditions to run the ODE model
for another time step, and so on. Though there are numerous cell divisions
occuring within the primordium during development and emergence, these
divisions are possibly less important to the question of emergence than the
overall growth of the primordium itself, and so the growth of the primodium
could initially be modelled as a single cell. However, the more cell divisions
occur, and the larger the primordia gets, the more there will in reality be
spatial distributions of model components such as auxin within it, so this
approach would only be effective up to a point. Defining exactly how the
primordia will grow will also be a challenge, and will need to incorporate
rules to define both the direction of growth and the change in shape driven
by cell divisions. An initial approach may be to evolve the spatial cellular
structure over a series of pre-determined ‘snapshots’ of developmental steps
with the concentrations in each cell of model components at the end of each
time step passed to the corresponding cell at the beginning of the following
time step. Confocal images of a single emerging primordium over the full
time scale of emergence could be used to determine the change in cellular
structure over time. Though such a model could predict the expected auxin
distribution and spatial expression pattern of key genes over time for a
changing cellular structure, the growth and emergence of the primordium
would be pre-determined, with no feedback on growth from auxin regulated
gene expression.
The obvious source of feedback from the existing model to the ability of
the primordium to emerge is the LAX3 dependent expression of PG in the
cortex. Polygalacturonases promote the degradation of pectin, reducing ad-
hesion between adjacent cell walls and allowing cell separation (Swain et al.
2011). The expression of PG in the specific cortical cells over the growing
primordium, in addition to the forces generated from primordium growth
may be what allows smooth emergence of new lateral roots. Including this
feedback in the model, however, is not straightforward and would require
the introduction of cell wall mechanics in addition to the programming
challenges presented by the inclusion of growth and cell division mentioned
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above. In addition to regulation of cell separation from PG, such a model
would also need to take into account differential expansion and relaxation
of cell walls due to the forces generated by a growing primordium, possibly
regulated by the expression of other cell wall remodelling enzymes. Fur-
thermore, the model framework would also need to address the problem
of a change in topology of the tissue structure over time as the growing
primordium moves between cells in overlying cell layers. This will require
rules as to how and when separation occurs. For example, is cell separation
modelled by the addition of a new spatial compartment representing a space
between cells, or does the number of compartments remain the same, with
the cell separation and emergence modelled solely by movement or addition
of vertices to the tissue structure?
The current model makes the assumption that since the cellular struc-
ture is largely maintained in the direction of root growth, the 2-D cross
section used is a reasonable approximation for the radial spread of auxin in
the root. Obviously to test this assumption and other questions a true 3-D
root simulation is desirable. Additional work will be needed for the soft-
ware framework to be able to perform the necessary calculations to solve
the model in 3-D, and in addition there will be challenges to overcome in
order to produce the initial cellular structure used by the model. Finally,
different tools will be needed to view the model output in 3-D than are cur-
rently used. A more direct way to simulate the spread of auxin and LAX3
in the direction of lateral root growth is to use the existing model with a
2-D cross section of the root in this plane.
Though several challenges remain to be overcome, the multicellular
model developed here represents an important first step in creating a more
complete model of lateral root emergence that includes the regulation by
auxin of genes that feed back on the mechanical processes governing growth
and development. The current model and software framework developed
may also be used to address additional questions relating to gene regulation
and auxin transport during lateral root emergence. In particular the model
can be used to simulate the spread of auxin and gene expression in other
plant species, such as cereals, with a more complex cellular root structure,
and in which the cortex presents a more significant barrier to emergence
than in Arabidopsis.
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